An Investigation of the Nature of the Neural and Local Mechanisms That Regulate Vascular Functioning by Barfaraz, Alireza
AN INVESTIGATION OF THE NATURE OF THE NEURAL AND LOCAL 
MECHANISMS THAT REGULATE VASCULAR FUNCTIONING
A thesis submitted in candidature for the degree of Doctor o f Philosophy to 
the Faculty of Medicine of the University of Glasgow
by
ALIREZA BARFARAZ 
DEPARTMENT OF PHARMACOLOGY
1994
ProQuest Number: 11007887
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 11007887
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
0 ^ )
CONTENTS
CONTENTS.................................................I-VI11
ACKNOWLEDGEMENTS........................................IX
PUBLICATIONS............................................ X-XI
SUMMARY.................................................. XII-XX
ABBREVIATIONS............................................XXI-XXV
INTRODUCTION................................................ 1-38
THE CARDIOVASCULAR SYSTEM........................... 1
The function of cardiovascular system........1
The organisation of the cardiovascular
system......................................... 1
HEART.................................................. 2
BLOOD VESSELS.........................................3
Structure of blood vessels.................... 4
Arteries.........................................4
Capillaries..................................... 6
Veins............................................ 6
History of sympathetic nerves................. 6
Adrenoceptors................................... 8
Adenosine triphosphate (ATP).................. 9
Evidences of ATP as a neurotransmitter....... 10
ATP cotransmission.............................. 11
Vascular smooth muscle contraction............ 11
The effect of vasoconstrictor agents causing
vascular contraction..........................1 2
Vasodilator agents causing vascular
relaxation..................................... 13
The role of the vascular endothelium and its
endogenous vasoactive agents.................14
Endogenous NO and its vasodilator activity... 15
Endogenous vasoconstrictor agents............. 16
Angiotensin and its vasoconstrictor activity.16 
The general mechanisms of action of vasodilator
drugs...........................................17
BLOOD.................................................. 18
Haemostasis and prevention of bleeding....... 18
LUNGS.................................................. 19
The pulmonary angiotensin converting enzyme..24
Autacoids........................................ 25
Pulmonary chemoreceptors as a storage site for
5-HT............................................ 25
AUTONOMIC NERVOUS SYSTEM............................ 27
Neuromodulation..................................28
Cotransmission...................................29
HYPERTENSION..........................................3 0
The role of major physiological control systems 
in the maintenance of the blood pressure...31
Pulmonary hypertens ion..........................32
Some drugs in the treatment of hypertension..33
5-HT IN THE PERIPHERAL TISSUES......................3 3
Various functions of 5-HT...................... 34
5-HT and its receptors..........................35
5-HT IN THE CENTRAL NERVOUS SYSTEM................. 3 6
Some important CNS functions of 5-HT..........37
THE AIMS OF THE STUDY...............................39-41
Pithed and anaesthetised rats................. 3 9
Lungs............................................. 40
II
Hindquarters..................................... 40
METHODS.....................................................42-50
Experimental rats..................................... 42
Krebs solution........................................ 42
Pithed rat preparation............................... 43
Adrenalectomy......................................... 44
Anaesthetised rat preparation....................... 44
Blood pressure measurement (Tail cuff method) 45
Lungs preparation..................................... 46
Hypoxic (14%02) gas preparation..................... 47
Hindquarters preparation............................. 47
Drugs...................................................48
Statistical analysis..................................49
Regression line analysis............................. 49
RESULTS.....................................................51-67
EFFECTS OF ELECTRICAL STIMULATION OF THE 
SYMPATHETIC OUTFLOW IN THE PITHED RAT USING 
THE SPINAL ELECTRODE AND THE EFFECTS OF DRUGS
ON THE RESPONSES PRODUCED.................... 51
Effects of electrical stimulation of the spinal
sympathetic outflow...........................51
Role of the adrenal medulla and effect of
propranolol.................................... 52
Effect of adrenalectomy........................ 53
Effect of alpha,beta methylene ATP
( a , B-mATP)..................................... 53
Effects of prazosin and yohimbine............. 54
Effect of captopril............................. 54
Effect of L-NAME................................. 55
Effect of L-arginine............................ 56
Effect of 5-hydroxytryptamine (5-HT)........... 56
THE EFFECTS OF DRUGS IN THE VASCULATURE OF THE
PERFUSED PULMONARY CIRCULATION OF THE RAT........57
Effects of Vasoconstrictors in the Perfused
Pulmonary Vasculature.........................57
Effects of phenylephrine (PE)............ 57
Effects of 5-hydroxytryptamine (5-HT)....57
Effects of potassium chloride (KC1)..... 58
Effects of noradrenaline (NA)............ 58
Effects of adrenaline (Adr)...............58
Effects of KC1 on 5-HT responses......... 59
Responses to PE in Wistar and Sprague Dawley
rats....................................... 59
Effects of Antagonists in the Perfused Pulmonary
Vasculature.................................... 60
Effects of ketanserin...................... 60
Effects of a combination of L-NAME, 
propranolol and yohimbine on pressor
responses to PE........................... 60
Effects of L-NAME.......................... 60
Effects of Flurbiprofen................... 61
Effects of hypoxia and propranolol.......61
Effects of Vasodilators in the Perfused Pulmonary
Vasculature.................................... 62
Effects of isoprenaline....................62
Effects of sodium nitroprusside (SNP)....62
THE EFFECTS OF DRUGS IN THE VASCULATURE OF THE
PERFUSED HINDQUARTERS CIRCULATION OF THE RAT_____ 63
Ill
Effects of Vasoconstrictors in the Vasculature
of the Perfused Hindquarters.............. 63
Effects of 5-HT............................ 63
Effects of PE...............................64
Effects of KC1............................. 64
Comparisons of the maximal pressor responses 
to KC1, 5-HT and PE in SHR and WKY
hindquarters vasculature................ 64
Effects of Antagonists in the Vasculature of the
Perfused Hindquarters........................ 65
Effects of L-NAME.............. 65
Effects of indomethacin................... 65
Effects of Vasodilators in the Vasculature of the
Perfused Hindquarters........................ 6 6
Effects of SNP..............................6 6
Effects of Carbachol.......................67
LIST OF FIGURES............................................. Ill
DISCUSSION...................................................146
General................................................ 146
Advantages of the pithed rat preparation...........146
Disadvantages of the pithed rat preparation....... 147
Studies in the pithed and anaesthetised rats...... 148
Perfused lungs preparations..........................169
Perfused hindquarters preparations..................179
BIBLIOGRAPHY................................................ 188
LIST OF FIGURES
1 -The structure of a blood vessel wall........... 6 8
2 -The renin-angiotensin system.................... 69
3 -The underlying mechanisms that modulate vascular
smooth muscle tone............................. 70
4 -Radiographs of pithed rats with pithing rod
electrodes in the vertebral canals
 Facing page 71-71
5 -Responses illustrated as increases in heart rate
and in blood pressure to the spinal nerve 
stimulation in the pithed rats............... 72
6 -Pressor responses to nerve stimulation in the
pithed rat...................................... 73
7 -Effect of adrenalectomy on pressor responses to
nerve stimulation in the pithed rat..........74
8 -Effect of propranolol on pressor responses to
nerve stimulation in the pithed rat..........75
9 -Effect of propranolol on pressor responses to
nerve stimulation in pithed rats with low and 
high basal blood pressures 7 6
10 -Effects of propranolol, adrenalectomy and prazosin,
on pressor responses to nerve stimulation in the 
pithed rat...................................... 77
11 -Effect of propranolol and adrenalectomy on dose-
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
IV
response curve to NA in the pithed rat...... 78
-Tachyphylaxis to pressor responses to or, 13-mATP, NA 
and nerve stimulation in the pithed rat
 Facing page 79-80
-Effect of prazosin on pressor responses to a
single dose of NA and nerve stimulation in the
pithed rat...................................... 81
-Effect of yohimbine on pressor responses to 
increasing doses of NA and to nerve 
stimulation in the pithed rat
 Facing page 82-82
-Effects of prazosin, yohimbine and guanethidine 
administered consecutively on pressor 
responses to nerve stimulation in the pithed
rat.............................................. 83
-Effects of captopril and prazosin administered 
consecutively on pressor responses to 
NA and nerve stimulation in the pithed rat..84 
-Effects of propranolol, captopril and prazosin, 
administered consecutively, on pressor 
responses to a single dose of NA and nerve
stimulation in the pithed rat................ 85
-Effect of L-NAME in blood pressure in the absence 
and presence of propranolol in pithed and 
anaesthetised rats
 Facing page 8 6 - 8 6
-Correlation between the resting blood pressure and 
the L-NAME-induced increase in blood pressure 
in the absence and presence of propranolol in
the pithed rats................................ 87
-Scattergrams between the resting blood pressure 
and the L-NAME-induced increase in blood 
pressure in the absence and presence of
propranolol in the anaesthetised rats....... 8 8
-Effect of L-NAME on pressor responses to nerve
stimulation in the pithed rat
 Facing page 89-89
-Effects of propranolol, L-NAME and 5-HT;
administered consecutively on pressor responses
to nerve stimulation in the pithed rat...... 90
-Effect of L-NAME on pressor responses to increasing 
doses of NA and to nerve stimulation in the
pithed rat........................ Facing page 91-91
-Effect of L-NAME on pressor responses to a
submaximal dose of 5-HT in the pithed rat...92 
-Effect of L-NAME on the pressor response to A, 13-
mATP in the pithed rat.........................93
-The effects of L-NAME and L-arginine administered 
consecutvely on the pressor responses to nerve 
stimulation and to NA in the pithed rats
 Facing page 94-95
-Effects of L-NAME and L-arginine on the pressor
responses to a submaximal dose of NA and to nerve
stimulation in the pithed rat
 Facing page 96-96
-Effect of L-NAME on pressor responses to increasing 
doses of 5-HT in the pithed rat
 Facing page 97-97
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
V
-Effect of L-NAME on pressor responses to increasing 
doses of 5-HT and nerve stimulation in the pithed
rat................................ Facing page 98-99
-Effect of L-NAME on the responses to 5-HT in the
anaesthetised rat.............................. 1 0 0
-Histograms of the effect of L-NAME on the triphasic 
responses to 5-HT in the anaesthetised rats.101 
-The apparatus used to perfuse Krebs-buffer
throughout the pulmonary circulation of the rat
lungs....................................... . . 1 0 2
-Pressor responses to cumulatively perfused and
singly perfused PE in the isolated, Krebs-buffer 
perfused pulmonary vasculature of the Wistar
rat.............................................. 103
-Effect of L-NAME on the pressor responses to 
cumulative concentrations of 5-HT in the 
isolated, Krebs-buffer perfused pulmonary
vasculature of the Wistar rat.................104
-Effect of L-NAME on the pressor responses to KC1 
in the isolated, Krebs-buffer perfused pulmonary
vasculature of the Wistar rat.................105
-Two types of pressor responses to NA and the
effect of propranolol, administered during the 
decline in the pressor response to NA, in the 
isolated, Krebs-buffer perfused pulmonary
vasculature of the Wistar rat.................106
-Effect of L-NAME at 12 ml min - 1  rate of perfusion 
on the pressor responses to a submaximal and a 
maximal concentration of adrenaline in the 
isolated, Krebs-buffer perfused pulmonary
vasculature of the Wistar rat............ ....107
-Effect of KC1 on the concentration-response curve 
to 5-HT in the presence of L-NAME in the isolated 
Krebs-buffer perfused pulmonary vasculature of
the Wistar rat................................. 108
-Concentration-response curve to PE in the isolated 
Krebs-buffer perfused pulmonary vasculature of
Wistar and Sprague Dawley rats...............109
-Effect of ketanserin on the pressor responses to 5- 
HT, in. the isolated, Krebs-buffer perfused 
pulmonary vasculature of Sprague-Dawley rat
 Facing page 110-110
-Effect of a mixture of L-NAME, propranolol and
yohimbine on the concentration-response curve to 
PE in the isolated Krebs-buffer perfused
pulmonary vasculature of the Wistar rat Ill
-Effect of L-NAME on the pressor response to a
submaximal concentration of 5-HT in the isolated 
Krebs-buffer perfused pulmonary vasculature of
the Wistar rat................................. 112
-Effect of L-NAME on the concentration-response 
curve to 5-HT in the isolated, Krebs-buffer 
perfused pulmonary vasculature of the Wistar
rat..............................................113
-Effect of L-NAME on the concentration-response
curve to PE in the isolated Krebs-buffer perfused
pulmonary vasculature of the Wistar rat 114
-Effect of flurbiprofen on the concentration-
46
47
48
49
50
51
52
53
54
55
56
57
58
VI
response curve to KC1 in the isolated Krebs- 
buffer perfused pulmonary vasculature of the
Wistar rat...................................... 115
-Effect of flurbiprofen on the concentration-
response curve to PE in the isolated Krebs-buffer 
perfused pulmonary vasculature of the Wistar
rat.............................................. 116
-Effect of flurbiprofen on the pressor response to a 
submaximal concentration of 5-HT in the presence 
of L-NAME in the isolated Krebs-buffer perfused
pulmonary vasculature of the Wistar rat 117
-Effect of flurbiprofen on the pressor responses to 
NA in the isolated, Krebs-buffer perfused
pulmonary vasculature of the Wistar rat 118
-Effects of propranolol and flurbiprofen,
administered in sequence, on the concentration- 
response curves to adrenaline in the presence of 
a mixture of L-NAME and yohimbine in the isolated 
Krebs-buffer perfused pulmonary vasculature of
the Wistar rat..................................119
-Pressor responses to NA, gassed with either 9 5 %C>2 , 
or 14%02, in the isolated, Krebs-buffer perfused
pulmonary vasculature of the Wistar rat 12 0
-Concentration-response curves to NA at 14%C>2 and 
9 5 % 0 2  gassed-Krebs-buffer, in the isolated 
perfused pulmonary vasculature of the Wistar
rat.......................................... 1 2 1
-Effect of propranolol on the responses to NA,
gassed with 14%C>2, in the isolated, Krebs-buffer 
perfused pulmonary vasculature of the Wistar
rat.............................. Facing page 122-122
-Effect of propranolol on the concentration-response 
curve to NA in 14%02 gassed-Krebs-buffer, in the 
isolated, perfused pulmonary vasculature of the
Wistar rat.................................. 123
-Effect of L-NAME on the inhibitory concentration-
response curve to isoprenaline, perfused on the
pressor response to 5-HT, in the isolated Krebs- 
buffer perfused pulmonary vasculature of the
Wistar rat.................................. 124
-Inhibitory concentration-response curve to
isoprenaline, perfused on the pressor response to 
PE, in the isolated Krebs-buffer perfused
pulmonary vasculature of the Wistar rat .125
-Inhibitory concentration-response curve to
isoprenaline, perfused on the pressor response to 
KC1, in the isolated Krebs buffer perfused
pulmonary vasculature of the Wistar rat .126
-Inhibitory concentration-response curve to SNP, 
perfused on the pressor response to 5-HT, in the 
presence of L-NAME in the isolated Krebs-buffer 
perfused pulmonary vasculature of the Wistar
rat.......................................... 127
-Effect of L-NAME on the inhibitory concentration-
response curve to SNP, perfused on the pressor 
response to PE, in the isolated Krebs-buffer 
perfused pulmonary vasculature of the Wistar 
rat.............................................. 128
VII
59 -Effect of L-NAME on the inhitory concentration-
response curve to SNP, perfused on the pressor 
response to KCl, in the isolated Krebs-buffer 
perfused pulmonary vasculature of the Wistar 
rat..............................................129
60 -Responses to SNP in the absence and presence of
Flurbiprofen in the isolated, Krebs-buffer 
perfused pulmonary vasculature of the Wistar 
rat..............................................13 0
61 -Pressor responses to 5-HT, in the isolated, Krebs-
buffer perfused hindquarters vasculature of the 
Wistar rat......................................131
62 -Concentration-response curves to the pressor effect
of 5-HT and to the inhibitory effect of SNP on 
submaximal responses to 5-HT in the isolated, 
Krebs-buffer perfused hindquarters vasculature of 
the Wistar rat................. Facing page 132-132
63 -Pressor responses to 5-HT on the ongoing pressor
response to PE, in the isolated, Krebs-buffer 
perfused hindquarters vasculature of the Wistar 
rats............................................ 13 3
64 -Concentration-response curves to the pressor effect
of PE and to the inhibitory effect of SNP on 
submaximal responses to PE in the isolated, 
Krebs-buffer perfused hindquarters vasculature of 
the Wistar rats................ Facing page 134-134
65 -Pressor responses to PE, in the isolated, Krebs-
buffer perfused hindquarters vasculature of the 
Wistar rat......................................135
6 6  -Pressor responses to KCl, in the isolated, Krebs-
buffer perfused hindquarters vasculature of the 
Wistar rat......................................13 6
67 -Concentration-response curves to the pressor
effect of KCl and to the inhibitory effect of SNP 
on submaximal responses to KCl in the isolated, 
Krebs-buffer perfused hindquarters vasculature of 
the Wistar rats................ Facing page 137-137
6 8  -Blood pressures in SHR and WKY rats.........138
69 -Concentration-response curves to PE, 5-HT and KCl,
administered in sequence in the isolated, Krebs- 
buffer perfused hindquarters vasculature of SHR
and WKY control rats....................... 139
70 -Concentration-responses to PE and 5-HT in the
isolated, Krebs-buffer perfused hindquarters 
vasculature of SHR rat.....................140
71 -Comparisons of the maximal pressor responses to PE,
5-HT and KCl in the isolated, Krebs-buffer 
perfused hindquarters vasculature of SHR and WKY 
control rats................................ 141
72 -Effect of L-NAME on the concentration-response
curve to 5-HT in the isolated, Krebs-buffer 
perfused hindquarters vasculature of the Wistar 
rats......................................... 142
73 -Effect of indomethacin on the concentration-
response curve to 5-HT in the isolated, Krebs- 
buffer perfused hindquarters vasculature of the
Wistar rats................................. 143
74 -Inhibitory concentration-response curves to SNP in
VIII
the isolated, Krebs-buffer perfused hindquarters
vasculature of SHR and WKY control rats 144
75 -Inhibitory concentration-response curves to
carbachol in the isolated, Krebs-buffer perfused 
hindquarters vasculature of SHR and WKY control 
rats............................................. 145
IX
ACKNOWLEDGEMENTS
I would like to express my thanks to the Head of the Department, Professor 
T.W . Stone, for allowing me to do research and using the laboratory 
facillities in the Department o f Pharmacology.
My many thanks and gratitude to my supervisor and the Head of Division, 
Dr. D. Pollock, who I am indebted to for standing by me and spending 
numerous hours introducing various aspects of the project and explaining 
diffe rent mechanisms that regulate vascular functioning.
I would also appreciate this opportunity to thank all the members of the 
Department for helping me to carry out the research, especially the 
technicians who helped me in setting up the apparatus and preparations for 
the experiments.
I am also grateful to Professor A. Harvey of the Department of 
Pharmacology in the University of Strathclyde for sending me tw o  papers 
about the snake venoms and their antivenoms, based on the project that I 
had during my MSc. course in that University.
XPUBLICATIONS
- Barfaraz, A. & Pollock, D. (1991).
The effects of drugs and de-medullation on pressor responses to 
preganglionic nerve stimulation in the pithed rat.
Br. J. Pharmacol. (Proceedings Supplement); vol. 104, 97P.
- Shaw, A.M .; Barfaraz, A.R.; Elbishti, W.; Pollock, D. and McGrath, J.C. 
(1992a, Dec.).
The effect of L-Nw -Nitro Arginine Methyl Ester and sodium Nitroprusside on 
5-HT- and KCI-induced responses in the perfused lung and pulmonary- 
arteries o f the rat.
Br. J. Pharmacol.; 107(S): 406 P.
- Shaw, A.M .; Barkell, E.; Rourke, S.; Barfaraz, A.R.; Pollock, D. and 
McGrath, J.C. (1992b, Oct.).
A comparison of the effects of L-Nw -Nitro Arginine Methyl Ester and 
Flurbiprofen on responses to vasoconstrictors in the pulmonary circulation 
of the rat perfused lung.
Br. J. Pharmacol.; 107(S): 197 P
Other publications
- Barfaraz A. and Harvey A.L. (1994).
The use of the chick biventer cervicis preparation to assess the protective 
activ ity  of six international reference antivenoms on the neuromuscular 
effects o f snake venoms in vitro.
Toxicon; vol. 32, No. 3, PP 267-272.
XI
- Harvey, A.L.; Barfaraz, A.; Thomson, E.; Faiz, A.; Preston, S. and Harris, 
J.B. (1994).
Screening of snake venoms for neurotoxin and m yotoxic effects using 
simple in vitro preparations from rodents and chicks.
Toxicon; vol. 32, No. 3, PP 257-265.
XII
SUMMARY
1 . In the pithed rat, stimulation of the autonomic ou tflow  at different levels 
between C-] and L3  produced characteristic increases in blood pressure and 
heart rate. Stimulation between Cg and T-j and between T 2  and T4  
produced large increases in heart rate w ith  only small increases in blood 
pressure. Stimulation at Tg.g produced the largest increase in blood 
pressure and a large increase in heart rate.
2. Spinal nerve stimulation at Tg_g characteristically produced pressor 
responses during stimulation and a secondary, pressor response that 
persisted after stimulation ceased. These responses were frequency- 
dependent so that the response at 20 Hz (supramaximal voltage, 0 .4  ms 
pulse-width, 100 pulses) was larger than that at 2 Hz (supramaximal 
voltage, 0.4 ms pulse-width, 100 pulses).
3. The pressor response to stimulation at Tg_g to 2 Hz and 20 Hz probably 
resulted from stimulation of nerve fibres to blood vessels and also to the 
adrenal glands, which contributed both to the component o f the pressor 
response that occurred during stimulation and to the secondary component 
tha t persisted after stimulation ceased. This was indicated by experiments 
in which adrenalectomy reduced the firs t component o f the pressor 
response that occurred during stimulation at Tg.g and abolished the second 
component that persisted after stimulation.
4. The effect o f propranolol (2 mg kg"^) on both components o f the pressor 
response to spinal nerve stimulation at Tg_g was complex and dependent on 
the basal blood pressure o f the pithed rat. In most pithed rats, propranolol 
enhanced both components of the pressor response to nerve stimulation.
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This was most marked at 2 Hz and most obvious in the secondary post­
stimulation component, which probably resulted from adrenaline released 
from the adrenals.
5. In some experiments where the blood pressure was low (< 1 8 -2 2  mm 
Hg) propranolol did not enhance the pressor response to spinal nerve 
stimulation. This may have been because in these few  rats propranolol 
impaired cardiac output and as a result the ability o f the heart to pump 
blood through the constricted blood vessels diminished, so that despite 
nerve stimulation-induced peripheral vasoconstriction, blood pressure did 
not increase.
6 . ar,ft-methylene ATP (cr,£-mATP,2x0.05 and 5x0.1 mg kg“ ^) produced 
pressor responses that showed tachyphylaxis. There was no evidence that 
a,ft-mATP desensitized the pressor response to spinal nerve stimulation at
t 8-9-
7. Captopril inhibited pressor responses to nerve stimulation and to 
exogenous NA (9 /vg kg“ ^). This result suggests that angiotensin contributes 
to the pressor response to spinal nerve stimulation. An alternative 
explanation o f this effect is that bradykinin breakdown might be inhibited by 
captopril so that more nitric oxide (NO), released by bradykinin, might be 
available to act as a physiological antagonist o f NA.
8 . There was no evidence of a prazosin-resistant pressor response to spinal 
nerve stimulation at Tg.g in the pithed rat.
9. L-NAME (45 mg kg~^) increased the basal blood pressure in the 
anaesthetized rat and also, but to a lesser extent, in the pithed rat in the
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presence of propranolol (2 mg kg '^). There was little difference in the 
extent to which L-NAME increased the basal blood pressure in the 
anaesthetized and the pithed rats in the absence of propranolol. In pithed 
rats but not in anaesthetised rats, the increment in the basal blood pressure 
caused by L-NAME was proportional to the level of the basal blood 
pressure. It appears that endogenous NO was continuously produced in 
both anaesthetized and pithed rats and had a role in keeping the basal blood 
pressure low. The greater increase in the basal blood pressure produced by
-I
L-NAME (45 mg kg" ) in anaesthetized rats was probably due to the 
w ithdrawal of the inhibitory effect o f NO on the sympathetic tone, which 
was thereafter able to operate unopposed and raise the blood pressure. 
Such a mechanism would not occur in the pithed rat.
10. In most experiments L-NAME did not affect pressor responses to spinal 
nerve stimulation at Tg.g. This lack o f effect of L-NAME on pressor 
responses to spinal nerve stimulation might be due to the fact that all the
-j
experiments were performed in the presence of propranolol ( 2  mg kg 
unlike those of MacLean et al. (1994), who showed that L-NAME increased 
both components but especially the second component o f the pressor 
response to the spinal nerve stimulation. It may be that pressor responses 
to spinal nerve stimulation can be enhanced either by propranolol or L- 
NAME but not by both simultaneously, suggesting that activation of fc- 
adrenoceptors may be linked eventually to activation of NO synthase so that 
blockade of one step (eg. the S-adrenoceptor) in this pathway renders 
subsequent inhibition o f a later step (eg. NO synthase) irrelevant. An 
alternative explanation of the lack of effect of L-NAME on the pressor 
responses to spinal nerve stimulation in the presence of propranolol is that 
blockade of -adrenoceptors in the heart may have reduced cardiac output 
so that the ability of the heart to maintain an elevated blood pressure was
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impaired. Despite this, nerve stimulation-induced increases in blood pressure 
were enhanced by propranolol, probably as a result of blocking vascular &2 ~ 
adrenoceptors. However, further vasoconstriction due to inhibition o f the 
synthesis o f NO might not be reflected in a further increase in blood 
pressure if L-NAME-induced vasoconstriction caused increased afterload on 
the heart and further diminished cardiac output. Another factor to be 
considered is that when the blood pressure is low, perhaps because of a 
propranolol-induced reduction in cardiac output, shear stress-induced 
production of NO w ill also be low and so the opportunity for L-NAME to 
enhance basal blood pressure is reduced. In some experiments, L-NAME 
apparently did enhance the pressor response to spinal nerve stimulation but 
this was only after exogenous NA (2 mg k g '1) had inhibited this response. 
In this experiment, the apparent ability of L-NAME to potentiate the nerve- 
mediated pressor response may merely have been due to recovery from the 
inhibitory effect of NA.
11. L-NAME (45 mg kg"1) increased the tox ic ity  of a, fc-methylene ATP 
(0.05 mg kg"1) in pithed rats.
12. Intravenous bolus injections of NA (0.09, 2 and 15 //g kg“ ^ ) produced 
dose-related pressor responses that were unaffected by L-NAME(45 mgkg
-j
) in the propranolol ( 2  mg kg" 1 )-treated pithed rats.
-i
13. Intravenous bolus injections of 5-HT (6 , 12, 25 and 50 j jg  k g "1) 
produced dose-related pressor responses in the presence of propranolol ( 2  
mg kg"1) in pithed rats. In some rats, 5-HT produced a slight secondary 
vasodepressor response, which was most marked in pithed rats tha t had 
higher blood pressures (50-60 mm Hg"1). In propranolol-treated 
anaesthetised rats, 5-HT produced a triphasic response in blood pressure,
XVI
which consisted of an initial brief depressor component, an intermediate 
pressor component followed by a final, prolonged depressor component. L- 
NAME (45 mg kg '^) enhanced and prolonged the pressor responses to 5-HT
I
(6 , 12 and 25 //g k g '1) in the pithed rat and in the anaesthetised rat L- 
NAME also enhanced and prolonged the secondary pressor component to 5- 
HT and reduced but did not abolish the depressor components to 5-HT.
14. In the pithed rat, a single dose of 5-HT ( 6  //g kg '^) inhibited both 
components of the pressor response to spinal nerve stimulation at 2 Hz and 
20 Hz. This effect occurred in the presence of L-NAME (45 mg k g " ')  and
-j
propranolol ( 2  mg kg
15. The ability of L-NAME (45 mg kg"^) to prolong responses to 5-HT may 
have arisen because of diminished inactivation of 5-HT in the pulmonary 
circulation, where L-NAME has profound effects.
16. These results indicate that the pressor response to pre-ganglionic nerve 
stimulation in the pithed rat at Tg.g is very complex. They also identify 
some of the problems likely to be encountered in studying complex 
phenomena such as co-transmission at neuro-effector junctions in the 
vasculature of the pithed rat.
17. Rat isolated lungs were perfused through the pulmonary artery w ith 
Krebs-buffer (35 °C) at a rate of 5 ml m in '^ .
18. The responsiveness of the pulmonary circulation to vasoactive agents 
was investigated by administering each drug in the Krebs-buffer and 
perfusing it until an equilibrium response was obtained. In some experiments 
when an equilibrium response was obtained, drug administration was
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discontinued and the preparation allowed to recover before another 
concentration of the drug was administered. In contrast to these "single 
concentration" experiments, in other studies the drugs were administered 
cumulatively, w ith the response to each concentration being allowed to 
reach equilibrium before the next higher concentration was administered.
19. In the perfused pulmonary circulation the drugs examined included the 
fo llow ing vasopressor agents: adrenaline (Adr), 5-hydroxytryptamine (5-HT), 
noradrenaline (NA), phenylephrine (PE) and potassium chloride (KCl). The 
vasorelaxants included, isoprenaline (Isop) and sodium nitroprusside (SNP).
20. Adrenaline (0.1-100 //M), NA (0.1-100 //M) and PE (0.1-100 /vM), all 
produced small concentration-dependent pressor responses in the perfused 
lungs. Responses to 5-HT (0.1-1000 /jM) were especially small. In contrast, 
KCl (3-80 mM) produced large well-maintained pressor responses.
21. Pressor responses to 5-HT (0.1-1000 /vM), PE (0 .0 1 -1 0 //M) and KCl (30 
mM) were enhanced by L-NAME (400 /yM).
22. Pressor responses to NA (0.1-100 /yM) were enhanced by propranolol 
(10 v M) but were unaffected by flurbiprofen (2 //M).
23. Pressor responses to PE (0.01-10 //M) were enhanced by L-NAME (400 
//M ). The addition of propranolol (10 //M) produced no further enhancement.
24. The responses to PE (0.01-100 jjM) and to 5-HT (0.1-100 jjN\) in 
"single concentration" experiments, where each concentration was perfused 
until an equilibrium response was obtained, after which administration was 
discontinued and the preparation allowed to recover, were much larger than
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those obtained in experiments where cumulative concentration-response 
curves were obtained.
25. 5-HT (0.1-100 /yM) administered cumulatively produced very small 
pressor responses even at the high concentration (100 /yM). The addition of 
L-NAME (400 /yM) produced a slight increase in the basal perfusion pressure 
and also increased the size and rate of development of the pressor 
responses to 5-HT. Responses to  high concentrations were enhanced to a 
greater extent than those to lower concentrations. These results suggest 
tha t there is a basal release of NO in the pulmonary circulation and that 5- 
HT may also release NO which then acts as its physiological antagonist.
26. In the presence of L-NAME, pressor responses to 5-HT (10-100 /yM) 
were enhanced by prior administration of a submaximal concentration of KCl 
(40 mM).
27. Flurbiprofen (2 //M) produced a small increase in the basal perfusion 
pressure and potentiated the presssor response to 5-HT (20 //M) in the 
presence of L-NAME (400 //M), suggesting that endogenous prostaglandins 
(perhaps prostacyclin, PGI2 ) may act as a physiological antagonist o f 5-HT.
28. Ketanserin (1 nM) a selective 5 -HT2 -receptor antagonist had little or no 
effect on the basal perfusion pressure but inhibited pressor responses to 
increasing doses of 5-HT in the presence of L-NAME (400 /yM).
29. Isoprenaline (0.01-10 /yM) administered cumulatively produced a 
concentration-dependent vasorelaxation in perfused pulmonary vasculature 
that had been constricted w ith either a submaximal concentration o f 5-HT 
(50 /yM) or PE (100 //M). Since the vasorelaxant effect of isoprenaline was
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unaffected by L-NAME, it appears that this inhibitory action of isoprenaline 
does not involve the synthesis of NO.
30. Isoprenaline (0.1-100 /yM) was less effective in relaxing the pulmonary 
vasculature when it had been constricted w ith KCl (50 mM) than when it 
had been constricted w ith 5-HT (50 /yM) or PE (100 /yM).
31. SNP (0.1 nM-100 /yM) produced small concentration-dependent
vasodepressor responses in pulmonary vasculature that had been 
constricted w ith PE (50 /yM) or KCl (40 mM). L-NAME (400 /yM) potentiated 
the vasodepressor responses to SNP (0.1 nM-100 /yM) in preparations in 
which the vasculature had been constricted w ith PE (50 /yM) or KCl (40 
mM).
32. These results indicate that endogenous NO has an important role in the 
pulmonary circulation in attenuating pressor responses to vasoconstrictors 
and perhaps also in modifying the responses to vasodilators such as SNP.
33. The effects of vasoactive agents were investigated in the vasculature of 
the rat hindquarters perfused w ith Krebs-buffer (35°C, 5 ml m in '^).
34. The vasopressor agents; 5-HT, PE and KCl and the vasodepressor 
agents carbachol and SNP were perfused in Krebs-buffer and cumulative 
dose-response curves were obtained for each drug.
35. Pressor responses to 5-HT (0.01-100 j j M )  were apparently potentiated 
by L-NAME (400 /yM), but when comparison was made w ith  appropriate 
time-controls, which were not exposed to L-NAME, 5-HT induced pressor 
responses were found to be unaffected by L-NAME.
XX
36. Pressor responses to 5-HT (0.01-100 /yM) were also unaffected by 
indomethacin (10 //M).
37. SNP (0.001-100 //M) produced dose-related inhibition o f submaximal 
pressor responses to 5-HT (1 /yM), PE (10 /yM) and KCl (60 mM).
38. SNP (0.001-100 //M) were more effective in inhibiting a standard 
submaximal pressor response to PE (EC7 q = 10 /yM) in rat hindquarters from 
W istar rats than in hindquarters from Spontaneously hypertensive rats (SHR) 
or the W istar Kyoto controls (WKY).
39. Carbachol (0.001-100 /yM) produced complex effects when 
administered in combination w ith PE (10 /yM) which was used to raise the 
tone in the perfused hindquarters. A t low doses carbachol increased the 
perfusion pressure but at higher doses carbachol inhibited the tone in a 
dose-dependent manner.
40. During experiments in which dose-response curves to PE, 5-HT or KCl 
were repeated in the same hindquarters preparation, the baseline tone rose 
during the experiments so that there was a tendency for the maximum 
response to be increased in the second dose-response curve.
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Abbreviations Used in the Text and Figures
AC Adenylate cyclase
ACE Angiotensin converting enzyme
ACh Acetylcholine
ADP Adenosine diphosphate
Adr Adrenaline
AI Angiotensin I
All Angiotensin II
AIII Angiotensin III
AMP Adenosine monophosphate
5 'AMP 5 'Adenosine monophosphate
ANAPP3 Arylazido amino propionyl ATP
ANS Autonomic nervous system
AP Action potential
APUD Amino-precursor-uptake-decarboxylation
ATP Adenosine triphosphate
ATPase ATPase enzyme
AV-node Atrio-ventricular node
AV-shunts Arterio-venous shunts
a Alpha-adrenoceptor
a ,B-mATP Alpha,beta-methylene adenosine
triphosphate 
B 2 Bradykinin2 -receptor
J3 Beta-adrenoceptor
bBP Basal blood pressure
Bk Bradykinin
BP Blood pressure
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bPP Basal perfusion pressure
C Captopril
cl— 6 First to sixth cervical vertebrae
Ca2+ Calcium ion
[Ca2+]i Intracellular calcium concentration
CaCl 2 Calcium chloride
Carb Carbachol
cAMP Cyclic adenosine monophosphate
cGMP Cyclic guanosine monophosphate
CGRP Calcitonin gene related peptide
CCK Cholecystokinin
CNS Central nervous system
c o 2 Carbon dioxide
DAG Diacyl glycerol
DNA Deoxyribonucleic acid
e c 70 Effective concentration (70% of the 
population data)
EDCF Endothelium derived contracting factor
EDV End diastolic volume
Flur Flurbiprofen
5'GMP 5 'Guanosine monophosphate
EDRF Endothelium derived relaxing factor
GABA Y amino butyric acid
GC Guanylate cyclase
Gi Inhibitory G protein
GIT Gastrointestinal tract
GP G protein
GS Stimulatory G protein
GTP Guanosine triphosphate
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Gu Guanethidine
Hi H^receptor (Histamine)
H 2 ^-receptor (Histamine)
Hb Haemoglobin
HbC>2 Oxyhaemoglobin
5-HIAA 5-hydroxyindoleacetic acid
HR Heart rate
5-HT 5-Hydroxytryptamine
Hz Hertz
IP 3 Inositol trisphosphate
ip intraperitoneal
Isop Isoprenaline
i.u. kg ” 1 International unit per kilogram
iv Intravenous
K+ Potassium ion
KC1 Potassium Chloride
KH 2 PO 4 Potassium dihydrogen ortophosphate
L 1 - . 3 First to third lumbar vertebrae
L-arg L-arginine
LHRH Luteinising hormone releasing hormone
L-NAME L-Nw-Nitro-Arginine Methyl Ester
LSD Lysergic acid diethylamide
M Muscarinic receptor
MetHb Methaemoglobin
MgSC>4 .7 H 2 0  Hydrated magnesium sulphate
MLCK Myosin light-chain kinase
n Number of observations
N 2 Nitrogen gas
Na+ Sodium ion
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NA Noradrenaline
NaCl Sodium chloride
NaHCC>3 Sodium hydrogen carbonate
NANC Non-adrenergic non-cholinergic nerves
NO Nitric oxide
NPY Neuropeptide Y
NS Nerve stimulation of spinal sympathetic
outflow
O 2 Oxygen gas
02“ Superoxide anion
P Probability
Pi Pl-purinoceptor
P 2 P2-purinoceptor
P2t P 2 -t~purinoceptor
P2x P2x-purinoceptor
P2y P2y-purinoceptor
P2z P2z-purinoceptor
PA Pulmonary artery
PcQ'2 Partial pressure of C0 2
PDE Phosphodiesterase
PDGF Platelet derived growth factor
PE Phenylephrine
PGE 2 Prostagladin E 2
PGF2a Prostagladin F2a
PGI 2 Prostacyclin
PGs Prostaglandins
Pl-turnover Phosphatidyl inositol hydrolysis
PKC Protein kinase C
PI Pulses
XXV
pla 2 Phospholipase A 2
PLC Phospholipase C
P° 2 Partial pressure of 0 2
Pr Prazosin
Prop Propranolol
Ptd Ins (4,5) P 2 Phosphatidyl inositol (4,5) 
bisphosphate
R Correlation coefficient
Si Electrical stimulation of the spinal 
sympathetic outflow at 2 Hz
s 2 Electrical stimulation of the spinal 
sympathetic outflow at 2 0 Hz
SA-node Sino-atrial node
SDR Sprague Dawley rat
SEM Standard error of mean
SHR Spontaneously hypertensive rat
SNP Sodium nitroprusside
t 1 - 1 2 First to twelvth thoracic vertebrae
txa 2 Thromboxane A 2
VIP Vasoactive intestinal peptide
voc Voltage operated calcium ion channels
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1INTRODUCTION 
THE CARDIOVASCULAR SYSTEM 
The Function of Cardiovascular System
The cardiovascular system has several important functions, which include 
transport, communication and immunological protection. _ Many of the 
substances required for cellular activ ity and the waste products of 
metabolism are also transported in the blood stream. Some of these such as 
oxygen and carbon dioxide, are transported bound to the red blood 
corpuscles, whilst others, such as nutrients and ions, are transported in 
solution in the plasma. The cardiovascular system also distributes hormones 
and other regulatory molecules from their sites o f origin to remote target 
organs whose functioning is controlled by these humoral signals. The 
cardiovascular system also protects against microorganisms and toxins, 
whose presence trigger complex immune mechanisms involving 
lymphocytes and soluble antibodies that are distributed w ithin the 
circulatory system.
The Organisation of the Cardiovascular System
The cardiovascular system consists of the heart and blood vessels, which 
together w ith the lymphatic vessels, constitute the circulatory system. The 
heart is a four-chambered pump, that pushes the blood into the vessels, 
which form a closed network of tubes, through which the blood flows to all
2the organs of the body and then returns to the heart (Malseed, 1990). The 
blood vessels that carry blood away from the heart are the arteries, which 
branch successively, to form arterioles and ultimately capillaries, which in 
turn lead to venules and finally to veins, through which the blood returns to 
the heart.
THE HEART
Venous blood returns to the heart via the right atrium, from which it is 
pumped to the right ventricle, which pumps blood through the pulmonary 
artery to the lungs. Blood that has been oxygenated and partly depleted of 
carbon dioxide, returns from the lungs through the pulmonary vein to the 
left atrium, from which it is pumped to the left ventricle, which then pumps 
oxygenated blood to the entire body.
The functioning of the heart is regulated by the autonomic nervous system, 
which supplies both sympathetic and parasympathetic fibres, that regulate 
heart rate and cardiac output. In the absence of any neural influence the 
heart w ill continue to beat according to the rhythm determined by the sino­
atrial node (SA-node). Normally, the spontaneous rate o f depolarization of 
the SA-node is modified by the activity of the sympathetic and 
parasympathetic (vagus) nerves, which respectively release noradrenaline 
(NA), which increases the rate of firing of the SA-node, and acetylcholine 
(ACh), which hyperpolarizes the SA-node (Fozzard et al, 1986; Gravanis, 
1987; Guyton, 1951 and Mazzanti and De Felice, 1987). Sympathetic and 
parasympathetic fibres also innervate the atrio-ventricular node (AV-node), 
whose conduction rate is increased by sympathetic activ ity and decreased 
by parasympathetic activity. Sympathetic fibres also innervate the
3musculature of the atria and ventricles and activation of these nerves 
increases the force of contraction and decreases the duration of systole. 
Because the terminals of the functionally-opposed sympathetic and 
parasympathetic nerves at the SA-node are close together, transmitter 
released by one type of nerve can inhibit the release of the other so that 
these nerves not only regulate the functioning of the heart directly but also 
influences it indirectly by inhibiting the activ ity of the opposing nerve 
(Boyle, 1988).
The functioning of the heart is also regulated by an intrinsic non-neuronal 
mechanism, that involves stretching of the heart when the end diastolic 
volume (EDV) increases within the physiological range. There is a direct 
relationship between the EDV, the contraction strength and the stroke 
volume, both o f which increases when the heart muscle is stretched and 
the EDV increases. This important characteristic, which is known as the 
Frank-Starling Law of the heart, explains how the heart normally adjusts to 
an increase in the total peripheral resistance (Weatherall et. al., 1987).
The functioning of the heart is also influenced by hormones, such as the 
thyroid hormones (thyroxine and triiodothyronine), which increase the 
sensitivity of the beta-adrenoceptors in the heart to NA and to circulating 
adrenaline from the adrenal medulla (Hohl et al, 1989; Tsujimoto et al, 
1987; Tse et al, 1980).
BLOOD VESSELS
Blood vessels have characteristic anatomical features such as smooth 
muscle and endothelial cells (Fig-1 ). The vascular endothelium modulates
4the reactivity of the smooth muscle (Robertson and Rosen, 1978; 
Vanhoutte et al, 1986) by releasing vasoactve agents in response to various 
stimuli (Vanhoutte et al, 1986; Vanhoutte and Luscher, 1986; Greenberg 
and Diecke, 1988). The vascular smooth muscle in the systemic and 
pulmonary circulations are controlled by the sympathetic branch of the 
autonomic nervous system unlike many organs such as the heart and 
gastrointestinal tract (GIT) which are innervated by both branches of the 
autonomic nervous system. In mammals, including man, the density of the 
adrenergic nerves to blood vessels decreases w ith age (Frewin et al, 1971; 
Waterson et al, 1974; Gerke et al, 1975).
Structure of Blood Vessels
Arteries are divided into three types according to their diameters, structure 
and function:
a) large elastic arteries b) muscular arteries c) arterioles 
Arteries
Histologically all arteries have three distinctive layers: The intima in the 
luminal side of the blood vessels is composed of the endothelial cells, 
basement membrane and different amounts of connective tissues. The 
media is the middle layer which is composed of smooth muscle and finally 
the adventitia which is the outermost layer. These three layers are less 
easily seen as the diameter of the arteries reduces (Clark and Glagov, 1985; 
Rao et. al., 1983; Ross et. al., 1976-1977, 1977 and Moran, 1975).
5In both elastic and muscular arteries, the intima and the inner part of the 
media get nutrition from the vascular lumen by perfusion whereas the vasa 
vasorum is for nourishing the outer media and hence there is a nutritional 
boundary in the vascular media which is susceptible to damage by changes 
in the thickness of the intima, mural thrombosis, impaired oxygenation and 
obstruction o f the vasa vasorum (Castleman and Sm ithw ick, 1948; Gamble, 
1986; Haust, 1978).
A large proportion of the elastic arteries is the media consist of 
concentrically arranged, fenestrated layers o f elastic tissue and intervening 
smooth muscle cells. The large number of elastic layers in the media of 
elastic arteries enable them to absorb and transmit the pulsatile force of the 
left ventricular systole and maintain intra-arterial pressure during diastole, 
creating a relatively constant pressure and flow  of blood.
The muscular arteries have almost no elastic layers in their media and the 
intima of these arteries is thinner but similar in composition compared to the 
elastic arteries. The media of the muscular arteries is also thicker than the 
adventitia (Neufeld and Blieden, 1978).
In large blood vessels, because of the proportion of smooth muscle to 
connective tissue, it is harder for the neurotransmitters and vasoactive 
agents to reach their receptor sites in smooth muscle (Vanhoutte, 1978). 
Arterioles are the smallest arteries and in the smaller arterioles there are 
only one or tw o layers of smooth muscles. The adventitia consists mainly of 
collagen and elastic fibres.
6Capillaries
The intima is the major part of the capillaries and consists mainly of 
endothelium. A t the point of branching of a capillary from an arteriole, there 
is a precapillary sphincter to regulate blood flow  into the capillary.
Veins
Veins are different from arteries in that they have thinner walls and are less 
well demarcated into three structural layers when tw o blood vessels of 
similar size are compared (Hirsh et. al., 1986; Lie et. al., 1977; Smith and 
Geer, 1983; Strandness and Thiele, 1981). Veins have scanty elastic layers 
and fewer smooth muscle cells in their media. These are mainly separated 
by collagen fibres, arranged in both circular and longitudinal fashions. All 
veins have valves in their lumens except the vena cavae and the common 
iliac veins.
In veins, nerves usually penetrate into the media, whereas in most arteries 
they penetrate into the adventitia-media border (Vanhoutte and Luscher, 
1986). Vascular smooth muscle has been reviewed by (Furchgott, 1955; 
Bohr, 1964; Somlyo and Somlyo, 1968 and Gabella, 1981).
History of Sympathetic Nerves
The discovery of the communication between the nerve terminals and the 
effector cells goes back over a century ago when it was suggested by Du 
Bois Reymond in 1877 that a chemical mediator might be the biological link.
7Oliver and Schafer (1895) were among the first to show that extracts from 
the adrenal medulla can increase the arterial blood pressure. The possibility 
that the chemical agent might be the same in both cases was postulated by 
Elliott (1905). Some years later Langley (1910) demonstrated that 
sympathetic nerve stimulation could also increase the arterial blood 
pressure.
Loewi in 1921 concluded from his famous experiment on frog heart that a 
physiologically-active substance was released from the sympathetic nerves 
onto cardiac muscle and accelerated its pumping activ ity. He set up two 
frog hearts in series and the physiological solution from the first heart was 
allowed to come into contact w ith the second heart. When the sympathetic 
nerve to the first heart was stimulated its cardiac activ ity  accelerated and 
after a while the activity of the second heart was also increased. Therefore 
a chemical, released from the nerve terminals in the firs t heart, activated the 
first heart and also activated the second heart. He named this neuronally- 
released chemical 'acce leranstoff.
Barger and Dale (1910) showed that there is a great sim ilarity between the 
actions of noradrenaline and the effect of sympathetic nerve stimulation in 
the peripheral tissues of mammals. Cannon and Uridil (1921) named this 
active substance 'sympathin' after the sympathetic nerves from which it 
was released. The sympathetic innervation proved not to be exclusive for 
the cardiovascular system and other tissues were also found to be 
innervated by these important nerves. Finkleman in 1930 showed that 
sympathetic nerve stimulation of a piece of rabbit intestine brought about its 
relaxation and also the relaxation of the second piece of rabbit intestine 
which was in communicaton w ith the first one through perfusion. 
Adrenaline also produced a similar kind of relaxation in this tissue. It was
8not until 1946 when von Euler showed that the main sympathetic 
transm itter was noradrenaline and not adrenaline, since the concentration of 
noradrenaline was much higher than adrenaline in the sympathetically 
innervated tissues. Von Euler also demonstrated that sympathectomy led to 
a decrease in the concentration of noradrenaline and hence relaxation of 
sympathetically-innervated blood vessels. In Cannon's experiment the 
sympathin activ ity was very similar to noradrenaline (Cannon and 
Rosenbleuth, 1933).
Adrenoceptors
In early experiments adrenaline was found to produce a vasopressor effect 
which consisted of tw o components, a dominant pressor component, 
caused mainly by vasoconstriction and a secondary depressor component 
caused by vasodilatation, which was mostly covered by the pressor 
component. The vasodilatation was more pronounced when the first 
component was inhibited by ergot extracts (Dale, 1906). Ahlquist (1948) 
noted tha t the order of potency of six sympathomimetics were different in a 
variety of tissues and postulated that different receptors might exist and 
hence the concept of o- and ^-adrenoceptors on the effector tissues, o- 
Adrenoceptors were also found on the nerve terminals and these were 
classified as 0 2 -adrenoceptors. Activation of these presynaptic neuronal 0 2 - 
adrenoceptors inhibited the release of neurotransmitter(s) into the synaptic 
cleft (Langer, 1974; Starke, 1977; Westfall, 1977 and Vizi, 1980). Both 
kinds o f o-adrenoceptors (ie. a-\- and 0 2 -adrenoceptors) were shown to be 
present post-synaptically (Langer, 1974). The post-junctional 0 2 - 
adrenoceptors may not be homogeneously distributed and could vary in 
their location at synaptic and extrasynaptic sites (McGrath, 1982) and
9among species (Alabaster et al, 1986). There is now evidence that 
noradrenaline may not be the only neurotransmitter released from the 
sympathetic nerves (Hokfelt et al, 1986; Furness et al, 1989).It is possible 
that other substances such as adenosine triphosphate (ATP) may be 
released together w ith NA as a cotransm itter (Stjarne, 1989).
There is evidence that in the pithed rat, the vasopressor response to 
sympathetic nerve stimulation may not be mediated exclusively by NA since 
there was a component in the response that was resistant to a- 
adrenoceptor blockade (Flavahan et al, 1985). This non ar-adrenoceptor 
component could be reduced in size by a,ft-methylene ATP which is a stable 
analogue of ATP and is a desensitizing agent for purinoceptors. This 
phenomenon was only seen in the presence of an a-adrenoceptor antagonist 
(Flavahan et al, 1985; Grant et al, 1985). This observation suggests that 
purines may be involved in cotransmission in the sympathetic nerves in the 
rat and may contribute to the pressor responses resulting from activation of 
these nerves.
Adenosine triphosphate (ATP)
Paradoxically, ATP also has vasodilator activity in many vascular beds 
including the coronary circulation (Wolf and Berne, 1956; Moir and Downs, 
1973), skeletal muscles (Boyd and Forrester, 1968; Berne et al, 1975, 
Haddy and Scott, 1968), adipose tissue (Sollevi and Fredholm, 1981) and 
cerebral blood vessels (Rubio et al, 1975). In addition ATP was also 
demonstrated to be present in the perfusate of hypoxic hearts (Paddle and 
Burnstock, 1974).Holton and Holton (1954) related the vasodilator activity
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of ATP to nerves when it was released during antidromic activity from 
sensory nerves.
There are tw o main types of peripheral purine receptors: P-j- and ?2~ 
purinoceptors (Burnstock, 1978). P2 -purinoceptors are more sensitive to 
ATP and can be selectively blocked by arylazido amino propionyl ATP 
(ANAPP3) (Hogaboom et al, 1980) or desensitised by a,£-mATP (Kasakov 
and Burnstock, 1983). P2 -purinoceptors was further subdivided into P2x-' 
P2 y - ' p2 z" ar,d P2rPurinocePtors' latter being platelet specific and 
responding to ADP (Burns, 1988; Daly, 1982; Daly, 19851. Activation of 
p2x'PurinoceP1:ors causes vascular smooth muscle contraction (Burnstock 
and Warland, 1987a) and P2 y-purinoceptors causes vascular smooth 
muscle relaxation (Burnstock and Warland, 1987b). All P2 -purinoceptors 
have some role in regulating Ca^ + , K + and N a+ movements and 
prostaglandin (PG) formation (Burnstock, 1988).
Evidences for ATP as a neurotransmitter
I) There are biological mechanisms for the synthesis and storage of ATP in 
nerves (Burnstock; 1985, 1988).
II) There are post-synaptic receptors for ATP and activation of them by 
exogenous ATP produces complex physiological effects. For instance ATP 
causes relaxation of the intestine (Ambache and Aboo Zar, 1970; Dean and 
Downie, 1978) but causes a transient contraction in the bladder (Burnstock 
et al, 1972). These effects are similar to those obtained following 
stimulation of non-adrenergic non-cholinergic (NANC) nerves in these 
tissues.
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III) Efficient uptake and enzymic degradation mechanisms are present for 
the inactivation of ATP. ATPase which is the enzyme responsible for the 
degradation of ATP is located on the cell plasma membrane (Manery and 
Dryden, 1979) and is abundant in the rat heart and lungs (Baer and 
Drummond, 1968).
IV) ATP is released during nerve stimulation in tissues such as taeni coli and 
bladder and can be detected using the sensitive ATP-specific firefly luciferin-
Juciferinase assay (Burnstock et al, 1978a,b). However, this evidence does 
not conclusively prove that ATP is a neurotransmitter since most excitable 
tissues including muscle cells can release ATP.
ATP Cotransmission
In adrenergic nerves, NA is stored w ith ATP, chromogranin and dopamine £- 
hydroxylase (Smith, 1972). ATP was also shown to be released from 
adrenal chromaffin cells (Douglas and Poisner, 1966; Douglas, 1968; 
Stevens et al, 1972) and released w ith NA from adrenergic nerves (Su et al,
1971).
Vascular Smooth Muscle Contraction
Smooth muscle cells are contracted by many pharmacologically-active 
substances. The underlying cause of the contraction is a rise in the 
cytosolic concentration of C a^4* ions (Bolton, 1979; Jones, 1981; Karaki,
1989) which bind to calmodulin. The Ca^ + -calmodulin complex activates
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the myosin light-chain kinase (MLCK) which is an enzyme that 
phosphorylates one of the constituents of myosin (Kamm and Stull, 1985). 
The phosphorylated myosin is then capable o f interacting w ith its 
counterpart, actin, to initiate the smooth muscle contraction (Bulbring and 
Tomita, 1987; Bulbring et al, 1982). However, smooth muscle differs from 
cardiac and striated muscles in having calmodulin rather than troponin for 
binding C a ^+ ions and the consequent interaction of myosin w ith actin in 
the contractile mechanism.
The Effect of Vasoconstrictor Agents Causing Vascular Contraction
There are number of ways by which pharmacological agents can cause 
smooth muscle to contract by increasing cytosolic free C a ^+ ions [Ca^ + ]j:
a) Phosphatidyl inositol hydrolysis (Pl-turn over). Activation of receptors 
coupled to cell membrane phospholipase C (PLC) leads to the production of 
inositol trisphosphate (IP3 ) and diacyl glycerol (DAG) (Berridge and Irvine, 
1984; Abdel-Latif, 1986; Berridge, 1987; Litosch, 1990). IP3  subsequently 
acts on its specific receptors (Furuichi et al, 1989) on the intracellular stores 
of C a ^+ ions in the endoplasmic reticulum (Carafoli, 1987), to release 
C a ^+ ions into the cytosol (Michel, 1986; Berridge, 1987; Fink et al, 1988) 
and cause the contraction (Rasmussen, 1983).
b) Activation of receptor-operated channels which open and allow the influx
9 1
of C a ^ ^  ions and also cause depolarisation.
c) Depolarisation of the cell membrane allows further entry of Ca^"*” 
through the voltage-gated C a^+ ion channels. These voltage-gated Ca^ +
13
ion channels may also be facilitated by agents such as endothelin which is a 
potent vasoconstrictor released from the endothelium and, indirectly, by 
agonists acting on the or-adrenoceptors.
Vasodilator Agents Causing Vascular Relaxation
Vasodilator agents cause vascular relaxation by reducing [Ca^ + ]j or directly 
by acting on the contractile mechanisms (Furchgott, 1981; Furchgott, 
Vanhoutte, 1989; Ignarro, Kadouitz, 1985).
a) Inhibit C a ^+ entry through voltage-gated C a ^+ channels. 
Hyperpolarisation through increased permeability of intracellular ATP- 
sensitive K + channels (Nayler, 1988; Cook, 1988; Quast and Cook, 1989).
b) Increase the synthesis of cyclic adenosine monophosphate (cAMP) or 
cyclic guanosine monophosphate (cGMP) production, or they may inhibit the 
breakdown of these nucleotides by phosphodiesterases.
The vascular plasma membrane controls C a ^-1" flux mainly through a 
specific ATPase that extrudes C a^+ from the cell and Na + /Ca^ + 
exchange by which three Na+ ions are exchanged for a C a ^+ ion (Van 
Breemen and Saida, 1989). In addition, the cell membrane adenylate 
cyclase which is the enzyme that catalyses the biosynthesis of cAMP from 
ATP has an important role in regulating [Ca^ + ]j. cAMP activates protein 
kinase A which inhibits myosin light-chain kinase and hence cause 
relaxation. cAMP is also required for the pumping of cytosolic C a^+ out of 
the cell (Conti and Adelstein, 1981; Eggermont et al, 1988; Van Breemen 
and Saida, 1989). The inhibitory effect of cAMP on voltage operated
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calcium (VOC) ion channels has been confirmed by Ousterhout and 
Sperelakis (1984). Guanylate cyclase catalyses the synthesis of cGMP from 
GTP. This enzyme is activated by nitric oxide (NO) derived from the vascular 
endothelial cells or from nitrovasodilators that release NO intracellularly. 
Nitrovasodilators and endogenous NO act by stimulating soluble guanylate 
cyclase (Murad et al, 1988). cGMP in turn activates protein kinase G which 
inhibits the contraction.
The Role of the Vascular Endothelium and its Endogenous Vasoactive 
Agents
The endothelial cells lining the vasculature act as a passive barrier to plasma 
proteins and release various vasoactive substances which include 
endothelium-derived relaxing factor (EDRF) which is characterised as nitric 
oxide (NO) (Moncada et al, 1987; Furchgott, 1988; Ignarro et. al., 1987a,b; 
Palmer et. al., 1987), and prostacyclin (PGI2 ) and the vasoconstrictor 
endothelins. PGI2  and NO also have inhibitory effects on platelets and 
therefore reduce their tendency to aggregate and cause vascular thrombotic 
occlusion (Radomski et al, 1987). The endothelial cells also produce the 
important vasoconstrictor, thromboxane A 2  (TXA2 ) which opposes the 
vasodilator effect of prostacyclin. In addition, endothelial cells also release 
endothelium derived contracting factor (EDCF) in response to distension and 
anoxia (De May and Vanhoutte, 1983; Rubanyi and Vanhoutte, 1985) and 
stretch (Katusic et al, 1986).
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Endogenous NO and its Vasodilator Activity
Many vasodilator substances such as acetylcholine (ACh), bradykinin (Bk), 
5-hydroxytryptam ine (5-HT) and histamine act through the release, via a 
Ca^ + -dependent mechanism, of vascular endothelial NO, which mediates 
the vascular relaxation (Furchgott and Vanhoutte, 1989). Vasopressin 
causes endothelium-dependent relaxation of basilar arteries but causes 
vasoconstriction in systemic blood vessels (Katusic et al, 1984). Various 
receptors are located on the endothelial cell membrane and the mediators 
which act on these receptors activate the Pl-mechanism and hence cause 
an increase in the production of IP3  and thus elevate intracellular C a ^4- 
ions. The amino acid L-arginine is the precursor for NO biosynthesis which 
is catalyzed by the enzyme NO synthase (Ignarro et al, 1987a,b; Collier and 
Vallance, 1989; Palmer et al, 1988). The released endothelial NO passes 
through the cell membrane and activates the smooth muscle guanylate 
cyclase. The consequent increase in the cGMP production causes a series 
of protein phosphorylations associated w ith reduced release of C a^4- ions 
from endoplasmic reticulum or reduced permeability to extracellar C a ^4- 
ions and consequently causes smooth muscle relaxation (Moncada et. al., 
1991).
NO has also been suggested to act as a mediator of cyto tox ic ity  in 
macrophages (Moncada et al, 1991; Hibbs et al, 1990) and in the central 
nervous system (CNS) it has been associated w ith the short-term effects of 
excitatory amino acids and in their long-term effects on brain development, 
learning and memory (Moncada et al, 1991) and other tissues (Collier and 
Vallance, 1989).
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Endogenous Vasoconstrictor Agents
These are long-acting potent vasoconstrictor peptides which are released 
from vascular endothelial cells in response to chemical and physical stimuli. 
They were first discovered by Yanagisawa et al (1988) and later, it was 
realized that there is a family of endothelin peptides designated endothelin 
1, 2 and 3. These were identified by analyzing human genomic DNA which 
revealed the existence of distinct loci for each endothelin subtype (Inoue et 
al, 1989). There are many endogenous vasoconstrictor substances these 
include sympathomimetic amines (eg. NA, adrenaline), peptides such as 
angiotensin II, vasopressin, thromboxanes (eg. TX A 2 ) and platelet derived 
growth factor (PDGF). In some pathological states the superoxide anion 
(O2 ") may accummulate and cause the endothelium-dependent contraction 
in blood vessels such as the dog basilar artery (Vanhoutte and Katusic,
1988).
Generally vasoactive substances can affect the resistance of vascular beds 
and hence alter the blood flow  to and the distribution of blood within 
d ifferent organs. Such effects are involved in disorders such as angina, 
migraine and hypovolaemic shock.
Angiotensin and its Vasoconstrictor Activity
Angiotensin is an endogenous peptide and has a role in hypertension. 
Angiotensin II (All) is a potent vasoconstrictor that acts through the Pl- 
mechanism. It mainly affects cutaneous, splanchnic and renal blood flow  
w ith less effect on the cerebral and skelatal muscle blood flow. It also 
affects coronary blood flow  and increases the rate and force of contraction
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of the heart, secondary to the release of NA from the sympathetic nerve 
terminals (Khairallah, 1972; McCubbin, 1974). A ll has less effect on the 
venous system than cr-adrenoceptor agonists. It also releases aldosterone 
from the adrenal cortex. Its significance can be revealed by drug such as 
captopril, which inhibits the synthesis of A ll (Fig-2) and therefore has a 
profound effect on the cardiovascular system (Zhu et al, 1993; Valloton, 
1987; Katzung, 1989).
Angiotensin converting enzyme inhibitors (ACE inhibitors) such as captopril 
and enalapril, are vasodilators that exert their effects through inhibition of 
the conversion of Al to the potent vasoconstrictor A ll. These ACE inhibitors 
have their most powerful effect when the production of renin in the kidneys 
has been increased through sympathetic nerve activ ity (Laurence, Bennett, 
1992b).
The General Mechanisms of Action of Vasodilator Drugs
Vasodilator drugs exert their effects in different ways. Some cause 
vasodilatation indirectly by releasing an endogenous vasodilator such as NO. 
Others inhibit the release or effect of an endogenous vasoconstrictor. For 
example, vasodilators may disrupt the sympathetic pathway to the 
vasculature, either by acting in the CNS (eg. clonidine, guanfacine), the 
autonomic ganglia (eg. hexamethonium, trimetaphan), the sympathetic 
nerve terminal (eg. guanethidine, reserpine) or on cr-adrenoceptors 
(eg.prazosin, doxazosin) (Goodman et al, 1990; Brown, 1980).
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Other vasodilator agents including &2 -adrenoceptor agonists, increase the 
intracellular level of cAMP through activation of cell membrane adenylate 
cyclase (Fig-3).
There are many clinical uses of the vasodilator drugs which are used to 
lower the blood pressure by reducing the resistance of blood vessels to 
perfusion such as in hypertension and cardiac failure.
BLOOD
Blood, which can also be considered as a fluid tissue, circulates throughout 
the body in the blood vessels. It carries O2  and nutrients as well as other 
necessary substances to the tissues. Haemoglobin (Hb), which is the 
oxygen-carrying pigment of the erythrocytes, is capable of binding avidly to 
NO and preventing its vasodilator activ ity (Gillespie and Sheng, 1988). 
Whether or not this property of Hb is significant in vivo in regulating the 
effects of endogenous NO remains to be determined.
Haemostasis and Prevention of Bleeding
In the event of vascular injuries, haemostasis is the mechanism for the 
prevention of blood lose and ischaemia which can have fatal consequences. 
The three main phenomena of haemostasis are:
a) vascular contraction
b) adhesion, activation and aggregation of platelets
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b) fibrin clot formation (blood coagulation)
The latter tw o phenomena are mainly involved in the formation of a 
haemostatic plug which blocks the vascular damaged area and stops the 
lose of blood. Each of these processes has its own specific role related to 
the size of the blood vessels involved (arterial, venous or capillary).
LUNGS
The differential amounts of structural smooth muscles in the systemic and 
pulmonary vasculatures play a major role in the wide differences in the 
blood pressure and blood flow  in these tw o distinct blood circulatory 
systems that are well adapted to their functional purposes.
The pulmonary artery and arterioles are more distensible and have greater 
compliance than the systemic vessels. The wall thickness of the pulmonary 
vasculature is less than that of the systemic vasculature for arteries of 
similar diameter. The pulmonary arteries can accommodate about tw o  thirds 
of the right ventricular output after each heart beat. However, the 
distensibility of pulmonary veins and systemic veins are not very different. 
Therefore, the pulmonary vascular bed is a low-resistance, high-flow 
circulation (Bhattacharya, Staub, 1980; Nagasaka et al, 1984; Dock, 1946). 
Flow in the microcirculation is pulsatile because of the low arterial 
resistance (Lee, Du Bois, 1955).
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The systolic pressure in the right ventricle is about 25 mm Hg and the 
diastolic pressure is about 0 to 1 mm Hg. These values are approximately 
one fifth  of those for the left ventricle in a normal human (Ganong, 1989b).
The pulmonary arterial systolic blood pressure (25 mm Hg) matches the 
systolic pressure in the right ventricle. The pulmonary arterial diastolic blood 
pressure is only about 8  mm Hg, which is more than the diastolic pressure 
in the right ventricle. This is due to the steady fall in the pulmonary arterial 
blood pressure as blood flows through the capillaries after closure of the 
pulmonary valve. The mean pulmonary arterial pressure js  arround 15 mm 
Hg.
The mean pulmonary capillary pressure is approximately 7 mm Hg when 
measured by indirect methods and this low pressure helps in the gas 
exchange between these capillaries and the alveoli. The capillaries in the 
lungs are very close to each other and often in close contact w ith one 
another. This makes the pulmonary capillaries look like a 'sheet' rather than 
a separated network of fragile blood vessels in the lungs. The pulmonary 
capillaries are large and have multiple anastomoses.
The mean pressure in the left atrium and in the pulmonary veins is about 2 
mm Hg when measured in humans in a supine position (Taylor et al, 1989).
The chief function of this vital circulation is in the regulation of O2  supply to 
the blood circulation and hence to the all tissues of the body as well as 
removing CO2  from the blood. Water evaporation which reduces the 
temperature of the body also occurs while the blood is being conveyed in 
this fragile vasculature (Souhami and Moxham, 1990).
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The lungs also contain a fibrinolytic system that lyses blood clots in the 
vasculature. Filtration of small blood clots out o f the blood circulation is 
another function of the lungs. This occurs when some branches of the 
pulmonary arteries are obstructed by blood clots. As a result, there is an 
increase in the pulmonary arterial pressure, caused by a reflex sympathetic 
nerve-mediated response. In addition, there is a reflex, rapid, small increase 
in respiration (ie. tachypnea). This latter response is due to activation of 
vagally-innervated pulmonary deflation receptors close to the vessel walls. 
There is evidence that 5-HT, released from platelets at the site of vascular 
embolization, can sensitize these deflation receptors (Ganong, 1989c).
Vasoactive regulation plays an important part in the local regulation of blood 
flow  (Grover et al, 1984; Dawson, 1984). Blood Pq 2 anc  ^ certain metabolic 
by-products such as P c02 ' adenosine, lactate, K + and inorganic 
phosphate can alter blood flow.
Low local alveolar O2  causes a vasoconstriction in the pulmonary blood 
vessels in that area. This is the opposite of what happens in the systemic 
vasculature (ie. vasodilatation in response to hypoxia). This property of 
pulmonary vasculature to hypoxia diverts blood flow  to better ventilated 
regions of the lungs and hence cause more effective oxygenation of blood. 
This mechanism, which is not throughly understood, might be due to the 
release of a vasoconstrictor or a class of vasoconstrictors from the alveolar 
epithelial cells, hence causing an increase in the vascular resistance. Higher 
than usual levels of CO2  also reduce pH in the area and may cause 
pulmonary vasoconstriction.
There is a difference in the blood pressure between the top and lower 
portions of the lungs due to gravity or hydrostatic pressure arising from the
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weight of the blood itself. This pressure gradient, which is about 23 mm Hg 
in humans, may be another factor in keeping the pulmonary vasculature 
open in the lower part of the lungs and in maintaining a higher blood flow  
there. In addition, more blood vessels are recruited to allow increased blood 
flow  through the lungs when the cardiac output is increased (eg. in 
exercise) and then the pressure difference between the top and lower part 
of the lung is also reduced in proportion (West et al, 1964; West, 1977; 
Murray, Nadel, 1988a). The overall pulmonary blood pressure remains 
approximately the same although the cardiac output increases during heavy 
exercise in a normal subject. That is achieved through higher blood flow  in 
the already-contributing pulmonary capillaries and also through recruiting 
inactive capillaries (Murray, Nadel, 1988b).
Pulmonary oedema normally occurs when the blood pressure increases in 
the pulmonary vasculature and therefore causes a shift of intravascular fluid 
out into the pulmonary interstitial space. When the left atrial pressure 
increases due to a disorder then the blood pressure in the pulmonary veins 
and capillaries are increased, hence causing an increase in the pulmonary 
arterial pressure (Guyton and Lindsey, 1959; Guyton et al, 1979).
The pulmonary capillaries are more leaky to blood proteins than the 
systemic capillaries and this makes the osmotic pressure in the pulmonary 
interstitial space higher than the interstitial space in the systemic capillaries 
(Staub, 1974). The epithelial cells lining the alveolar walls are very thin and 
can easily be ruptured by a positive pulmonary interstitial pressure (ie. a 
pressure more than the atmospheric pressure) (Staub, 1983; Tucker et al, 
1973; Mason and Effros, 1983).
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In diseases such as pneumonia and during inhalation of noxious gases, such 
as sulphur dioxide and chlorine, the pulmonary capillary membranes are 
damaged and this accelerates the leakage of plasma fluid and proteins into 
the interstitial space. Pulmonary alveolar oedema occurs secondary to an 
excess in pulmonary interstitial oedema due to a rupture in the alveolar 
epithelial cells. This interferes with the gas exchange mechanism and leads 
to suffocation (Guyton and Lindsey, 1959). There is a slight net mean 
filtration pressure (ie. 1 mm Hg) in the lungs which filters pulmonary 
intravascular fluid into the interstitial space. The lymphatic system helps to 
remove the excessive fluid in the pulmonary interstitial space.
Under normal conditions the alveoli are kept dry even though there are 
openings in the alveolar lining epithelium and protein molecules as well as 
electrolytes and water can get through. The higher osmotic pressure in the 
pulmonary interstitial space can be the underlying force that attracts the 
protein molecules and fluids from the alveoli into the interstitial space 
(Effros, 1984).
Contrary to the heart, which is innervated by both branches of the 
autonomic nervous system, the pulmonary vasculature is only innervated by 
the sympathetic nerves (Nadel and Barnes, 1984). Stimulation of the 
cervical sympathetic ganglia where the sympathetic nerves innervating the 
pulmonary vasculature originate, increases the resistance of the blood 
vessels in the lungs and causes a reduction in blood flow . This pulmonary 
vasoconstriction is mediated through o-adrenoceptors but vasodilatation of 
this vascular bed can be produced by circulating adrenaline (Adr) released 
from the adrenal medulla. This effect of circulating adrenaline is mediated 
via ^ 2 -adrenoceptors (Su, Bevan, 1976).
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The pulmonary vasculature responds to a number of vasoactive substances. 
For example, pulmonary arterioles are constricted by NA, Adr., All, 
thromboxanes and PGF2 a ar*d are dilated by isoprenaline, ACh and PGI2- 
Pulmonary venules are constricted by 5-HT, histamine and Escherichia coli 
endotoxins (Murray and Nadel, 1986).
Various physiologically-active substances are synthesized, stored and 
released into the pulmonary blood circulation from the pulmonary arteries 
(eg. prostaglandins, histamine, kallikrein, etc.). Other substances are 
removed by the pulmonary veins (eg. prostaglandins, bradykinin, the 
adenine nucleotides (ATP, ADP, AMP and adenosine), 5-HT, NA, ACh (Said, 
1982; Furchgott, 1984). A number of other vasoactive hormones pass 
through the pulmonary vasculature w ithout being metabolized (eg. Adr., 
dopamine, oxytocin, vasopressin and All) (Ganong, 1989c).
Some nerve fibres and amine-precursor-uptake-decarboxylation (APUD) cells 
in the lungs contain biologically-active peptides (eg. vasoactive intestinal 
peptide (VIP), NO, substance P, opioid peptides, CCK and somatostatin). 
The exact functions of most of the peptides is still poorly understood but it 
appears that some of them such as VIP and NO may be involved as non- 
adrenergic non-cholinergic (NANC) bronchodilator mediators (Burnstock, 
1969).
The Pulmonary Angiotensin Converting Enzyme (ACE)
The lungs are also a reservoir for ACE. This enzyme is located in the luminal 
surface of the pulmonary capillaries (ie. on the surface o f endothelial cells 
and particularly in pits called caveolae). Its main function is the conversion
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of Al to All. The vasodilator, bradykinin which acts through releasing 
endogenous NO is also inactivated by ACE (Erdos et. al., 1978; Erdos,
1990).
Autacoids
Autacoids are physiologically-active, endogenous substances such as 
histamine, 5-HT, angiotensin, nitric oxide (NO), prostaglandins, endothelins, 
etc. (Laurence, Bennett, 1992a; Pohl, Kaas, 1994) which have their own 
effects in the lungs. Histamine is found in all body tissues, particularly in the 
mast cells and their related blood basophils. The lungs have the highest 
concentration of histamine. Histamine causes dilatation of blood vessels 
through endothelial H-|-receptor activation and release of NO to vascular 
smooth muscle causing vasodilatation. Histamine, increases also the 
permeability of venules, reduces the blood pressure and contracts most 
smooth muscles, including the bronchial smooth muscle of the lungs. 
Histamine also accelerates the heart rate via H2 -receptors (Dale and 
Foreman, 1989; Ganellin and Parsons, 1982; Hill, 1987 and Black et al,
1972).
Pulmonary Chemoreceptors as a Storage Site for 5-HT
Hormones or neurotransmitters such as 5-HT can also affect the pulmonary 
vascular bed. Chemoreceptors in the neuro-epithelial bodies w ithin the 
lungs, have stores of 5-HT. These neuro-epithelial bodies are located in the 
lower respiratory system (ie. small airways and alveoli). The specific 
physiological role of 5-HT in the lungs and in many other organs is unclear.
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Neuronal or chemical stimuli such as hypoxia releases 5-HT, which could 
have a role in regulating regional blood flow  in the lungs.
Normally, a large fraction of the pulmonary vasculature is open to perfusion 
but there are also some high resistance blood vessels that are closed. These 
can open and reduce the perfusion pressure perhaps in response to an 
increase in the production of NO. Nw -Nitro-L-Arginine Methyl Ester (L- 
NAME) is the inhibitor for the biosynthesis of NO (Ignarro, 1989; Palmer et. 
al., 1988).
Endogenous NO appears to have some regulatory effect on pressor 
responses to agonists such as 5-HT, phenylephrine (PE) and potassium 
chloride (KOI). This was suggested by experiments in which NO synthase 
inhibitors enhanced pressor responses to these agonists (Shaw et al, 
1992a,b,c).
The biosynthesis and release of NO in the pulmonary vasculature is likely to 
be regulated by many factors that are mostly unclear. NO may be produced 
and released by pressor agonists that cause vasoconstriction and hence 
increase intraluminal pressure and shear stress which also releases PGI2  
from the endothelial cells ( Bhagyalakshmi and Frango, 1989). However, the 
basal release of NO may be responsible for some or all of its inhibitory 
actions (Archer et al, 1989). In addition to these factors, endogenous NO 
may also be produced and released through receptor interactions of some 
agonists such as 5-HT, which acts on endothelial receptors (Houston, 
Vanhoutte, 1988; Martin et al, 1987).
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THE AUTONOMIC NERVOUS SYSTEM
The autonomic nervous system (ANS) consists o f the sympathetic and 
parasympathetic divisions. They both have their preganglionic cell bodies in 
the CNS and the postganglionic cell bodies in the autonomic ganglia. In 
addition, the enteric nervous system (Gershon, 1981) which innervates the 
intramural plexus of the gastrointestinal tract (GIT) is in close association 
w ith the sympathetic and parasympathetic divisions of the ANS (Furness 
and Costa, 1987).
The root of the sympathetic nerves originate in the thoracic and lumbar 
vertebral column. There are tw o paravertebral chains w ith some sparse 
midline ganglia. The postgangionic nerves leave these sympathetic ganglia 
and innervate tissues such as the cardiovascular system, the 
gastrointestinal tract, the bladder and the genitalia. The parasympathetic 
nerves leave CNS in cranial nerve ou tflow  (the vagus) and in the sacral 
outflow . The parasympathetic ganglia contrary to the sympathetic ganglia 
usually lie near to the target organs. Transmitters of the autonomic nervous 
system are mainly ACh and NA although cotransmission with other 
transmitters such as 5-HT, ATP, dopamine, u amino butyric acid (GABA) 
and several other neuropeptides are also possible.
The autonomic preganglionic neurons are cholinergic and release ACh which 
acts on the nicotinic cholinoceptors that are located on the cell bodies of 
the postganglionic nerves, although muscarinic cholinoceptors are also 
present and also play an excitatory role. Postganglionic sympathetic 
neurons are commonly noradrenergic though in some cases, as in the sweat 
glands, they are cholinergic. The postganglionic parasympathetic neurons 
are mainly cholinergic and release ACh which acts on the muscarinic
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cholinoceptors of tissues such as salivary glands to increase their secretions 
(Ganong, 1989a).
Neuromodulation
Neuromodulation in the autonomic nervous system is a common 
phenomenon and consists of the ability of chemical mediators to increase or 
decrease the amount of transmitter released (Kaczmarek and Levitan, 1987; 
Rand et al, 1987 and Burnstock, 1987).
When the action potential is propagated down the axon and reaches the 
nerve terminal, it releases neurotransmitters such as NA from the 
sympathetic nerve terminals. Neurotransmitters as well as having 
stimulatory effects on the effector cells, such as smooth muscles for NA 
and exocrine glands for ACh, can also inhibit their own release from the 
nerve terminal through a negative feedback mechanism, commonly called an 
auto-inhibitory feedback (Rand et al, 1982; Starke et al, 1989). The effect 
of neurotransmitters on their own nerve terminals are not always inhibitory 
but may also be excitatory in some occasions, though the inhibitory effect 
is usually predominent (Vizi, 1980; Starke et. al. 1989). The auto-inhibitory 
or excitatory feedback mechanisms involve the usual second messenger 
regulation and cell membrane ion channels. Many endogenous mediators 
such as 5-HT, prostaglandins (PGs), adrenaline, A ll, adenosine, histamine, 
dopamine, GABA, enkephalin, opioids and other peptides as well as the 
transmitters themselves exert presynaptic modulatory control over 
autonomic transm itter release (Rang and Dale, 1991).
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Cotransmission
Cotransmission involves the release of more than one transmitter from the 
same nerve (Hokfelt et. al. 1986; Furness et. al. 1989). Cotransmission may 
result in postsynaptic synergism between tw o  transmitters in some blood 
vessels. For example, there is a synergistic effect of neuropeptide Y (NPY) 
on the vasoconstrictor action of NA in addition to its ability to inhibit NA 
release (Edvinsson et al, 1987). The release of NPY may also be frequency 
dependent and more NPY might be released at higher frequencies (Stjarne,
1989). Another example is the NA/ATP cotransmission that occurs in some 
blood vessels and in the vas deferens. Whereas ATP has a fast depolarizing 
vasoconstrictor activity, NA produces more slowly developing response 
(Stjarne, 1989). The synergistic effect of ACh and Leuitenizing hormone 
releasing hormone (LHRH) in the sympathetic ganglia, where LHRH also has 
a depolarizing effect and is a cotransmitter w ith  ACh (Jan and Jan, 1983).
In cotransmission, one transmitter may be inactivated earlier than the other 
one(s). One cotransm itter may have its site of action further away from the 
site of release and hence have a delayed or a longer lasting effect. There 
are other NANC transmitters and cotransmitters in the peripheral nervous 
system (PNS) such as substance P and calcitonin gene related peptide 
(CGRP). Substance P in sympathetic ganglia has a slow depolarizing effect 
(Otsuka and Konishi, 1983) and in non-myelinated sensory neurons causes 
vasodilatation (Foreman, 1987). CGRP, another NANC transmitter, causes 
vascular leakage and neurogenic inflammation again in the non-myelinated 
sensory neurons (Saria et al, 1989).
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HYPERTENSION
Hypertension is a sustained increase in the blood pressure which if it is not 
properly treated would lead to other life threatening diseases such as 
coronary thrombosis (Eich et.al, 1966), renal failure (Guyton et. al., 1990) 
and strokes (Lund-Johanson and Omvik, 1990) (Kannel, 1974). There are 
some recognisable causes of hypertension such as phaeochromocytoma 
that can be cured. However, most types of hypertension are less easily 
treatable and are classified as essential hypertension.
The causes of elevated blood pressure are usually multifactorial (Rose, 
1986, Benowitz and Bourne, 1989) and include genetic and environmental 
factors. The severity and duration of hypertension also have serious 
consequences for the arterial wall.
In sustained hypertension, the increase in the peripheral vascular resistance 
can be caused by:
a) An increase in sympathetic neurotransmitter discharge
b) The presence of vasoconstrictor agents in the circulation
c) An increase in the level of sodium and thus in the extracellular fluid
d) An increase in the production and release of renin from the kidneys, 
hence more biosynthsis of the potent vasoconstrictor All
e) Excessive responsiveness to other key factors
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Or a combination of these factors.
In hypertension, there is also an elevation of the magnitude of the pressor 
response to a standard pressor stimulus. This could be the result of the 
vascular structural changes. Resistance vessels have walls that are thicker 
than normal in hypertension. This characteristic not only increases vascular 
resistance but also amplifies all pressor responses caused by vascular 
smooth muscle contraction (Folkow, 1982; Owen and Schwartz, 1983; 
Mulvany et. al., 1985).
In hypertension there may be an increased sensitivity to various agonists
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such as 5-HT or a deficiency in the plasma membrane binding of C a ^ 'r ions 
or an increased membrane permeability to Na + , K + and C a ^+ ions. There 
may also be a fault in the contractile process of vascular smooth muscle in 
the hypertension and this may be related to the Ca^ + binding protein that 
regulates contraction (Hatton et. al., 1987; McCarron, 1989). Generally, an 
increase in the cytosolic concentration of C a ^+ is associated with 
increased vascular tone in hypertension (Cohen, 1983).
The Role of Major Physiological Control Systems in the Maintenance of 
the Blood Prssure
Several physiological systems are involved in the control o f blood pressure: 
these are the sympathetic nervous system, the renin-angiotensin- 
aldosterone system, which has a crucial role in the control of N a+ ion 
excretion and body fluid volume, (Valloton, 1987) and nitric oxide (Moncada 
et al, 1991).
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In hypertension, the baroreceptors and the renal blood pressure control are 
apparently set at a higher blood pressure (Benowitz and Bourne, 1989). The 
secretion of renin in the kidneys from the cells o f juxtaglomerular apparatus 
can be increased by an abnormality in the vascular smooth muscle cell 
membrane that causes renal artery sclerosis and hence a fall in the renal 
blood flow . The secondary effect o f the renal blood flow  reduction is a 
further increase in the blood pressure. Therefore it is necessary to determine 
the original cause of the hypertension to increase life expectancy.
Pulmonary Hypertension
Normally, pulmonary blood vessels are very distensible and can 
accommodate an increase in the blood flow  w ithout a marked change in the 
pulmonary blood pressure. However, pulmonary hypertension can develop 
when:
a) The pulmonary vascular bed is constricted
b) The pulmonary vasculature is distended too much w ith a high flow
c) There are pathological changes, especially in the inner layer of the 
pulmonary blood vessels including the intima and/or the media layers of the 
muscular arteries and the arterioles
A defect in the ventricular septum can also give rise to pulmonary 
hypertension. Less commonly in atrial septal defect or in the patent ductus 
arteriosus, pulmonary hypertension occurs. The defective pumping activity 
of the heart due to the anatomical abnormalities mentioned, can be the
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underling causes for the development of the pulmonary hypertension, since 
more blood is accumulated in the pulmonary vasculature in relation to 
lowered cardiac output (Kissane, 1990).
Some Drugs in the Treatment of Hypertension
S-adrenoceptor blocking drugs alone or in combination w ith diuretics are 
used to treat hypertension. This is not the best choice since fc-blockers have 
their own specific side effects. ACE inhibitors and C a^+ channel 
antagonists have been used widely because of their relative lack of side 
effects and metabolic effects. Other effective vasodilators include 
nitroprusside, which releases NO in the vascular smooth muscle, and 
diazoxide which is a K + channel stimulant and therefore causes vascular 
hyperpolarization (Quast and Cook, 1989) have been used increasingly.
The general use of vasodilators is mainly to augment local tissue blood flow , 
to attenuate the central venous pressure and reduce arterial pressure. The 
cardiac work is reduced when there is a reduction in the cardiac pre-load 
and after-load. When there is a reduction in the cardiac pre-load, the filling 
pressure is reduced. A reduction in the cardiac after-load would reduce the 
vascular resistance.
5-HT IN THE PERIPHERAL TISSUES
5-hydroxytryptamine which can be considered as a local hormone and a 
neurotransmitter because of its various physiological actions and locations
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was firs t found in 1948. It is abundant in platelets, in the GIT (chromaffin 
cells and enteric neurones) and in CNS (Green, 1985; Fozard, 1989).
5-HT is synthesized from dietary tryptophan and its metabolism closely 
resembles that of NA (tyrosine is the precursor for the production of NA). 
Tryptophan is converted to 5-hydroxytryptophan in the presence of the 
enzyme tryptophan hydroxylase and then decarboxylated to 5-HT by a non­
specific decarboxylase (L-aromatic acid decarboxylase). The metabolism of 
5-HT is through monoamine oxidase and an aldehyde dehydregenase that 
converts 5-HT to an aldehyde and then to the main degradative product 5- 
HIAA (5-hydroxyindoleacetic acid) which is readily excreated in the urine. 5- 
HT is taken up or transported to the 5-HT-containing cells by a spcific 
transport system.
Various Functions of 5-HT
5-HT has many actions and functions. These include:
a) Vasoconstriction in large arteries and veins, though the sensitivities of 
these large blood vessels differ
b) In the microvasculature, 5-HT acts on 5-HT receptors to inhibit 
transmitter release from the adrenergic nerve terminals. It also dilates 
arterioles, increases capillary permeability and constricts venules (Rang and 
Dale, 1991)
c) In platelets, which act as a 5-HT reservoir, 5-HT causes platelet 
aggregation, leading to thrombosis when the vascular wall is injured. The
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accumulation of platelets also encourages further release of 5-HT from 
platelets. This is an important process in haemostasis (Houston and 
Vanhoutte, 1986)
d) Increases the m otility of the GIT. This action of 5-HT is either due to 
direct excitation of the GIT smooth muscles or to an indirect e ffect on the 
enteric neurons
e) 5-HT also has the ability to contract smooth muscle in the bronchi and in 
the uterus _
f) In the C N S,. 5-HT has a variety of effects which stem from both 
excitatory and inhibitory actions
g) 5-HT initiates pain (Richardson, 1990; Le Bars, 1988) by acting on the 
peripheral sensory nociceptive nerve endings that also causes flare and 
wheal
5-HT and its Receptors
5-HT receptors are classified into different subtypes. These include 5-HT-j, 
5 -HT2  and 5 -HT3  receptors (Bradley et al, 1986; Peroutka, 1988). 5-HT-j 
receptors which are mainly in the CNS are further subdivided into four 
categories. These are A,B,C and D. In addition to the CNS location o f the 5- 
HT-] receptors, other 5-HTi receptor sites in the choroid plexus, the 
stomach, the enteric neurons and in the blood vessels are alse involved. The 
effects of 5-HT in nerves are mainly to inhibit transm itter release, chiefly by
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inhibiting adenylate cyclase and in the case of 5 -H T ic , by stimulating Pl- 
turnover (Hoyer, 1988 and Julius et al, 1988).
5-HT2 receptors occur in the smooth muscle and in platelets, as well as in 
the CNS. They mainly have excitatory effects on smooth muscle (Roth et al, 
1986; Cory et al, 1986) and nerves (Hide et al, 1989; Conn and Sanders- 
Bush, 1984, 1986). Ketanserin and mianserin are specific antagonists for 
these receptors. Activation of which is associated w ith increased Pl- 
turnover.
5 -HT3  receptors are found in the peripheral nervous system (PNS) including 
nociceptive sensory nerves, autonomic nerves and enteric nerves. These 
have excitatory activity which is mediated through an action on plasma 
membrane ion channels, that are linked to the 5 -HT3  receptors. In 
inflammation; Pain, flare and wheal, are also mediated via this 5 -HT3  
receptors. Subtypes of 5 -HT3  might also exist but this is still uncertain 
(Richardson and Engel, 1986). 5-HT also plays a role in migraine (D'Andrea 
et al, 1994; Martelletti et al, 1994) and carcinoid syndrome (Zambrzycki and 
Elliott, 1993).
5-HT IN THE CENTRAL NERVOUS SYSTEM (CNS)
The first time it was suspected that 5-HT might act as a central 
neurotransmitter was in 1953 when Gaddum realized that lysergic acid 
diethylamide (LSD), a hallucinogenic drug, acted as an antagonist of 5-HT 
on peripheral tissues and might also owe its central effects to antagonism of 
5-HT.
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The central pathway in which 5-HT is involved, includes several large 
groups of 5-HT-containing cells in the pons and upper medulla. These are 
found close to the midline (raphe) and are sometimes referred to  as raphe 
nuclei. The main tw o clusters of 5-HT cells are rostral and caudal serotonin 
nuclei in the rat brain (Rang and Dale, 1991). The rostral serotonin nuclei 
which also contains many noradrenergic nerves has projections to different 
parts of the brain via the midial forebrain bundle. These areas o f the brain 
include cortex, hippocampus, thalamus, limbic system and hypothalamus. 
However, the caudal serotonin nuclei has its projections to the medulla and 
spinal cord. Various experimental works have suggested that 5-HT interacts 
w ith several receptors (Peroutka, 1988) and the outcome of these different 
receptor activation are postsynaptic excitation and inhibition as well as 
presynaptic inhibition. 5-HT cells show a highly regular slow  neuronal 
discharge pattern which can be antagonised by 5-HT*| agonists, indicating 
the involvement of an inhibitory feedback mechanism.
Some Important CNS Functions of 5-HT
The brain has only about 1% of the total body 5-HT content (Green, 1985) 
and the main CNS related functions of 5-HT pathways include:
a) Different kinds of behavioural responses (Di Chiara et al, 1971).
b) Feeding behaviour (Marazziti et al, 1988; Curzon, 1990).
c) Regulation of sleep (Koella, 1988; Jouvet, 1967), wakefulness and 
general mood.
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d) Regulation of neuronal sensory pathways.
e) Regulation of body temperature (Myers, 1981; Jacob and Girault, 1979) 
mediated by hypothalamus.
5-HT may also be involved in the central control o f blood pressure, in 
learning and memory (McEntee and Crook, 1991; Altman and Normile, 
1988), sex (Gorzalka et al, 1990; Fernandez-Guasti et al, 1987), 
neuroendocrine regulations (Van De Kar, 1991; Cowen et al, 1990), motor 
activ ity (Sternbach, 1991) and biological rhythms (Wesemann and Weiner,
1990).
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THE AIMS OF THIS STUDY  
Pithed and Anaesthetised Rats
One of the main objectives of this study was to investigate the 
cardiovascular responses to spinal nerve stimulation and drugs and to 
examine the various contributing factors which can modify these responses. 
The pithed rat was used by Bulloch & McGrath (1988) who suggested that 
co-transmission involving NA and ATP occurs in the sympathetically 
innervated blood vessels. This study re-examined this possibility and tried to 
elucidate whether co-transmission involving NA and ATP occurs and if so, 
to what extent this co-transmission contributes to the pressor responses to 
spinal nerve stimulation. This study also examined the role of the adrenal 
medullae and the catecholamines released from these glands into the blood 
stream (Bevan et al, 1980; Clutter et al, 1980) and investigated how &- 
adrenoceptors influence the pressor responses to spinal nerve stimulation. 
The possibility that other locally released vasoactive agents, including All 
(Rand et al, 1990; Majewski et al, 1984) and bradykinin (Rang & Dale,
1991) may also contribute to and complicate the pressor responses to 
spinal nerve stimulation was considered. This study also examined the 
effect of 5-HT which can be released from many sites including platelets 
into the blood circulation and affect the cardiovascular system (Saxena and 
Villalon, 1990; Vanhoutte, 1985). In addition, the role of NO (Moncada et 
al, 1991; Furchgott & Zawadzki, 1980) in the cardiovascular system and its 
effect on the responses to 5-HT were examined.
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Lungs
This study examined the effect of some vasoactive agents including 
vasopressor agents (5-HT, PE, KCI, NA and adrenaline) and vasodepressor 
agents (isoprenaline and SNP) in the pulmonary circulation. An important 
objective o f these experiments was to establish whether NO modulates 
pulmonary vascular tone and the responses to vasoactive agents, 
particularly 5-HT, in the pulmonary vasculature (Newby and Henderson, 
1990).
Some prostaglandins also have vasoactive effects and may affect the 
pulmonary vascular resistance (Aiken, 1984; Wood et al, 1981) and these 
endogenously released prostaglandins may also modify the responses to 
vasoactive agents. An objective of this study was to determine whether 
endogenous prostanoids affect pressor responses to vasoconstrictors in this 
vascular bed.
Cyclic nucleotides (cAMP and cGMP) are the main second messengers 
involved in vasodilatation. Agonists that act on ^-adrenoceptors are known 
to exert thier vasorelaxant effect by increasing the synthesis o f cAMP in the 
vascular smooth muscle cells (Furchgott & Vanhoutte, 1989 and Furchgott 
& Martin, 1985). One aim of this study was to determine the effects of the 
^-adrenoceptor agonist on the vasoconstrictor effects o f 5-HT, PE and KCI.
Hindquarters
Another aspect of this study was to investigate the effect of vasoactive 
agents in the hindquarters vasculature (Folkow et al, 1970; Cooper and
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Wylie, 1979) which, unlike the pulmonary circulation, is a high resistance 
vascular bed. Fluid flow-induced shear stress may cause the release of 
endothelial vasodilator agents (Davies, 1989 and Griffith et al, 1988) which 
may be of great importance in keeping the vascular beds open to perfusion. 
One objective of this study was to determine whether NO (Hutcheson & 
Griffith, 1991) and perhaps PGI2  (Pohl et al, 1986b and Koller & Kaley, 
1990b) have any role in modifying tone and the responses of this vascular 
bed to vasoactive agents, especially 5-HT. Cumulative dose-response 
curves to vasopressor agents such as 5-HT, PE and KCI and vasodepressor 
agents such as carbachol and SNP, which were added to the Krebs-buffer 
that was perfused through the hindquarters vasculature, were also 
investigated.
It is known that in hypertension, the resistance of blood vessels is 
increased, perhaps in response to some abnormalities in the C a ^ +  ion 
handling of arterial smooth muscle cells and this has been shown in 
spontaneously-hypertensive rats (SHR) (Bohr & Webb, 1988). In 
hypertension there is an increase in the incidence of myogenic tone, an 
increase in the responsiveness of the vascular bed to vasoconstrictor agents 
and a decrease to vasodilator agents. It is also reported that arteries from 
SHR have a spontaneous active tone (Asano et al, 1986 and W inquist & 
Bohr, 1983) that is known as myogenic tone which is independent of local 
innervation, circulating hormones and metabolic influences. This study 
investigated the responsiveness of vasculature of the rat hindquarters to 
both vasoconstrictors and vasodilators. Comparisons were made between 
the responses obtained in hindquarters preparations from SHR and WKY 
control rats.
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METHOD
Experimental rats
The rats used for research purposes were kept in a controlled area. Their 
food was obtained from (Labsure CRM diet) and ordinary tap water was 
used for their drinking. The temperature and light of the animal house were 
controlled. The temperature was maintained between 18-22°C and the 
lighting of the area was regulated in a cycle of tw elve hours light (ie. 6:30- 
18:30 h) and twelve hours dark. Adult male rats were used in all the 
experiments throughout the project. Most experiments were carried out 
using Wistar rats but in some experiments Sprague Dawley, Spontaneously 
Hypertensive (SHR) and Wistar Kyoto (WKY) rats were used.
Krebs solution
Krebs physiological buffer which was originally described by Krebs and 
Henseleit in 1932 was used for perfusions and drug preparations.
Its composition (mM):
NaCI, 118.5; KCI, 4.75; CaCI2, 2.5; M gS04 .7H 2 0 , 1.0; KH2 P0 4 , 1 .2 ; 
NaHC0 3 , 25.0; Glucose, 22.2.
It was also gassed with a mixture of 9 5 % 0 2  / 5 % C 0 2 .
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Pithed rat preparation
Male W istar rats (250-350 g) were anaesthetised w ithtrichloroethylene and 
respired artificia lly (stroke volume = 2.5 ml, rate = 55 min"^) w ith  air through 
a polythene cannula that was tied into the trachea. Each rat was pithed by 
inserting through the orbit a steel guide tube, through which a flexible teflon 
tube containing the electrode was passed (Gillespie and Muir, 1967; 
Gillespie et al, 1970). This teflon sheathed electrode was inserted into the 
foramen magnum and down the spinal canal to the point of furthest 
penetration in the sacral region (Fig-4). An indifferent electrode was inserted 
under the skin behind the skull and along the length o f the spine. The left 
carotid artery was cannulated to record blood pressure and the femoral vein 
was cannulated to permit the administration of drugs. Blood pressure and 
pressor responses were recorded w ith a Grass pressure transducer and 
were displayed on a Linseis pen recorder. The temperature (30°C) of the rat 
was maintained during the experiment w ith a table lamp. In most studies a 
1 cm electrode was used (Fig-4). This was easily achieved since the relative 
lengths of the teflon shielding tube and the electrode itself were known. The 
position of the electrode in the spinal column was determined 
radiographically. In preliminary experiments the effect of stimulating at 
different positions was investigated and the responses obtained were then 
related to the position of the electrode w ithin the spine. From such 
experiments, information was also obtained about the positions of the spinal 
outflows in rats of different sizes (100-400 g). These studies provided data 
that was used to chart the spinal outflows and the consequences of 
stimulating at different positions (Fig-5). In most studies stimulation w ith a 1 
cm electrode between the eight and the ninth thoracic vertebrae (Tq and 
Tg) was used. This position was chosen since it corresponded to that used 
in previous studies where purinergic nerves and co-transmission had been
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studied (Bulloch & McGrath, 1988). In most experiments, electrical 
stimulation was w ith supramaximal voltage, 0 .4  ms pulse-duration for 5 and 
50 s at 2 Hz and 20 Hz. Gallamine (10 mg kg"^, iv.) was administered as a 
muscle relaxant to stop muscle tw itch ing during electrical stimulation. 
During the experiment further injections were usually necessary to maintain 
neuromuscular blockade.
Adrenalectomy
Rats were pithed according to the method described above and acute 
bilateral adrenalectomy was performed via lateral incisions above each 
kidney. Adrenalectomy made the blood pressure unstable and caused a fall 
in the basal blood pressure. Therefore, after adrenalectomy, pithed rats 
were le ft for about 15 to 2 0  min until the blood pressure became stable 
before carrying out the rest of the experiment. Blood pressure was 
measured via the left carotid artery and drugs were administered via the 
right femoral vein.
Anaesthetised rat preparation
Adult male W istar rats (250-350 g) were injected w ith sodium 
pentobarbitone (60 mg k g "1, ip.), which was enough to keep the rat 
unconscious for approximately 2 h. Further doses of sodium pentobarbitone 
were administered throughout the experiments to maintain anaesthesia. The 
trachea was then cannulated and each rat was respired artificia lly w ith an 
air pump (stroke volume = 2.5 ml, rate = 55 min'**).
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The left carotid artery and one femoral vein were also cannulated to allow 
blood pressure measurement and drug administration, respectively. The 
carotid artery was then connected through its cannula to a Grass pressure 
transducer and a Linseis pen recorder to record the basal blood pressure as 
well as any changes induced by drug administrations. Saline (0.2 ml) was 
injected after each intravenous drug injection to wash the drug into the 
circulation. The areas exposed by dissection were also covered w ith a saline 
moistened tissue paper to prevent the underlying living tissues getting dried.
Blood pressure measurement (tail cuff method)
Rats were kept in a warming chamber (temperature at 37°C) for about 15 
min to cause vasodilatation before measuring blood pressure using the rat 
tail artery. Prior warming of the rat made recording of the blood pressure 
easier. Each rat was then brought out of the warming chamber and was 
placed in a restrainer. The tail of the rat was passed through an inflatable 
cu ff and a pressure transducer which were connected to a pre-calibrated 
storage oscilloscope. The position of the inflatable cu ff was in the base of 
the tail, close to the body and the pressure transducer was distal, midway 
along the tail.
In order to measure the systolic blood pressure, a motor driven piston was 
used to inflate the basal cuff which eventually stop the arterial blood flow  in 
the tail. The pressure could be rapidly released by deflating the cuff. The 
point on the calibrated screen of the oscilloscope where the pulsing of the 
blood pressure first disappeared and later reappeared again, due 
respectively to inflation and deflation of the cuff, were recorded and 
indicated the systolic blood pressure.
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Lungs preparation
Male W istar rats (250-350 g) were anaesthetised w ith sodium 
pentobarbitone (60 mg kg '^ , ip.) and heparinised w ith  heparin sulphate 
(2000 i.u. kg '^ , ip.) to prevent blood clotting. Once the rat was under deep 
anaesthesia and unresponsive to mechanical stimuli such as pressing its 
foot, the trachea was dissected, exposed and cannulated w ith a polythene 
cannula. A fter tracheotomy the rat was killed by exanguination. A stainless 
steel cannula which was connected to a 20 cm syringe, filled w ith Krebs- 
buffer was then quickly inserted into the pulmonary artery through an 
incision in the right ventricle of the heart and then tied in place. Another 
incision was made in the left atrium to allow the Krebs-solution 
contaminated, w ith blood to escape. Usually, 20-30 ml Krebs-buffer under 
approximately a 2 0  cm H2 O pressure would be suffic ient to wash the blood 
out of the pulmonary circulation.
When all the blood was washed out, the lungs changed colour from pink to 
white. During this process the lungs were mechanically ventilated w ith an 
air pump which was connected to the tracheal cannula. This facilitated the 
washing of the blood out o f the pulmonary circulation w ith  Krebs-buffer.
The lungs were then left in situ and placed on a heating water blanket at a 
temperature of 37°C and were usually perfused at a flow  rate of 5 ml min" 
w ith Krebs-buffer at 35°C (Fig-32). The perfusion pump used in these 
experiments was a peristaltic, constant output pump, which produced a 
pulsatile flow  through the pulmonary circulation. The lungs were perfused in 
situ and were covered w ith a plastic blanket to keep them warm and moist. 
Pulmonary artery perfusion pressure was monitered using a Statham 
pressure transducer (model no. P21B) which was connected to the
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perfusion circuit. The perfusion pressure and any drug-induced changes in 
the perfusion pressure were then recorded on a Linseis pen recorder. All the 
measurements either for changes in the basal perfusion pressure or for the 
effects of drugs were recorded from the upper parts of the traces 
(equivalent to the systolic pressure). The mean basal pulmonary arterial 
pressure was usually at 12-15 mm Hg. Drugs were administered by simply 
perfusing the pulmonary circulation w ith Krebs-buffer, containing the drugs 
and obtaining a stable equilibrium response.
Hypoxic (14% O2) gas preparation
Douglas bags were prepared and used as a reservior to hold a mixture, 
containing 14% O2 , 5% CO2  and 81% N2  gasses. This low  O2  gas mixture 
which was much lower than the usual 95% O2  mixture used to gas Krebs- 
buffer, was used to study the effect of perfusing a hypoxic solution through 
the pulmonary vasculature.
Hindquarters preparation (Brown, 1982)
Experimental rats were heparinized (2000 i.u. k g '1, ip.) about 10 min before 
killing by exanguination. The abdominal cavity was cut open, the intestine 
and rest of the organs in the cavity were removed. The abdominal artery 
was then dissected free from the surrounding connective tissues to insert a 
polythene cannula for the Krebs-buffer perfusion. The cannula which was 
connected to a 20 ml syringe containing the Krebs-buffer solution was tied 
in place w ith the tip of it being located just above the abdominal arterial 
bifurcation that gives rise to the common iliac arteries which supply the
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legs. Then the rat was cut in half below the kidneys and the hindquarters 
circulation was washed w ith Krebs-buffer to remove any blood left in the 
blood vessels. Usually 20-30 ml of Krebs-buffer solution under a 20 cm 
H2 O pressure was sufficient to remove the residual blood in the 
hindquarters vasculature.
The hindquarters were place on a heating water jacket (37°C) and 
connected to an adjustable peristaltic perfusion pump, which perfused 
Krebs-buffer (35°C) through the vasculature o f the hindquarters. The
■1
perfusion rate was usually at 5 ml min" 1 and the apparatus assembly for the 
hindquarters preparation was the same as it was for the lungs preparation. 
All the measurements either for the basal perfusion pressure or the effects 
of drugs were recorded from the upper parts of the traces.
Rectal temperature was measured by a thermometer to monitor the 
temperature of the hindquarters.
Drugs
The following drugs were used in this study:
Adrenaline (B.D.H.), o,ft-mATP (Sigma), ascorbic acid (May & Baker), 
captopril (Sigma), carbamylcholine chloride (carbachol) (Sigma), flurbiprofen 
(Sigma), gallamine triethiodide (Sigma), guanethidine sulphate (Ciba), 
heparin sodium (Sigma), 5-hydroxytryptam ine hydrochloride (Sigma), 
indomethacin (Sigma), isoprenaline (Sigma), KCI (Fisons), ketanserin 
(Sigma), L-arginine hydrochloride (Sigma), L-NAME (Sigma), L-phenylephrine 
hydrochloride (Sigma), noradrenaline bitartrate (Sigma), prazosin
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hydrochloride (pfizer), propranolol hydrochloride (Sigma), sodium 
nitroprusside (Sigma), sodium pentobarbitone (May & Baker), yohimbine 
(Sigma).
Drugs were prepared in 0.9%  saline for use in the experiments w ith  pithed 
and anaesthetised rats. In experiments in lungs and hindquarters, drugs 
were dissolved in the Krebs-buffer solution.
Statistical analysis
The results were expressed as (Means ±  SEM). Comparisons of data were 
carried out using Student's t-test, where appropriate, the non parametric 
Mann-Whitney test. A probability value of < 0.05 was considered to be 
significant.
Regression line analysis
In some experiments, comparisons of concentration-response relationships 
to an agonist in the absence and presence of an antagonist were performed 
through the comparison of the regression lines of the curves. This can be 
done by the method described by Bowman and Rand (1980) and using the 
follow ing formulae, the tw o  regression lines were tested for coincidence be 
a t-test.
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RESULTS
Effects of Electrical Stimulation of the Sympathetic Outflow in the 
Pithed Rat Using the Spinal Electrode and the Effects of Drugs on 
the Responses Produced
Effects of electrical stimulation of the spinal sympathetic outflow
Electrical stimulation of the sympathetic ou tflow  (NS) in the pithed rat at 
d ifferent levels within the spinal canal produced characteristic increases in 
the heart rate (HR) and blood pressure (BP). The magnitude of these 
responses differed according to the region of the thoraco-lumber outflow  
stimulated. The results obtained are shown in Fig-5. The largest pressor 
responses were obtained at the eighth to the ninth thoracic vertebrae (Tg.g) 
(Figs-5,6). Stimulation at this position also produced a large increase in HR, 
which suggested that the adrenals were also being stimulated at this point, 
since the cardio-accelerator nerves arise at the sixth cervical to the second 
thoracic vertebrae (Cg-T2 ) (Gillespie et al., 1970) and could not account for 
such a response. Subsequent experiments in adrenalectomised rats 
confirmed that a large component of the pressor response produced by 
stimulation at Tg_g was caused by the release of catecholamines from the 
adrenal medullae (Figs-7,10). In this study, the largest increases in HR 
occurred at the second to the fourth thoracic vertebrae (T2 -4 ), which is 
close to the point where the cardio-accelerator nerves leave the column. At 
this point, the pressor response was small. The most likely explanation of 
the cardio-acceleration caused by stimulation at other segments is that
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circulating catecholamines from the adrenal glands are responsible for 
increasing HR.
Role of adrenal medulla and effect of propranolol
Pressor responses to nerve stimulation at Tg.g were usually biphasic and 
this was most marked at higher frequencies of stimulation (Fig-6 ). The first 
phase occurred during stimulation and the second phase persisted after 
stimulation had stopped (Fig-6 ). The occurence of such a biphasic response 
also suggests that there may be a substantial adrenal component in the 
response to spinal nerve stimulation at Tg_g. This possibility was examined 
in a number of ways. First, the effects of propranolol (2 mg kg ) on 
responses to nerve stimulation were examined (Fig-8 ). Propranolol inhibited 
the cardio-accelaration (not shown) and usually potentiated the second 
phase of the pressor response, which persisted after nerve stimulation had 
stopped. This is consistent w ith the possibility that electrical stimulation at 
Tg_g released catecholamines from the adrenal medullae. In some 
experiments, where the resting BP was very low (BP< 1 8 -2 2  mmHg), 
propranolol did not potentiate the second phase of the pressor response, 
but instead inhibited the pressor response, particularly to stimulation at 2 0  
Hz (Fig-9). It may be that in these animals, blockade of cardiac &•]- 
adrenoceptors by propranolol, impaired their ability to maintain a pressor 
response, since the heart could not cope w ith pumping blood into the 
constricted peripheral vasculature. Another possibility is that propranolol 
may have impaired the renin-angiotensin mechanism.
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Effect of adrenalectomy
The effects of adrenalectomy on the responses to spinal nerve stimulation 
was examined in the pithed rats. Adrenalectomy inhibited both components 
of the pressor response to nerve stimulation and usually converted the 
biphasic response into a small monophasic response that occurred only 
during nerve stimulation (Figs-7,10). Adrenalectomy did not inhibit 
responses to injected NA (Fig-11).
Effect of alpha, beta-methylene ATP (a,B-mATP)
or,S-mATP (2x0.05 mg kg" 1 and then 0.1 mg k g '1) produced large pressor 
responses, which showed tachyphylaxis that developed slow ly and was 
readily reversible w ith time (Fig-12). In experiments in which desensitization 
to the pressor effect of a,&-mATP developed, responses to nerve stimulation 
also declined but not to a greater extent than did responses to equi-active
-I
doses of exogenous NA (9 j jg  k g '1). Cessation of administration of ar,£- 
mATP restored the sensitivity to a,ft-mATP as measured by the return of the 
pressor response to a,£-mATP but did not restore the sensitivity to NA or to 
spinal nerve stimulation (Fig-12). Further administration of ar,ft-mATP 
produced a pressor response that again showed tachyphylaxis but the 
standard responses to NA and spinal nerve stimulation were unaffected (Fig- 
12 ).
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Effects of prazosin and yohimbine
Prazosin (2 mg k g '1) inhibited both components of the pressor response to
stimulation of the spinal autonomic outflows at Tq_9 and inhibited pressor
■\
responses to injected NA (0.3 /vg kg " ') (Fig-13). The prazosin-induced 
decline in pressor responses to spinal nerve stimulation matched the 
prazosin-induced decline in pressor responses to injected NA (Fig-13).
Yohimbine (1 mg k g '1) inhibited pressor responses to injected NA (0.1, 1.3, 
2 2 . 2  /vg kg"^) and converted the biphasic pressor responses to spinal nerve 
stimulation into monophasic responses of brief duration. In these residual 
responses, the secondary response that persisted after nerve stimulation 
was abolished but the pressor response that occurred during stimulation 
was slightly potentiated, probably reflecting inhibition of presynaptically- 
mediated autoinhibition and increased release of NA (Fig-14). Any residual 
nerve stimulation-induced pressor response that remained after treatment 
w ith prazosin and yohimbine was abolished by guanethidine ( 2  mg kg ') 
(Fig-15). In some pithed rats, yohimbine (2 mg k g '1) caused the basal BP to 
fall and become unstable and this was followed quickly by death.
Effect of captoprii
1 1 In the presence of propranolol (2 mg k g '1), captoprii (1 mg k g '1) did not
affect the basal BP (36 mg k g '1) in the pithed rat (Fig-16). However,
pressor responses to spinal nerve stimulation at Tg.g and to injected NA
(0.3 /vg k g '1) were inhibited by captoprii (1 mg k g '1). In the presence of
1 1 captoprii (1 mg k g '1), prazosin ( 2  mg k g '1) further inhibited the pressor
responses to nerve stimulation and NA (Figs-1 6 ,1 7).
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Effect of L-NAME
In the absence of propranolol, L-NAME (45 mg kg"1) increased the basal 
blood pressure to a similar extent in anaesthetized (Mean = 59.0 mm Hg, 
SEM = 13.6 mm Hg, n = 3) and pithed (Mean = 68.5 mm Hg, SEM = 14.8 mm 
Hg, n = 4) rats but in the presence of propranolol (2 mg kg'**) which lowered 
the basal blood pressure, L-NAME (45 mg k g '1) raised the basal blood 
pressure to a lesser extent in pithed rats (Mean = 12.3 mm Hg, SEM = 1.8 
mm Hg, n = 19) than in anaesthetized rats (Mean = 55.6 mm Hg, SEM = 8.8 
mm Hg, n = 12) (Fig-18). In the pithed rat, the extent to which L-NAME 
raised the basal BP was proportional to the initial level of the basal BP in 
the absence (correlation coefficient R = 0.96, n = 5, 0.01 < P<0 .001) and 
presence (correlation coefficient R = 0.64, n = 19, 0.01 < P < 0 .001) of
*i
propranolol (2 mg kg-1) (Fig-19) but in anaesthetised rats, there was no 
linear correlation between the basal blood pressure and L-NAME-induced 
increase in the blood pressure either in the absence or presence of 
propranolol (2 mg kg"1) (Fig-20).
L-NAME (45 mg kg"1) occasionally enhanced pressor responses to spinal 
nerve stimulation (NS) and NA but overall it did not potentiate pressor 
responses to NS (Figs-21,22), or injected NA (0.1-15 j j q  k g '1) (Fig-23) but
-i
did potentiate pressor responses to injected 5-HT (25 j j g k g '1) in the 
presence of propranolol (2 mg k g "1) (Fig-24). A fter administration of L- 
NAME (45 mg k g '1), recovery from the enhanced pressor responses to 
drugs or spinal nerve stimulation was usually slower than the recovery prior 
to administration of L-NAME (Figs-21 and 24). The effect of a,ft-mATP was 
lethal after L-NAME (45 mgkg"1) and the rat did not survive (Fig-25).
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Effects of L-arginine
L-arginine (45 mg kg ') lowered the basal BP, reversed the effects of L-
-i
NAME (45 mg k g '1) and inhibited pressor responses to injected NA and to 
nerve stimulation (Figs-26,27). L-arginine also shortened the duration of 
action of responses to injected NA and to spinal nerve stimulation (Fig-26).
Effects of 5-hydroxytrytamine (5-HT)
A
In pithed rats 5-HT (6-50 /yg k g '1) produced dose-related pressor responses 
in the absence and presence of L-NAME (45 mg kg '^) while propranolol (2
A
mg k g '1) was present throughout the experiments (Fig-28). Pressor 
responses to 5-HT were potentiated and prolonged by L-NAME (45 mg kg"^
) (Figs-28,29). 5-HT ( 6  //g kg"^) inhibited the pressor components to the 
spinal nerve stimulation (2 Hz, 20 Hz, 100 pulses) of the sympathetic 
ou tflow  at Tg_g. This inhibitory effect of 5-HT occurred in the presence of 
both propranolol (2 mg kg"**) and L-NAME (45 mg kg"**) (Fig-22). In 
anaesthetised rats, 5-HT produced a triphasic response in the blood 
pressure which consisted of an initial brief depressor component, a 
secondary pressor component followed by a final prolonged depressor 
component. This triphasic response to 5-HT was most marked at higher 
doses of 5-HT (12-55 j jg  kg"**). L-NAME (45 mg kg '^ ) produced a large 
increase in the baseline blood pressure and enhanced and prolonged the 
secondary pressor component and reduced but did not abolish the 
depressor components to 5-HT (Figs-30,31).
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The Effects of Drugs in the Vasculature of the Perfused 
Pulmonary Circulation of the Rat
Preliminary experiments, performed using different perfusion rates (3, 5 and
1 112 ml m in '1), indicated that a perfusion rate of 5 ml min ' 1 was satisfactory.
Higher perfusion rates produced preparations tha t were unstable, gave 
variable results and developed oedema early in the experiment. In this 
study, drugs were perfused for a sufficient period to produce an equilibrium 
response.
Effects of vasoconstrictors in the perfused pulmonary vasculature 
Effects of Phenylephrine (PE)
PE was administered in a range of concentrations (0.1-100 /yM), each of 
which was perfused until a stable equilibrium response was obtained (Fig- 
33). PE produced small pressor responses, the size of which was dependent 
on the manner of perfusion. PE produced very small pressor responses 
when perfused cumulatively w ith no interval between each drug 
concentration perfused (Fig-33 Panel A). These small pressor responses to 
PE were better maintained than were pressor responses to 5-HT.
Effects of 5-hydroxytryptamine (5-HT)
5-HT (0.1-10000 /vM) was administered by perfusion to obtain an 
equilibrium response. 5-HT produced very small pressor responses when it
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was perfused cumulatively in increasing concentrations (Fig-34 Panel A). 
The pressor responses to 5-HT were not well-maintained.
Effects of Potassium Chloride (KCI)
KCI produced well-maintained pressor responses in the perfused pulmonary 
vasculature. In order to obtain a dose-response curve to KCI, increasing 
concentrations of KCI (3-80 mM) were perfused until at each concentration, 
a stable, equilibrium response was obtained (Fig-35 Panel A).
Effects of Noradrenaline (NA)
NA (1-100 jC/M) produced small pressor responses even when perfused 
continuously to produce equilibrium responses. Recovery was quick after 
washing the drug out of the pulmonary circulation w ith  Krebs-buffer (Fig- 
36, right hand panel). In some experiments, NA (1-100 //M) produced 
poorly-maintained pressor responses, particularly at submaximal ( 1 0  jjW\) 
and maximal (100 /yM) concentrations. In these experiments, the addition of 
propranolol to the perfusate during the declining phase of the pressor 
response to NA (100 j j M )  raised the tone and produced a well-maintained 
pressor response to NA (Fig-36, left hand panel).
Effects of Adrenaline
Adrenaline (10 and 100 /;M) produced small, poorly-maintained pressor 
responses when perfused continuously to produce equilibrium responses
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(Fig-37 Panel A). Adrenaline-induced responses were small even when there 
were recovery intervals between each concentration perfused.
Effects of KCI on 5-HT responses
Some pressor responses to 5-HT (1-100 / /M) administered in the presence 
of L-NAME (400 //M), were potentiated in preparations, which had 
previously been perfused with and constricted by a submaximal 
concentration of KCI (40 mM). In these preparations the pressor responses 
to submaximal and maximal concentrations of 5-HT were larger than those 
obtained in preparations that had not previously been exposed to KCI (Fig- 
38).
Responses to PE in Wistar and Sprague Dawley rats
PE (0.01-100 //M) produced pressor responses in the perfused pulmonary 
vasculature of W istar and Sprague Dawley rats. When the cumulative 
concentration response curves to PE were compared, it was clear that the 
submaximal pressor responses (0.1-1 //M) obtained in lungs from Sprague 
Dawley rats were larger than those obtained in W istar rats (Fig-39).
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Effects of antagonists in the perfused pulmonary vasculature 
Effects of Ketanserin
Ketanserin (1 nM) had little effect on the basal perfusion pressure but 
inhibited the pressor responses to equilibrium perfused concentrations of 5- 
HT (1, 10 and 100 jjM) in the presence of L-NAME (400 jjM) (Fig-40). It is 
likely tha t the 5 -HT2  receptor is involved in the pulmonary vasoconstriction 
caused by 5-HT.
Effects of a combination of L-NAME, Propranolol and Yohimbine on 
pressor responses to PE
The pressor responses to PE (0.1-100 //M) in the perfused pulmonary 
vasculature of the rat were enhanced by perfusing the vasculature w ith a 
combination of L-NAME (400 //M), propranolol (10 /vM) and yohimbine (1 
/vM). This was reflected in the cumulative concentration-response curve to 
PE (Fig-41).
Effects of L-NAME
L-NAME (400 //M) caused a small but prolonged rise in the basal perfusion 
pressure in the perfused lungs and enhanced the pressor responses to 5-HT, 
PE, KCI and adrenaline (F igs-34,42,43;44;35;37).
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Effects of Flurbiprofen
Flurbiprofen (2 //M) had little effect on the basal perfusion pressure in the 
Krebs-buffer perfused pulmonary circulation. Flurbiprofen only enhanced 
responses to the middle range of concentrations of KCI (30 mM) but did not 
affect the responses to other concentrations of KCI (Fig-45). Flurbiprofen (2 
/yM) had no effect on the responses to PE (0.01-100 /yM) (Fig-46). In 
addition, Flurbiprofen (2 /yM) enhanced the pressor responses to a middle 
range concentration of 5-HT (20 /yM) perfused to equilibrium in the presence 
of L-NAME ( 400 /yM) (Fig-47). Flurbiprofen (2 /yM) increased the rate of rise 
of the pressor responses to NA (0.1-10 /yM) (Fig-48) but had little effect on 
the pressor responses of adrenaline (0.1-100 /yM) (Fig-49).
Effects of hypoxia and propranolol
When the percentage of oxygen in the gas mixture used to oxygenate the 
Krebs-buffer was reduced and the composition of the gas mixture was 
changed from 9 5 % 0 2  and 5 %C0 2  to 14% 02, 5 %C0 2  and 8 1 %N2 , the 
pressor responses to NA were reduced (Figs-50,51). The addition of 
propranolol (10 /yM) to the perfusate, gassed w ith 14% 02, increased the 
pressor responses to NA (Figs-52,53).
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Effects of vasodilators in the perfused pulmonary vasculature 
Effects of Isoprenaline
Isoprenaline (10"^-10“^  M) caused vasorelaxation in the pulmonary 
vasculature, in which the tone had been increased by perfusing the vessels 
w ith Krebs-buffer, containing vasopressor agents which included 5-HT (50 
/yM), PE (100 /yM) and KCI (50 mM). In these experiments each 
concentration of isoprenaline was perfused until a stable, _equillibrium 
response was obtained. The concentrations of the vasoconstrictors were 
submaximal. Isoprenaline almost completely inhibited the vasoconstrictor 
effects of 5-HT (Fig-54) and PE (Fig-55) but only partially inhibited the 
vasoconstrictor effect of KCI (Fig-56). The vasorelaxant effect of 
isoprenaline (10'®-10“® M) was unaffected by L-NAME (400 //M) (Fig-54).
Effects of SNP
SNP (10“ ^ - 1 0 “^  M) caused vasorelaxation in the pulmonary vasculature, in 
which the tone had been raised by perfusing the vessels w ith  Krebs-buffer, 
containing vasopressor agents, which included 5-HT (20 //M), PE (50 / /M) 
and KCI (40 mM). In these experiments, each concentration of SNP was 
perfused until a stable, equilibrium response was obtained. The 
concentrations of the vasoconstrictors were submaximal and increasing 
concentrations of SNP produced correspondingly increased inhibitory 
responses. In the presence of L-NAME (400 /yM), SNP (10“ 1 ^ -10 “ 4  M) 
readily inhibited the pressor responses to 5-HT (20 /yM) and to PE (50 /yM) 
(Figs-57,58) but in the absence of L-NAME (400 /yM), SNP only partially
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inhibited the pressor response to PE (50 /yM) (Fig-58). SNP (10" ^ - 1 0 " ^  M) 
produced small concentration-dependent relaxations of KCI-induced tone 
and these relaxations were enhanced in the presence of L-NAME (400 //M) 
(Fig-59). Apparently, flurbiprofen (2 /yM) also increased the inhibitory effect 
of increasing concentration of SNP on the ongoing pressor response of PE 
(5 0 /yM) (Fig-60).
The Effects of Drugs in the Vasculature of the Perfused 
Hindquarters Circulation of the Rat 
Effects of vasoconstrictors in the vasculature of the perfused 
hindquarters
Effects of 5-HT
5-HT (0.1-100 / /M) had a concentration-dependent vasoconstrictor effect 
which was well-maintained in the vasculature of the rat hindquarters and 
this was reflected in the increased resistance of the hindquarters to 
perfusion (Fig-61). The pressor responses to 5-HT, each concentration of 
which was perfused until a stable, equilibrium response was obtained, was 
large enough and readily allowed a cumulative concentration-response curve 
to be produced (Fig-62 panels A & B). The pressor effect o f 5-HT (0.001-10 
/yM) was additive w ith the pressor response to PE (10 //M) (Fig-63).
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Effects of PE
PE (0.1-100 /yM) had a vasoconstrictor effect in the vasculature of the rat 
hindquarters, and this was reflected in the cumulative concentration- 
response curves (Fig-64 panels A & B). Responses to PE were well- 
maintained (Fig-65).
Effects of KCI
KCI (10-300 mM) also increased the resistance of the vasculature of the rat 
hindquarters to perfusion. Pressor responses to KCI (10-300 mM) were large 
and well-maintained (Figs-66,67 panels A & B).
Comparisons of the maximal pressor responses to KCI, 5-HT and PE in 
SHR and WKY hindquarters vasculatures
SHR rats (Mean = 184.29 mmHg, SEM = 6.85 mmHg, n = 7, P <0 .001 ) have 
higher basal blood pressure than WKY rats (Mean = 120.00 mmHg, 
SEM = 3.78 mmHg, n = 7) and this is illustrated in Fig-6 8 . There was no 
significant difference between the pressor responses to KCI, 5-HT and PE in 
hindquarters from SHR compared w ith responses to these vasoconstrictors 
in WKY control rats (Fig-69). Fig-70 shows sample traces of pressor 
responses to increasing concentrations of cumulatively perfused PE (0.1- 
100 /yM) and 5-HT (0.1-10 //M) in a SHR hindquarters vasculature. A 
comparison of the peak pressor responses to KCI (100 mM), 5-HT (10 //M) 
and PE (1 0 0 //M) in SHR and WKY control hindquarters vasculature showed 
a significant difference (P<0.01) between the peak pressor responses of
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KCI and PE in SHR rats (Fig-71 lower panel). The peak pressor response to 
KCI was larger than those to both 5-HT and PE in WKY control rats (Fig-71 
upper panel).
Effects of antagonists in the vasculature of the perfused 
hindquarters
Effects of L-NAME
L-NAME (400 //M) increased the basal perfusion pressure in the rat 
hindquarters and apparently enhanced the pressor responses to 5-HT (0.01- 
100 /yM) when comparison was made between responses to 5-HT, before 
and after administration of L-NAME. However, when comparison was made 
between responses to 5-HT after L-NAME and responses to 5-HT 
administered for the second time to hindquarters preparations, which had 
not received L-NAME and therefore which acted as time controls, L-NAME 
did not significantly potentiate the responses to 5-HT (Fig-72).
Effects of Indomethacin
Indomethacin (10 //M) produced a small, transient pressor response, 
followed by a slight depressor effect on the basal perfusion pressure in the 
hindquarters of the rat. Indomethacin (10 //M) did not affect the pressor 
responses to 5-HT (0.01-100 //M) (Fig-73).
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Effects of vasodilators in the vasculature of the perfused 
hindquarters 
Effects of SNP
SNP (10"^-10"^ M), perfused cumulatively to equilibrium, produced 
concentration-dependent inhibitions of pressor responses to submaximal 
concentrations of 5-HT (1 //M), PE (10 /yM) and KCI (60 mM) in the Krebs- 
buffer perfused hindquarters vasculature of W istar rats. SNP completely 
inhibited pressor responses to 5-HT (Fig-62 panels C & D) and PE (Fig-64 
panels C and D) and almost completely inhibited KCI (Fig-67 panels C & D)- 
induced pressor responses. SNP as a source of endogenous NO, was 
therefore, very effective in opposing the pressor responses to agonists that 
activated the Pl-mechanism, but was less effective in inhibiting responses to 
KCI.
In hindquarters vasculature from SHR and WKY rats, SNP (10"^-10“® M) did 
not completely inhibit the pressor response to a submaximal concentration 
of PE (10 /yM)(Fig-74). However, there was no significant difference 
between the inhibitory effect of SNP on PE-induced pressor responses in 
hindquarters vasculature from SHR and WKY rats. This observation 
indicates that, SNP was less effective in inhibiting pressor responses to PE 
in SHR and WKY rats' hindquarters vasculature than it was in W istar rats.
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Effects of carbachol
The effects of carbachol (10 '^-10 ' 4  M) were examined in the perfused 
hindquarters of SHR and WKY rats. Carbachol was perfused cumulatively in 
increasing concentrations in Krebs-buffer to obtain equilibrium responses in 
preparations in which the tone had already been raised by a submaximal 
concentration of PE (10 /vM). Carbachol produced a complex concentration- 
response curve, which consisted o f an early pressor response at low 
concentrations, followed by inhibitory responses at high concentrations. 
There was no difference between the complex effects of carbachol in SHR 
and in WKY rats (Fig-75).
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Low blood pressure, salt depletion,
5-adrenergic or central nervous system stimulation 
and certain ?Gs
Angiotensinogen
•enin release from 
juxtaglomerular cells
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i he underlying mechanisms that modulate vascular smooth muscle tone.
A schematic diagram showing the principal mechanisms that modulate tone 
in vascular smooth muscle. The endothelial cell release EDRF (NO) and 
PG12 1 which respectively activate cytosol ic guanylate cyclase (GC) to 
produce cGMP, and membrane adenylate cyclase (AC) to produce cAMP. 
AC, unlike GC, is regulated via both excitatory and inhibi tory receptors, 
which control  the enzyme by activating G-proteins (Gj and Gs ). NA released 
from noradrenergic nerves acts on cr-| -adrenoceptors to cause Pl-hydrolysis, 
which results in the production of IP3  and DAG which cause contract ion. 
NA release is regulated via various presynaptic receptors. The tone of 
vascular smooth muscle is the resultant of the opposing mechanisms that 
cause contraction and relaxation (Sharifi, 1992).
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-Fig-4
Radiographs of pithed rats with pithing rod electrodes in the vertebral  
canals.
A- Diagram of the pi thing roc electrode assembly i l lustrating tne stimulat ing 
electroae. tne teflon insulation tuoe anc the steel guide tube.
B&C- Two radiographs of pithec 'ats i l lustrating the pithing roc eiectroces 
inserted through the eye orbit, tne foramen magnum and into the vertebral  
canal. Raciograpn-B showing the position of tne electroc.e at Tg. j .  whicn 
gave the maximal increase in oeart rate (beats m in * 1-. Raaiograoh-C 
snowing tne posit ion of tne eiectroce at T o . q  wnicn gave tne maximal 
increase in blood pressure (mmHg . The teflon insulation :s not racio-ooaaue 
ana therefore can not be observed.
-Fig-5 72
Responses il lustrated as increases in heart rate and in blood pressure to the 
spinal nerve stimulat ion in the pithed rats.
u -
100 80 60 40 20 0 0 20 40 60 80
A  HR Beais in in _ lz  P iTimh'G
Responses in the pithed rat to preganglionic st imulat ion of the sympathet ic  
ou t f low  at 20 Hz using a teflon shielded electrode w i th  a 1 cm electrode 
and supramaximal voltage and 0.4 ms pulse-durat ion. The histograms show 
the responses (Mean ± SEM, n = 4 )  expressed as increases in heart rate ( 
HR, basal HR = 216.7  beats min ± 23.3 beats min , n = 3) and
increases in blood pressure ( BP, Basal BP = 23.1 mm Hg ± 42 mm Hg,
n = 4). The posit ions of the electrode are indicated by the corresponding 
vertebrae, from the first cervical (C-j) through the thoracic vertebrae (T-j-
T -] g ) down to the third lumbar (L3 ). The posit ion of the electrode was
checked radiographically. In most experiments the electrode was located at 
1"8-9' w here the maximal increase in BP was obtained.
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Fig-6
Pressor responses to nerve stimulation in the pithed rat.
3 6 mm K
x m m
The characteristic pressor resoonses to electrical st imulation of the spinal 
sympathet ic ou t f low at T g . g  with supramaximal voltage, 0 .4  ms pulse- 
durat ion at 2 Hz (S-j) and 20 Hz (Sg) for 100 pulses in the pithed rat. The
periods of nerve stimulat ions are shown as ( -----  = 60s and — =5s) .  The
original basal blood pressure is also snown to the left of the trace.
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Fig-7
Effect of adrenalectomy on pressor responses to nerve stimulation in the 
pithed rat.
mm Ha —
Si
15 mm Ha —
Adrenalectomy
s -
The characteristic pressor responses to electrical stimulation of the spinal 
sympathet ic ou t f low  at Tg.g  with supramaximal voltage, 0 .4  ms pulse- 
duration at 2 Hz (S-j) and 20 Hz (Sg) tor 100 pulses in the pithed rat. The 
trace in pane! B is a cont inuat ion of that in panel A. Adrenalectomy lowered 
the basal blood pressure ana substantially reduced the pressor responses to 
nerve stimulat ion. Propranolol (2 mg kg , iv.) was present throughout the
experiment. The periods of nerve stimulations are shown as (----- = 50s and
= 5s). The original basal blood pressures are also shown to the left of the 
traces in each panel.
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Fig-9
Effect of propranolol  on pressor responses to nerve stimulat ion in pithed 
rats with low and high basal blood pressures.
—  o0  -
60 -
- '10 r1 I
2  2 0 -
I i
I I I
0 L
2 ! i z 201
:ontrol
i
Prop
(2mgkg’ 1)
©
>25-30 
mm Hg
2Hl
®
■ir +■
T
20iiz
<18-22
20Hzmm-Hg 2HZ
Histograms showing pressor responses (mm Hg, Mean ±  SEM, n > 1 0 )  to 
electrical stimulation at Tg.g at 2 Hz and 20 Hz in control  (untreated) pithed 
rats and in pithed rats treated with propranolol (Prop, 2 mg kg' , iv., A and 
B). In the histograms, "S" indicates the pressor response obtained during 
electrical stimulat ion and the "a" indicates the peak post-stimulat ion 
response, obtained after stimulat ion had stopped. St imulation at 20 Hz 
produced larger responses than those obtained at 2 Hz and all of these 
responses w ith  the except ion of the response obtained during stimulat ion at 
20 Hz, were usually increased by propranolol (2 mg kg'  ). In some rats w ith  
low resting blood pressures (Panel B), propranolol did not increase 
responses to stimulat ion but reduced the response obtained during 
st imulation at 20 Hz. It may be that in these rats, the balance of the 
opposing effects of propranolol  reduced the capacity to maintain a pressor 
response to electrical stimulation. The ability of propranolol  to block 
vascular f tg-adrenoceptors would normally tend to enhance the pressor 
effects of circulating catecholamines but this would only be possible as long 
as the abil i ty of propranolol to block cardiac -adrenoceptors did not impair 
cardiac output and the capacity of the heart to maintain a pressor response. 
The basal blood pressures are also shown for panel A ( > 2 5 - 3 0  mm Hg) and 
panel B ( < 1 8 - 2 2  mm Hg). These were the resting blood pressures after 
propranolol  administration and before nerve stimulation. (* 0 . 0 5 > P > 0 . 0 1 ,  
* *  0.01 > P > 0 . 0 0 1 ) .
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Fig-13
Effect of prazosin on pressor responses to a single dose of IMA and nerve 
stimulat ion in the pithed rat.
1 min
u nun ncr
NA
NA St
2 3 ntm he
NA NA S i S-
The pressor responses to NA (0.3 j jq kg , iv.) and to electrical stimulation 
of the spinal sympathet ic outf low at Tg.g with supramaximal vol tage, 0.4  
ms pulse-duration at 2 Hz (St )  and 20 Hz (Sg) for 100 pulses in the pithed 
rat. The trace in panel B is a continuation of that in panel A. Prazosin (Pr, 2 
mg kg , iv.) substantial ly reduced the pressor responses to NA and nerve 
stimulat ion but did not abolish them completely. Propranolol  (2 mg kg , iv.) 
and Captopri l (1 mg kg" , iv.) were present th roughout this experiment.  The 
periods of nerve stimulations are shown as (----- = 50s and —= 5s) .
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Fig-18
Effect of L-NAME on blood pressure in the absence and presence 
propranolol  in pithed and anaesthetised rats.
L - N A M EL - N A M E
P i t h e d .  A n a e s th e t is e d
L - N A M E L - N A M E N A M E
Pithed A n a e s t h e t i s e d Pithed A n a e s t h e t i s e
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Fig-18
In pithed and anaesthetised rats, L-NAME (45 mg kg' , iv.) increased the 
basal blood pressure (mm Hg, Mean + SEM, n > 3 ) in the absence and
presence of propranolol (Prop, 2 mg kg , iv.). In all four panels (A,B,C,D),
the basal blood pressures are shown as open columns and the ones w ith L- 
NAME are shown as patterned columns. Panel A, illustrates the effect of 
propranolol in lowering the basal blood pressure and lowering the size of L- 
NAME-induced increase in blood pressure in the pithed rat. Panel B, 
illustrates no effect o f propranolol on the basal blood pressure and the L- 
NAME-induced increase in blood pressure in the anaesthetised rat. Panel C, 
illustrates, higher basal blood pressure and higher maximal blood pressure, 
induced by L-NAME in the anaesthetised rat compared w ith the pithed rat. 
Panel D, illustrates, higher basal blood pressure and higher maximal blood 
pressure, induced by L-NAME in the presence of propranolol in the
anaesthetised rat compared w ith the pithed rat. The asterisks above each 
test column show the significant differences w ith their correspondent 
column in the control group in each panel (* 0 .0 5 > P > 0 .0 1 , * * *
PcO .001). All L-NAME-induced rises, in the absence and presence of 
propranolol, in the pithed and anaesthetised rats are significant ( + 
0.05 > P > 0 .0 1 , + + + PcO .001).
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Fig-19
Correlation between the resting blood pressure and the L-NAME-induced 
increase in blood pressure in the absence and presence of propranolol  in the 
pithed rats.
©
P i t h e c  (1  -  N A M E '
P i t h e d  ( P r o p  -  L —N A l f E )
0 2 0  AO 6 0  8 0  1 0 0   ^ 2 0  1 AO 1 6 0  1 8 0
R e s t i n g  b l o o d  p r e s s u r e  ( m m  H g )
1 00
8 0
20
- 2 0
a - 6 0
0 2 0  A0  6 0  B0  1 0 0  1 2 0  1 A0  1 6 0  1 8 0
R e s t i n g  b l o o d  p r e s s u r e  ( m m  H g )
The regression lines showing the linear relationship between the resting 
blood pressure (mm Hg) and the L-NAME (45 mg kg '  , iv.)-induced 
increases in blood pressure (mm Hg) in the absence (panel A) and presence 
(panel B) of propranolol (Prop, 2 mg kg" , iv.) in the pithed rats. The extent 
to which L-NAME raised the basal blood pressure was proportional to the 
initial basal blood pressure in the absence (panel A, correlation coeff ic ient 
R = 0.96, n = 5, 0.01 > P > 0.001) and presence (panel B, correlation
coeffic ient R = 0.64, n = 19, 0.01 > P > 0 . 001) of propranolol.
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Fig-20
Scanergrams between the resting blood pressure and the L-NAME-induced 
increase in blood pressure in the absence and presence of propranolol  in the 
anaesthetised rats.
© ©
A n a e s t h e t i s e d  ( L  — N A M E ) A n a e s t h e t i s e d  ( P r o p  -  L - N A M E )
0 2 0  AO 60  BC 1 0 0  2 0  1 a o  1 6 0  1 BO
R e s t i n g  b l o o d  p r e s s u r e  ( m m  K g )
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- A 0  L
- 6 0  I—
2 0  A0 6 0  BO 1 0 0  1 2 0  1 A0  1 6 0  1 8 0  
R e s t i n g  b l o o d  p r e s s u r e  ( m m  H g )
The scattered data, showing no linear relationship between the resting 
blood pressure (mm Hg) and the L-NAME (45 mg k g ' ,  iv.)-induced 
increases in blood pressure (mm Hg) in The absence (Panel A) and presence 
(Panel B) of propranoiol  (Prop, 2 mg kg' , iv.) in the anaesthetised rats.
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Fig-22
Effects of Propranolol, L-NAME and 5-HT; administered consecutively on 
pressor responses to nerve stimulation in the pithed rat.
Histograms of pressor responses (mm Hg, Mean ±  SEM, n > 1 1 )  in the 
pithed rat to electrical stimulat ion of the spinal sympathet ic ou t f low  at Tg .g  
w ith  supramaximal voltage, 0.4  ms pulse-duration at 2 Hz (S-]) and 20 Hz 
(Sg) for 100 pulses. Stimulat ion at 2 Hz and 20 Hz produced character ist ic 
responses, which are shown here as peak responses obtained during 
st imulat ion with  the secondary, smaller post-st imulus responses that 
persisted after stimulation ceased, indicated by the smaller adjoining 
histogram. Propranolol (Prop, 2 mg kg" , iv.) enhanced the pressor 
responses to electrical stimulation at 2 Hz and also enhanced the 
secondary, smaller post-stimulus response that persisted after st imulation at 
2 PLz and 20 Hz. After propranolol, the administrat ion of L-NAME (45 mg 
k g ' 1, iv.) raised the basal blood pressure but had no other effect.  5-HT ( 6  
jjq k g ,  iv.) inhibited the pressor responses obtained during and also 
persist ing after electrical stimulation of the sympathet ic nerves at 2 Hz and 
20 Hz. The starting basal blood pressure was (Mean = 34.32 mm Hg, SEM 
= 2 .63 mm Hg, n = 11). ( * *  0.01 > P > 0.001, * * *  P < 0 .0 0 1 ) .
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Fig-25
Effect of L-NAME on the pressor response to a,E»-mATP in the pithed rat.
mm Hg
i
The pressor responses to a,&-mATP (0.05 mgkg , iv.) in the absence and 
presence of L-NAME (45 mgkg , iv.) in the pithed rat. L-NAME produced a 
small rise in the basal blood pressure and enhanced the tox ic i ty  of c,R>- 
mATP. Propranolol (2 mgkg , iv.) was present throughout this experiment.
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□ H o j u j 0 L
Effect of L-NAME on the pressor responses to cumulative concentrations of 
5-HT in the isolated, Krebs-buffer perfused pulmonary vasculature of the
Wistar rat
L-NAME
( 400 jUM)
Traces showing pressor resDonses to cumulat ively perfused increasing 
concentrat ions of 5-HT (0.1-100 /yM) in the Krebs-buffer perfused rat 
pulmonary circulation in the absence (panel A) and presence (panel B) of L- 
NAME (400 /yM). The trace in panel B is a cont inuat ion of the trace in panel 
A. L-NAME enhance the 5-HT-induced pressor responses at the submaximal 
concentrat ions ( 1 0 -1 0 0 /yM).
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Fig-38
Effect of KCI on the concentrat ion-response curve to 5 -HT in the presence 
of L-NAME in the isolated Krebs-buffer perfused pulmonary vasculature of 
the Wistar rat.
O C o n t r o l  
•  P r e t r e a t e d  
w i t h  KCI
30
* * *25
1 5
1 0
5
0dM 0.1 1 0 1 00 1 0 0 0
[ 5 - H T ]  (/xM)
Concentration-response curves to 5-HT (1-100 /yM) in the Krebs-buffer 
perfused rat pulmonary circulation, in the presence of L-NAME (400 //M) 
and in the absence and presence of an initial equil ibrium perfused single 
submaximal concentrat ion of KCI (40 mM) which was then stopped and the 
preparation allowed to recover before the concentration-response curve to 
5-HT was obtained. Each concentrat ion of 5-HT was perfused to obtain an 
equi l ibrium resDonse and then the preparation washed with  Krebs-buffer 
containing L-NAME to allow it to recover before the next concentrat ion was 
perfused. KCI enhanced the pressor responses to 5-HT (10-100 /yM). The 
results are shown as Means ± SEM, n = 3. The basal perfusion pressure 
before the start of the control  curve was (Mean = 14.67 mm Hg, SEM = 3.93 
mm Hg, n = 3) and of the test curve was (Mean = 8.33 mm Hg, S E M = 0 .3 3  
mm Hg, n = 3). (* 0 . 0 5 > P > 0 . 0 1 ,  * * *  P <0 .001) .
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Fig-39
Concentration-response curve to PE in the isolated Krebs-buffer perfused 
pulmonary vasculature of Wistar and Sprague Dawley rats.
O PE ( W i s t a r )
•  PE ( S p r a g u e  
D a w le y )
ttf
►—I
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3BBUtn
A
3o
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1 5
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1 2
1 0
B
6
4
2
0 -----------
0. 001  0.01 100  1 0 0 01 00.1
[P E ]  OxM) 
C u m u l a t i v e  p e r f u s i o n s
Concentration-response curves to PE (0.01-100 /yM), perfused cumulatively, 
in the Krebs-buffer perfused pulmonary vasculature of Wistar and Sprague 
Dawley rats. The pressor responses to PE (0.1 and 1 /yM) were bigger in 
Sprague Dawley rats. The results are shown as Means ±  SEM, n > 3 .  The 
basal perfusion pressure before the start of the control  curve was 
(Mean = 1 3.7 mm Hg, S EM = 0.93 mm Hg, n = 1 0) and of the test curve was 
(Mean = 22.0 mm Hg, SEM = 6.0 mm Hg, n = 2). (* 0.05 > P> 0.01).
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Fig-41
Effect of a mixture of L-NAME, propranolol and yohimbine on the
concentration-response curve to PE in the isolated Krebs-buffer perfused
pulmonary vasculature of the Wistar rat.
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Q)
U
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O<OS
O C o n t r o l  
•  L - N A M E  - 
( 4 0 0  ,uM) 
P r o p r a n o l o l  
( 1 0  ^ M )  
Y o h i m b i n e  
(1  MM)
30
25
20
5
5
0 -----------
0 . 0 01  0.01 0.1 1 0 100 1 0 0 0
[P E ]  C/xM) 
C u m u l a t i v e  u e r f u s i o n s
Concentration-response curve to ^E (0.01-100 /vM), perfused cumulatively, 
in the aosence and presence o* a mixture of L-NAME (400 //M)» propranoioi  
(10 /yM) anc yohimbine (1 >uM) in me Krebs-buffer perfused rat pulmonary 
circulation. The mixture of antagonists enhanced tne pressor responses to 
PE. The results are snown as Means = SEM, n > 3 .  The basai perfusion 
pressure Pefore the start of tne control curve was (Mean = 13.7 mm He, 
SEM = 0.23 mm Hg, n = l0 )  anc of tne test curve was (Mean = 18.0 mm Hg, 
S E M = 0 .0  mm Hg, n = 1 ). * 0 . 0 5 > P > 0 . 0 1 ,  + "■ 0.01 > P > 0.001 ).
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Fig-42
Effect of L-NAME on the pressor response to a submaximal concentration of
5-HT in the isolated Krebs-buffer perfused pulmonary vasculature of the
Wistar rat.
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5KT
(50/xM)
L -N A M E
(400/xM).
Histograms snowmc tne pressor responses to an eouii iDrium perfused, 
singie submaximal concentration of 5-HT (50 //M) in the aosence anc 
presence of L-NAME .4Q0 pVA), in the Kreos-ouffer perfused rat puimonary 
circulation. L-NAME enhanced tne pressor resoor.se to 5-HT. The results are 
snown as Means = SEM, n > 1 4 .  The starting, oasai perfusion pressure was 
(Mean = 12.79 mm Hg, SEM = 0 .7 9  mm Hg, n = 14). {* * * P < 0 .0 0 1 ) .
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Fig-43
Effect of L-NAME on the concentration-response curve to 5-HT in the
isolated, Krebs-buffer perfused pulmonary vasculature of the Wistar rat.
O C o n t r o l  
•  L - N A M E
20 i
★ ★ ★
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co
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- 8 - 7 6 - 5 4 - 3 -  2 -  1
Log [ 5-HT ] M
Concentration-response curves for 5-HT in the rat pulmonary vasculature. 5- 
HT was administered by perfusion until a stabie equi l ibr ium resDonse was 
obtained at each concentrat ion (Means = SEM, n = 8 ). This figure shows 
responses to 5-HT before (O) and after <•) administration of L-NAME (500 
pM)  to the Krebs-buffer solution. L-NAME increased responses to 5-HT.
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Fig-44
Effect of L-NAME on the concentration-response curve to PE in the isolated
Krebs-buffer perfused pulmonary vasculature of the Wistar rat.
EC
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•  PE-i-L—NAME
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2
0
0.1 1 10 
[P E ]  ( / i M )  
C u m u l a t i v e  p e r f u s i o n s
1 0 0  1 0 0 0
Concentration-resoonse curves to 3E (0.01-100 p M), perfused cumulat ive ly,  
in the absence and presence of L-NAME <400 /;M) in the Krebs-buffer 
perfused rat pulmonary circulation. L-NAME ennanced the pressor 
responses of PE. The resu::s are shown as Means -  SEM, n > 4 .  The basal 
perfusion pressure before tne start of tne control curve was (Mean = 13.7 
mm Hg, SEM = 0.93 mm he, n = 1 0) anc of tne test curve was (Mean = 20.5 
mm Hg, SEM = 1.53 mm He, n = 7L * 0.05 > P >  0.01, + + 0 . 0 1  > P > 0 . 001).
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Fig-45
Effect of flurbiprofen on the concentration-response curve to KCI in the
isolated Krebs-buffer perfused pulmonary vasculature of the Wistar rat.
50
oc O KCI
• KCl + Flur 
(2^M )e 40
E
03
u 30 
3K
03
03
A  20
O
03
1 1 0 1 00
[KC I ]  (m M )
Concentration-response curves to KCi 13-80 mM) in tne Krebs-buffer 
perfusec rat pulmonary circulation, in tne absence and presence of 
fiuroiprofen (Fiur, 2 //M). Eacn concentration of KCI was perfused until an 
equilibrium response was ootainec anc tnen the perfusion was stopped anc 
tne preparation was allowed to recover oefore the next concentra t ion was 
perfused. Fiuroiprofen :2 pM)  enhanced the pressor response to KCI at oniy 
one point in tne concentration-response curve (30 mM) and did not affect 
tne maximal pressor response to KCI. The results are shown as Means = 
SEM, n = 4. The basa: perfusion pressure oefore the start of the control 
curve was .(Mean = 1 2.5 mm Hg, SEM = 1.94 mm Hg, n = 4 ) anc of the test 
curve was (Mean = 14.5 mm Hg, SEM = 1.55 mm Hg, n = 4 ) .  ( +
0.05 > P >0 .0 1 ) .
1 1 6
Fig-46
Effect of flurbiprofen on the concentration-response curve to PE in the
isolated Krebs-buffer perfused pulmonary vasculature of the Wistar rat.
O PE
•  PE +  F l u r  (2
S
*4e
©u
dB
B©
n. 30
do
B
s
1 0 0 01 0 1 000 . 0 0 1  0. 01 0.1 41
[P E ]  (m M )
Concentration-response curves to PE (0.01-100 p M) in tne Kreos-buffer 
perfused rat pulmonary circulation, in tne aosence and presence of 
f iuroiprofen (Fiur, 2 //M). Eacn concentrat ion of PE was perfused unti l  an 
equilibrium response was obtained anc then tne perfusion was stopped and 
tne preparation was allowed to recover before tne next concentra t ion was 
perfused. Flurbiprofen had no effect on the ^E-incucec pressor responses. 
The results are shown as Means n SEM, n >  3. The basal perfusion 
pressure before the start of the control curve was (Mean = 20 .83  mm Hg, 
SEM = 3.23 mm Hg, n = 6 ) and of tne test curve was (Mean = 16.5 mm Hg, 
SEM = 1.5 mm Hg, n = 2).
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Fig-47
Effect of f lurbiprofen on the pressor response to a submaximal 
concentrat ion of 5-HT in the presence of L-NAME in the isolated Krebs- 
buffer perfused pulmonary vasculature of the Wistar rat.
BC
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BET
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f lu r
Histograms showing pressor responses to a submaximal concentra t ion of 5- 
HT ,20 jjM)  in  tne aosence anc presence of f iuroiprofen (Flur, 2 pW\) in tne 
Kreos-buffer perfused rat puimonary vasculature. L-NAME (400 p M) was 
present th roughout this experiment. Fiuroiprofen enhanced the pressor 
response to 5-HT. Tne resuits are snown as Means — SEM, n > 1 0 .  Tne 
starting oasai perfusion pressure was (Mean = 1 3 .2 5  mm Hg, SEM = 0 .94  
mm Hg, n = 8 ). + 0 . 0 5 > P > 0 .0 1 ) .
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Fig-49
Effects of propranolol and flurbiprofen, administered in sequence, on the 
concentration-resDon.se curves to adrenaline in the presence of a mixture of 
L-NAME and yohimbine in the isolated Krebs-buffer perfused pulmonary 
vasculature of the Wistar rat.
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g 30 -
3 25 -
20
10 r
0
0.01
O C o n t r o l  
•  P r o p r a n o l o l  
(1 0  ,u.M)
V  P r o p r a n o l o l  
( l"o mm) 
F l u r b i p r o f e n  
(2 MM)
0.1 1 1 0 1 00 1 0 0 0  
[ A d r e n a l i n e ]  ( a-M)
Concentraiion-resDOP.se curves to adrenaline (0.1-100 /vM) in the absence 
and presence of propranolol (10 //M) and f iuroiprofen (2 a/M) wni ie L-NAME 
(400 f jM) and yohimbine (1 //M) beinc present th rougnout the experiment in 
tne Krebs-ouffer perfused rat pulmonary circulation. Each concentrat ion of 
adrenaline was perfused until an equilibrium response was obtained and 
tnen the perfusion was stopped and tne preparation was al lowed to recover 
oefore the next concentrat ion was perfused. The results are shown as 
Means -  SEM, n > 2 .  Tne basal perfusion pressure before the start of tne 
control curve was (Mean = 15.5 mm Hg, SEM = 2.9 mm rig, n = 4), and of 
the curve in the presence of propranolol was (Mean = 2 1 . 6  mm Hg, 
SEM = 2.9S mm Hg, n = 5) and of tne curve in the presence of both 
propranolol and fiuroiprofen was (Mean = 19.5 mm Hg, SEM = 3.5 mm Hg, 
n = 2 ).
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Fig-51
Concenirai ion-resDonse curves ic NA ai 1 4 % 0 2  and 9 5 % 0 2  aassed-Krebs- 
buffer, in tne isolated, perfused pulmonary vasculature of the Wistar  rat.
«  1
S 1
d
s
c
d
u
c
L
2
D
B
6
2
D.D1 1 1 C
[N A ]  { f i i L )
1 DO
O 9 5 % C 2 
•  14 % 02
000
Concenirstion-resDon.se curves to NA (0.1-100 //M) in the Kreos-buffer 
perfused rat pulmonary circulation. Each concentrat ion of NA was perfused 
until an equil ibrium response was ootamed and then the perfusion was 
stopped and tne preparation w'as allowed to recover before tne next 
concentrat ion was perfused. This experiment examined tne effect of 
reducing the percentage of oxygen in the gas, Dubbied th rough the Krebs- 
buffer from 9 5 % 0 2  to 1 4 0/o02- Tne results are shown as Means ±  SEM, 
n > 2.
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Fig-53
Effect of Propranolol on tne concentration-response curve to NA in 14%C>2 
aassed-Krebs-buffer, in the isolated, perfused pulmonary vasculature of tne 
Wistar rat.
1 4 % 0 2
O C o n t r o l  
•  P r o p r a n o l o l  
(1 0  jxM)
D. 0 1 0.1 1 10 
[NA] ( m M)
1 00  1 ODD
Concentrstion-response curves to NA (0.1-100 p\\A) in the absence and
presence of propranolol (10 zvM) in Kreos-buffer, gassed w i th  a mixture of
1 A°/o0 2 , 5°/oC02 snc 8 1 % N 2 anc perfused tnrougn the rat pulmonary 
circulation. Eacn concentrat ion of NA was perfused until an equi l ibrium 
response was obiainec anc then tne perfusion was stopped and the 
preparation was allowed to recover oefore the next concentra t ion was 
perfused. Propranolol enhanced tne pressor responses to NA. The results 
are snown as Means -  SEM, n = 2. The basal perfusion pressure before the 
star: of tne control curve was -(Mean = 15.0 mm Hg, SEM = 4 . 0  mm Hg, 
n = 2) and of the test curve was (Mean = 21.5 mm Hg, SEM = 1.5 mm Hg,
n = 2). r  0.05 > P > 0.01).
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Fig-54
Effect of L-NAME on tne innionory concentrat ion-response curve 10 
isoprenaiine, perfused on tne Dressor response to 5-HT, in the isolated 
Krebs-buffer perfused puimonary vasculature of the Wistar rat.
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Innionory concentrat ion-response curves to isoprenaiine (10 -10 M),
perfused cumulatively, on tne ongoing pressor response to a submaxima! 
concentrat ion of 5-H7 (50 /yM) in the absence and presence of L-NAME 
(400 /yM) in tne Kreos-ouffer perfused rat puimonary circulation. Each 
concentrat ion of isoprenaiine was perfused until an equi l ibrium inhibi tory 
response was obtained. The reason for not having tne lower part of tne 
percentage inhibitory effect of isoprenaiine was tne character ist ic pressor 
response to 5-HT which was not well-maintained. Tne inhibi tory e ffect  of 
isoprenaiine was measured from the peak pressor response to
5-HT and nence it was unclear wnetner isoprenaiine at lower concentra t ions 
( < 1 0 ~7  M) had any inhibitory effect as the pressor response to 5-HT had 
aiready oeciinec on its own. Tne results are snown as Means ±  SEM, n > 2 .
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Fig-55
Inhibitory concentration-response curve to isoprenaiine, perfused on tne
pressor response to PE, in the isolated Krebs-buffer perfused puimonary
vasculature of the Wistar rat.
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pretreated witn  an eauii iorium oerfusec singie concentrat ion of KC! (50 mM) 
in tne Kreos-ouffer oerfused 'a: puimonary circulation. Eacn concentra t ion 
of isoprenaiine was oerfusec until an eauiiiorium inniDitory response was 
ootainec. The results are shown as Means -  SEM, n = 2.
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Fig-56
Inhibitory concentration-response curve to isoprenaiine, perfused on the
pressor response to KCI, in the isolated Krebs-buffer perfused pulmonary
vasculature of the Wistar rat.
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perfused cumulat ively,  on the ongoing pressor response to a submaximal 
concentrat ion of KCi (50 mM) in the Krebs-buffer perfused rat puimonary 
circulation. Each concentration of isoprenaiine was perfused until an 
equil ibrium inhibitory response was obtainea. The results are shown as 
Means ±  SEM, n = 3.
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Fig-57
Inhibitory concentration-response curve to SNP, perfused on the pressor
response to 5-HT, in the presence of L-NAME in the isolated Krebs-buffer
perfused pulmonary vasculature of the Wistar rat.
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1 0  7Inhibitory concentrat ion-response curve to SNP (10 -10 M), perfused
cumulat ively, on the ongoing pressor response to a submaximal 
concentrat ion of 5-HT (20 /yM) in the presence of L-NAME (400 /yM) in the 
Krebs-buffer perfused rat pulmonary circulation. Each concentrat ion of SNP 
was perfused until an equilibrium inhibitory response was obtained. The 
results are shown as Means ± SEM, n > 6 .
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Fig-58
Effect of L-NAME on the inhibitory concentrat ion-response curve to SNP, 
perfused on the pressor response to PE, in the isolated Krebs-buffer 
perfused pulmonary vasculature of the Wistar rat.
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1 0  4Inhibitory concentrat ion-response curves to SNP (10" -10 ’ M) , perfused
cumulatively, on the ongoing pressor resoonse to a maximal concentrat ion 
of PE (50 /yM) in the aosence and presence of L-NAME (400 /yM). Each 
concentrat ion of SNP was perfused until an equi l ibrium inhibitory response 
was obtained. L-NAME enhanced the inhibitory effect of SNP on the 
ongoing pressor response to PE. The results are shown as Means ± SEM, 
n >  3, (* 0.05 > P >  0.01, * *  0.01 >P > 0 .0 0 1 ) .
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Fig-59
Effect of L-NAME on the inhibitory concentrat ion-response curve to SNP, 
perfused on the pressor response to KCI, in the isolated Krebs-buffer 
perfused pulmonary vasculature of the Wistar rat.
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Concentrat ion-response curves to SNP (10 -10" M), perfused
cumulatively, on the ongoing pressor responses to submaxi mal 
concentrat ions of KCI (40 mM) in the absence and presence of L-NAME 
(400 /vM) in the Krebs-buffer perfused rat pulmonary circulation. L-NAME 
enhanced the inhibitory effect of SNP on the ongoing pressor response of 
KCI when tne regression lines of the two  concentrat ion-response curves 
were compared according to the method and formulae described in the 
Bowman and Rand (1980). The results are shown as Means ±  SEM, n = 4 ,  
0.01 > P > 0 . 0 0 1 ) .
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Fig-63
Pressor responses to 5-HT on the ongoing pressor response to PE, in the 
isolated, Krebs-buffer perfused hindquarters vasculature of the Wistar rat
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Histogram showing the pressor responses to cumulat ively perfused, 
increasing concentrat ions of 5-HT (0.001-10 /yM) on the ongoing pressor 
response to a submaximal concentration of PE (10 /yM) in the rat 
hindquarters vasculature, perfused with Krebs-buffer. The results are Means 
± SEM, n = 2. The starting basal perfusion pressure was (Mean = 48 mm 
Hg, SEM = 3 mm Hg, n = 2).
Fiy
 
64 
Co
nc
en
lr
at
io
n-
re
sp
on
se
 
cu
rv
es
 
lo 
the
 
pr
es
so
r 
ef
fe
ct
 
of 
PE 
an
d 
to 
th
e 
in
hi
bi
to
ry
 
ef
fe
ct
 
of 
SN
P 
on 
su
hm
ax
im
al
 
re
sp
on
se
s 
to 
PE 
in 
the
 
is
ol
at
ed
, 
Kr
eb
s 
bu
ffe
r 
pe
rfu
se
d 
hi
nd
qu
ar
te
rs
 
va
sc
ul
at
ur
e 
of 
the
 
Wi
st
ar
 r
at
s.
i T
3
g O O o c c G c G G G G
CN o 00 C O N " CN O C D C D N * CN
CN CN T— T— T — T — T—
( 3 H  h i t i i ) s j T i s s a j d  n o x s n T ^ g j
134
<■> 0 > Q_> 0 CL
00 > 0 —
0 i_
> 000
_0 O
o O _0 I0 __ fm oO 0000 0
—/
0 C/30 o
5 D
'ZD
0
> T~^_
o. 00 00
P
Eoo/■»>‘'O D
i_
0
cu 0 W0
P
u
o “
--- .—^ O"
0 ~D £'*— 00
0
0
"a?r—
0 o
000
o '0
o 05 00 U
0 i 0o 00
0>
5
0
0oo
oo
co
C ^  
_ — n 0
'■  a .
f  z  S-o 
^ 2 
-C o  >  —oo —> —
o  ooo Z . Z. O 0 O _C£2 > — 00
« =-£ 8 (0 • =  -
^  0 P ~ 
CC r  5  Z
o ~ 2
o r  o . — oo^ h= 0 
= -
, w  a
'8  !  “  ~
T 0 o -
000
L_
0
p
0>1—
0
1 3
0
0
i_
! ?i
p
f-
0
00 .
0 II
^  iCD >I Q
05 _o 
Ll co
5 P i
°  o. 
^  °  oQ_ O -P
0
§ 20 ULI
—  CO 
|+ l  
w 2
C 0<D 0
0 3.u_C. 0
®  mi- 0
Fi
g-
65
 
Pr
es
so
r 
re
sp
on
se
s 
to 
PE
, 
in 
the
 
is
ol
at
ed
, 
Kr
eb
s-
bu
ffe
r 
pe
rfu
se
d 
hi
nd
qu
ar
te
rs
 
va
sc
ul
at
ur
e 
of 
the
 
Wi
st
ar
 r
at
135
Th
e 
tra
ce
 
sh
ow
s 
pr
es
so
r 
re
sp
on
se
s 
to 
cu
mu
la
tiv
e 
co
nc
en
tr
at
io
ns
 
of 
PE 
(0
.1
- 
10
0 
//M
) 
in 
the
 
Kr
eb
s-
bu
f 
fer
 
pe
rfu
se
d 
hi
nd
qu
ar
te
rs
 
va
sc
ul
at
ur
e 
of 
the
 
ra
t. 
Ea
ch
 
co
nc
en
tr
at
io
n 
of 
PE 
wa
s 
pe
rfu
se
d 
un
til
 a 
sta
ble
 
(e
qu
ili
br
iu
m)
 r
es
po
ns
e 
wa
s 
ob
ta
in
ed
.
Fi
g-
66
 
Pr
es
so
r 
re
sp
on
se
s 
to 
KC
I, 
in 
the
 
is
ol
at
ed
, 
Kr
eb
s 
bu
ffe
r 
pe
rfu
se
d 
hi
nd
qu
ar
te
rs
 
va
sc
ul
at
ur
e 
of 
the
 
Wi
st
ar
 r
at
136
DH LULL 03
Th
e 
tra
ce
 
sl
:;:
.vs
 
pr
es
so
r 
re
sp
on
se
s 
to 
cu
m
ul
at
iv
e 
co
nc
en
tr
at
io
ns
 
of
 
KC
I 
(10
 
30
0 
//M
) 
in 
the
 
Kr
eb
s-
bu
ffe
r 
pe
rfu
se
d 
hi
nd
qu
ar
te
rs
 
va
sc
ul
at
ur
e 
of 
th
e 
ra
t. 
Ea
ch
 
co
nc
en
tr
at
io
n 
of
 
KC
I 
wa
s 
pe
rfu
se
d 
un
til
 
a 
st
ab
le
 
(e
qu
ili
br
iu
m
) 
re
sp
on
se
 
wa
s 
ob
ta
in
ed
.
33
Fi
g-
67
 
Co
nc
en
tr
at
io
n-
re
sp
on
se
 
cu
rv
es
 
to 
the
 
pr
es
so
r 
ef
fe
ct
 
of 
KC
I 
an
d 
to 
th
e 
in
hi
bi
to
ry
 
ef
fe
ct
 
of 
SN
P 
on 
su
bm
ax
im
al
 
re
sp
on
se
s 
to 
KC
I 
in 
the
 
is
ol
at
ed
, 
Kr
eb
s-
bu
ff
er
 p
er
fu
se
d 
hi
nd
qu
ar
te
rs
 
va
sc
ul
at
ur
e 
of 
the
 
Wi
st
ar
 r
at
s.
i i
OH
/
O H LO
CD
>
CO
Cm
ZQQ
QCOJ
a
o S
« O
CD
o9
Dm
zDQ
WO
- a  o 0
M o
CD '
O  ^ d
o rt
-  -  B «j r
d 2
u  a u
w d «>—• u  cx
0)
,— * t> ■3a d
o M-l oo a d
•“ M K
I— 1 d dQ *— < a «Mu d »Mbd d QJcu 1— 1u Pm
0 .
o O O O o o o C D O o o O
CM O CD CO CM o CD CO M - CM
CM CM r — T— r - T— r —
(E g  m m )  a i n s s s i d  n o i s n j j s j
137
o o 
co
> r- Q- CO
CD ■ — 0. w
> CD JD Z3o. CO
JD D CD
D _CD
2D JZ JZ
O *~ h -
a COCD O <D
>*3 >  CD
CD '— ' u_
CO CO
3 CD CJ o
■_ w \ s *—
<■> 5 733 ■~- CD
— . w CD
1 °  
- o
?Q_
CD
CD
<
jo
CD
CD
>  00 r *
_ n  oco w 
co C3 v-/ >» CO >
■- 3
^  03 —.
r- O  03
.=  co -p
"ro ~CO V_ <— 0) -
CO J I
o g 
E^>
cd 
2 0)
CD
CD ■—
'3= CO 
—  CO
-  CD
CO
2 ™
W o 
— co 
cd c
— o
S  co 
== CD
o
■ —  co
0 . 2  o
CD
CD CO
Co
CO * >
cd Lju 
— cn
f  +1
co
£ ' 2
b 2
m CO C3  -----  -°? ^  3 £  c «c
T 3  a ; CD 
O  _r^  co ^  
CD
CO 3  
1—  CD 
O
o  O
LL tn  ^  CD
c^.2
r~
o ^
a .  a)
>_ CD
Fig-68 Blood pressures in SHR and WKY rats.
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Histogram showing the blood pressures, measured by the tail cuff  method in 
SHR and WKY control rats. The results are Means ±  SEM, n = 7, + + * 
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Fig-69
Concentration-response curves to PE, 5-HT and KCI, administered in
sequence in the isolated, Krebs-buffer perfused hindquarters vascuiature of
SHR and WKY control rats.
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Cumulative concentration-response curves to PE (0 .1 -100 /yM), 5-HT (0.1- 
100 /yM) and KCI (10-300 mM), administered in sequence in Krebs-buffer 
perfused hindquarters vasculature from SHR and WKY control rats. KCI 
(100 mM) produced larger maximal pressor responses than PE (100 /yM) and 
5-HT (10 /yM) in both strains, in which the basal perfusion pressure 
increased throughout the experiments. bPP represents the basal perfusion 
pressure (mm Hg) for each curve. The results are Means ±  SEM, n = 4 .
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Fig-71
Comparisons of The maxima! pressor responses to PE, 5-HT and KCI in the
isolated, Krebs-buffer perfused hindquarters vasculature of SHR and WKY
control rats.
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Histograms, showing maximal pressor responses to 5-HT (10 /yM), PE (100 
/yM) and KCI (100 mM) in the Krebs-buffer perfused hindquarters 
vasculature of WKY (upper panel) control  and SHR (lower panel) rats. There 
was a signif icant difference (* * 0.01 > P > 0 . 0 0 1 )  between the peak pressor 
responses to PE and KCI in SHR rats, whereas, in WKY rats, significant 
differences were found between the peak pressor responses to KCI and PE 
(* 0.05 > P > 0.01);  and between peak pressor responses to KCI and 5-HT (*
0.05 > P > 0.01) ,  The results are Means ± SEM, n = 4.
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Fig-72
Effect of L-NAME on the concentration-response curve to 5-HT in the
isolated Krebs-buffer perfused hindquarters vasculature of the Wistar rats.
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Cumulative concentrat ion-response curves to 5-HT (0 .01-100 /;M ) in the 
absence and presence of L-NAME (400 pM) in the Krebs-buffer perfused 
hindquarters vasculature of the rat. Each concentrat ion of 5-HT was 
perfused until a stable (equilibrium) response was obtained. The upper panel 
shows tw o  consecut ive (control) concentrat ion-response curves to 5-HT 
only. The lower panel shows a control concentration-response curve to 5- 
HT alone and a subsequent concentrat ion-response curve obtained in the 
presence of L-NAME (400 //M). bPP represents the basal perfusion pressure 
(mm Hg) for each curve. The results are Means 22 SEM, n = 3 (upper panel) 
and n = 6 ( lower panel), * 0 . 0 5 > P > 0 . 0 1 ,  * * 0.01 > P > 0 . 001.
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Fig-73
Effect of indomethacin on the concentration-response curve to 5-HT in the
isolated, Krebs-buffer perfused hindquarters vasculature of the Wistar rats.
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Cumulative concentrat ion-response curves to 5-HT (0 .01-100  /yM) in the 
absence and presence of Indomethacin (10 /yM) in the Krebs-buffer perfused 
hindquarters vasculature of the rat. Each concentrat ion of 5-HT was 
perfused until a stable (equilibrium) response was obtained. The upper panel 
shows two  consecut ive (control) concentrat ion-response curves to 5-HT 
only. The lower panel shows a control  concentrat ion-response curve to 5- 
HT alone and a subsequent concentrat ion-response curve obtained in the 
presence of Indomethacin (10 /yM). bPP represents the basal perfusion 
pressure (mm Hg) for each curve. The results are Means ±  SEM, n = 3 
(upper panel) and n = 4  (lower panel).
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Fig-74
Inhibitory concentration-response curves to SNP in the isolated, Krebs-
buffer perfused hindquarters vasculature of SHR and WKY control rats.
a;
on
C
O
AQQ
CD
f-t
U
O
n
DQ
ID
U
(X
ra
0)
o
3
Tj
d
Oh
00
8 0
T
60
40
20
0
1 0 9 - 8  - 7  - 6  - 5  - 4  - 3
O WKY 
•  SHR
Log [S NP]  (M) 
C u m u l a t i v e  p e r f u s i o n s
q  a
Inhibitory concentration-resDonse curves to SNP (10 -10 M) in the Krebs-
buffer perfused hindquarters vasculature of SHR and WKY control  rats, in 
which the perfusion pressure had been raised by PE (10 /yM). Each 
concentrat ion of SNP was perfused until an equil ibrium inhibitory response 
was obtained. The results are Means ±  SEM, n = 4 .
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Fig-75
Inhibitory Concentration-response curves to carbachol in the isolated, Krebs-
buffer perfused hindquarters vasculature of SHR and WKY control rats.
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Krebs-buffer containing PE (10 /yM). Initially, at low concentrat ions, 
carbachol produced adcitional constrictor responses which were replaced by 
vasorelaxant responses at higher concentrat ions. The results are Means = 
SEM, n > 3.
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DISCUSSION
General
The pithed rat preparation was developed by Shipley and Tilden (1947) and 
was later refined to allow selective stimulation of the spinal autonomic 
outflows (Gillespie and Muir, 1967; Gillespie, Maclaren and Pollock, 1970). 
This preparation has been used to examine autonomic neurotransmission 
and the nature of the receptors involved in the sympathetic regulation of 
blood vessels. It is a very convenient preparation since it allows the 
autonomic nerves to be stimulated electrically at the point where they leave 
the spinal column (Fig-4). In this preparation, by altering the amount of 
electrode exposed w ith in  the spinal canal, it is possible to stimulate either 
the entire sympathetic ou tf low  or selected fractions o f it, so tha t particular 
vascular beds can be affected. Since the spinal autonomic ou tf low  is 
stimulated as the nerves leave the spinal column and before they mingle, 
the stimulation achieved is specific and avoids the problems tha t may arise 
when nominally pure sympathetic nerves are stimulated adjacent to the 
organ they innervate. However, as this study has demonstrated, the pithed 
rat is a very complex preparation and although it is easy to set up and 
readily provides cardiovascular responses to spinal autonomic nerve 
stimulation, the results obtained must be interpreted w ith  caution.
Advantages of the pithed rat preparation:
1. It is possible to stimulate the sympathetic ou tf low  to the vasculature 
easily
147
2. Different levels o f the sympathetic o u tf lo w  can be specifically stimulated
3. The Central Nervous System (CNS) is destroyed and so does not 
influence the pressor responses to spinal nerve stimulation
4. There are no cardiovascular reflexes present to modify the pressor 
responses
5. There is no anaesthetic present to influence the response to nerve 
stimulation
Disadvantages of the pithed rat preparation:
1. The resting blood pressure is abnormally low
2. Temperature regulation is d ifficu lt
3. Because of the low  resting blood pressure and lack o f CNS, endogenous 
substances may be released to modify and complicate the pressor 
responses
4. Respiration is artificial and very different from tha t in the intact animal
5. Repeated injections of aqueous solutions containing drugs may alter the 
blood volume
This study re-examined the cardiovascular responses o f the pithed rat to 
spinal autonomic nerve stimulation. In addition, since previous w ork  in this 
preparation has provided evidence that co-transmission, involving both NA 
and ATP, occurs in sympathetically-innervated blood vessels (Bulloch and 
McGrath, 1988), this study re-investigated this possibility. This study also 
examined the role of the adrenals in the pressor response to spinal nerve 
stimulation and the contribution of the ft-adrenoceptors to this response. 
This study also considered the possibility tha t other locally-released
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vasoactive agents might affect the pressor response to spinal nerve 
stimulation.
This study also examined the effects of 5-HT in the cardiovascular system 
of the anaesthetised and pithed rats and in the isolated perfused lungs, in 
which the pressor effects o f 5-HT were masked by locally-released NO, 
which has diverse biological activities, since it is a vasoactive, a cyto tox ic , 
a platelet regulatory and a neurotransmitter agent (Furchgott & Zawadzki, 
1980; Moncada et al, 1991). Accumulating evidence also indicates tha t NO 
has a significant role in cardiovascular disease ( Gordon et al, 1989; Drexler 
et al, 1991).
Studies in the pithed and anaesthetised rats
Stimulation of the spinal autonomic ou tf low  produced characteristic pressor 
responses and cardio-acceleration, the magnitude o f which was determined 
by the location of the electrode within the spinal canal (Fig-5) and by the 
stimulation parameters used. At most levels of stimulation, the pressor 
response was biphasic, w ith  one component that occurred during 
stimulation and a secondary response that persisted after stimulation 
ceased. This occurred during stimulation of the spinal sympathetic ou tf low  
at position Tg .g  which was used in this study because stimulation here 
produced the biggest pressor response to spinal nerve stimulation (Fig-6 ). In 
addition, the cardio-acceleration that occurred usually also persisted when 
stimulation ceased. These observations suggest that the secondary pressor 
response and the cardio-acceleration may be caused by circulating 
catecholamines released during stimulation from the adrenals. This was 
confirmed during the experiments in which the adrenals were removed after
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having obtained standard pressor responses to spinal nerve stimulation (Fig- 
7). In those circumstances, the secondary pressor response was abolished. 
In addition and perhaps more importantly, the pressor response obtained 
during stimulation was greatly reduced. This observation contrasts w ith  that 
of MacLean et al (1994), who reported that the initial component o f the 
pressor response to nerve stimulation was purely neuronal. The discrepancy 
between their results and those obtained in the present study may be partly 
explained by the fact that the simulation parameters used in this study were 
d ifferent from those used by MacLean at el (1994), who used fewer pulses. 
However, it is still surprising that if electrical stimulation was effective in 
releasing catecholamines from the adrenals, tha t this did not occur or was 
not detectable during stimulation. In this study, there certainly was evidence 
that catecholamines were released during electrical stimulation, since
adrenalectomy greatly reduced the size of the pressor response obtained 
during stimulation, as well as reducing the secondary pressor response 
(Figs-7,10).
The adrenal medulla and the catecholamines released from it, have
important physiological roles in the regulation of the cardiovascular system 
(Bevan et al, 1980; Clutter et al, 1980). The release of these vasoactive 
catecholamines from the adrenals could further complicate the responses to 
drugs investigated in the pithed rat. If catecholamines are released from  the 
adrenals during stimulation of the spinal ou tf low , as the present results 
indicate, then this would have to be taken into consideration if this
preparation is used to analyse the nature of neurotransmission in the
sympathetic nerves that innervate blood vessels. It would also be important 
to be aware of this possibility if this preparation was used to examine 
presynaptic mechanisms, which regulate transm itter release, since 
circulating adrenaline might act on presynaptic ft-adrenoceptors to
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counteract the auto-inhibition caused by neuronally-released NA (Majewski 
and Rand, 1981; Rand et al, 1975 and Langer, 1979). Moreover, the 
potentiating e ffect of circulating catecholamines on the cardiac output 
would also be a contributory factor to the pressor response, especially since 
in the pithed rat there would be no reflex mechanism to restrain the effect 
of adrenaline on the heart.
The cardiovascular effects produced by stimulation o f the adrenal glands in 
the pithed rat, were similar to those evoked by exogenous adrenaline 
(Flavahan & McGrath, 1980), which is the main catecholamine secreted by 
the adrenals (Yamaguchi & Kopin, 1979). In this study, evidence indicating 
that adrenaline is released during spinal nerve stimulation, was obtained 
w ith  propranolol, which increased the pressor response obtained both 
during and after spinal nerve stimulation at 2 Hz as well as increasing the 
secondary pressor response obtained after stimulation at 20 Hz (Fig-8 ). The 
inability o f propranolol to  potentiate the pressor response to stimulation at 
20 Hz during stimulation may have been because stimulation at this 
frequency, produced even before administration o f propranolol, a maximal 
response so that the vasodilator effect of adrenaline (acting on vascular &2 - 
adrenoceptors) was completely overcome by the vasoconstrictor effect of 
very large amounts of neuronally-released NA. The effect of propranolol on 
the pressor responses to the spinal nerve stimulation was in agreement w ith 
the results obtained by Flavahan et al (1985). These results suggest that 
when the pressor response to spinal nerve stimualtion is used, for example, 
to study the nature of neurotransmission in blood vessels, it is necessary to 
remove at least the effect of circulating adrenaline on te-adrenoceptors w ith 
a non-selective ft-antagonist such as propranolol, which would antagonise 
the effect of catecholamines on the heart and on ^-adrenoceptors 
elsewhere. The effects of this treatment on the pressor response are
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certainly complex and potentially conflic ting. This was apparent in those 
experiments in which propranolol reduced rather than enhanced pressor 
responses to spinal nerve stimulation (Fig-9). In these experiments, in which 
characteristically the basal blood pressure was very low  (< 1 8 -2 2  mmHg), it 
is possible tha t when the effects o f catecholamines on the heart were 
blocked by propranolol, the heart was unable to continue to pump the blood 
into the constricted blood vessels and so the pressor response was minimal. 
These observations make it clear that the role o f the heart in the pressor 
responses to spinal nerve stimulation is easy to overlook. If the 
contributions of the heart and the adrenals are not taken into account, then 
the interpretation of the results will be d if f icu lt and may lead to serious 
misconceptions.
An important purpose of this study was to determine whether there was 
any evidence tha t co-transmission occurred in sympathetically-innervated 
blood vessels in the pithed rat. Previous w ork  had shown that stimulation of 
the sympathetic ou tf low  in the pithed rat caused a pressor response that 
was partly noradrenergic and partly purinergic (Flavahan et al, 1985; Grant 
et al, 1985). The evidence for this was derived from experiments in which 
stimulation of the sympathetic fibres to the blood vessels produced a 
pressor response that had a component which was not blocked by the a -  
adrenoceptor antagonist, prazosin, but was abolished by <7 ,&-mATP 
(Burnstock & Warland, 1987; Ramme et al, 1987; Bulloch & McGrath, 
1988), which desensitizes P2 x _Purinoceptors to ATP. This study rexamined 
this hypothesis but took account o f other factors tha t might be expected to 
influence the responses to stimulation of the sympathetic  o u tf lo w  via the 
spinal electrode.
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The results obtained in this study w ith  <7,ft-mATP do not support the v iew  
that there is a purinergic component in the pressor response to stimulation 
of the sympathetic ou tf low . This can be concluded from  the experiments in 
which repeated administration of ar,£-mATP caused desensitization o f the 
pressor response to <7,&-mATP (Fig-12). In these experiments, responses to 
spinal nerve stimulation also declined but not to a greater extent tha t did 
the control response to exogenous NA. Moreover, although interruption of 
the administration o f a,ft-mATP restored the sensitivity to £7,&-mATP, it did 
not restore the sensitivity to NA or to nerve stimulation. These results do 
not support the v iew  that purinergic co-transmission contributes to the 
pressor response to spinal nerve stimulation at Tg.g  in the pithed rat. These 
results conflic t w ith  those of Bulloch and McGrath (1988) w ho also 
examined the e ffect o f or,£-mATP on pressor responses to spinal nerve 
stimulation in the pithed rat. There certainly were differences between the 
methods used in the present study and those used by Bulloch and McGrath 
(1988) but it is d if f icu lt to see how these could explain the discrepancies 
between the results obtained in the tw o  studies. For example, in this study, 
the pithed rats were respired artificially w ith  air, whereas Bulloch and 
McGrath (1988) used 40%  oxygen and 60%  nitrogen. In addition, there 
was a slight difference in the location of the electrode during stimulation, 
which was achieved in this study w ith  the electrode being exposed at Tg_g 
but in the study carried out by Bulloch and McGrath, the electrode was 
exposed at Tg_g. It is d ifficu lt to avoid the conclusion that if there is a 
purinergic component in the sympathetically-mediated pressor response to 
spinal nerve stimulation in the pithed rat, then it must be very small, since 
most of the pressor response is the result of stimulation of the fibres to the 
adrenal medulla, from which catecholamines are released.
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The pithed rat has a high circulating renin activ ity  (De Jonge et al, 1982) 
due to its low resting blood pressure. There are many reports indicating a 
facilita tory action o f angiotensin II (All) on peripheral noradrenergic 
transmission (Rand et al, 1990; Zimmerman, 1978; Majewski et al, 1984; 
Starke, 1977). In this study, the results obtained w ith  captopril provided 
further evidence about the complexity o f the pressor response to stimulation 
of the spinal autonomic outflows. Captopril had little e ffect on the resting 
blood pressure (BP), only occasionally producing a slight fall in BP (Fig-16). 
However, captopril inhibited pressor responses to injected NA and also 
inhibited responses to spinal nerve stimulation at both 2 Hz and 20 Hz (Figs- 
16,17). This observation suggests tha t endogenous angiotensin II, whose 
synthesis captopril inhibits, enhances the responses to NA and to spinal 
nerve stimulation in this preparation. Majewski in 1989 also reported that 
captopril decreased NA release in the pithed rat when the sympathetic 
ou tf low  was stimulated. Another more complex explanation is based upon 
the fact that angiotensin converting enzyme (ACE) which is inhibited by 
captopril not only converts angiotensin I (Al) to angiotensin II (All) but also 
inactivates the vasodilator, bradykinin (Vanhoutte et al, 1993; Busse et al, 
1993; Erdos, 1990). The inhibitory e ffect of captopril on pressor responses 
to nerve stimulation and NA may therefore be due to inhibition o f the 
synthesis of All and/or to prolongation of the e ffec t of bradykinin, which 
releases EDRF (NO), whose action would oppose tha t o f constrictors, such 
as NA.
The results considered so far indicate that the pressor response to spinal 
nerve stimulation in the pithed rat is very complex. a \-Adrenoceptors 
contribute a great deal to the vascular pressor responses and the 
characterization of the postjunctional -adrenoceptor-mediated pressor 
response was made w ith prazosin, a selective a-]-adrenoceptor antagonist
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(Timmermans & Van Zwieten, 1982; McGrath, 1982; Drew & Whiting, 
1979). In this study in the presence of propranolol and captopril, prazosin, 
inhibited the pressor response to spinal nerve stimulation and the extent of 
the inhibition produced was no less than was the inhibition o f the standard 
pressor response to exogenous NA (Figs-16,17). This observation does not 
support the v iew  tha t there is a prazosin-resistant component in the pressor 
response to  spinal nerve stimulation at Tg.g.
Several interesting observations were obtained w ith  L-NAME. Intravenous 
injections o f L-NAME produced a prolonged rise in the basal blood pressure 
in both anaesthetised and pithed rats. The rise in the baseline blood 
pressure was about four and a half fold higher in the anaesthetized rats than
-i
in the pithed rats in the presence of propranolol (2 mg k g '1) (Fig-18 panel 
D). The main reason w hy the basal blood pressure was increased by L- 
NAME to a greater extent in anaesthetised rats than in pithed rats, was 
probably because in the former there was a tonic discharge in the 
autonomic sympathetic pathway and consequently a controlled release of 
NA to the e ffector cells in the blood vessels in these animals. NO synthesis 
was inhibited in both pithed and anaesthetised rats but the major difference 
would be this sympathetic tone which when unopposed by endogenous NO, 
caused the blood pressure to rise to a greater extent in the anaesthetised 
rats. Shear stress could be another reason for the difference since in the 
anaesthetised rat, blood pressure was higher and hence the shear stress on 
the intraluminal surface of the vasculature would probably also be higher 
and thus could release more NO into the blood circulation (Forstermann et 
al, 1994). The fac t that the L-NAME-induced increase in the basal blood
_ -I
pressure was the same, in the absence of propranolol (2 mg kg ), in both 
pithed and anaesthetised rats (Fig-18 panel C), was surprising, not least 
because the basal blood pressure prior to the administration of L-NAME was
155
higher in the anaesthetised rats than in the pithed rats. It may be tha t the 
pressor response to L-NAME in the anaesthetised rat was restrained by 
cardiovascular reflexes, despite the evidence to the contrary in intact 
animals (Gardiner et al, 1990; MacLean, MacMillan, 1993). On the other 
hand, a more likely explanation of the similar pressor responses to L-NAME 
in pithed and anaesthetised rats is tha t in the anaesthetised rats, L-NAME 
produced a maximum pressor response and no higher response was 
possible.
In pithed rats, L-NAME increased the blood pressure and the size o f this 
response was directly proportional to the resting blood pressure both in the 
absence and presence of propranolol (2 mg kg"^) (Fig-19). This was 
reflected in the positive correlation between the L-NAME-induced increment 
in blood pressure and the basal blood pressure prior to the administration of 
L-NAME in the absence (correlation coeff ic ien t R = 0 .96, n = 5,
0.01 > P > 0 .001) and presence (correlation coeff ic ien t R = 0 .64, n = 19, 
0.01 > P > 0 .001) of propranolol (2 mg kg"^). This may indicate that the 
higher the basal blood pressure, the more NO is produced, perhaps as a 
result of increased shear stress on the endothelium. However, in the
anaesthetised rats, there was no significant correlation between the L- 
NAME-induced increment in the blood pressure and the basal blood pressure
-i
either in the absence or in the presence of propranolol (2 mg kg ) (Fig-20). 
This may reflect merely the variability o f the data or it may reflect the 
greater complexity of the anaesthetised rat, wh ich  still had an intact
nervous system that would be capable of reflexly modifying, the L-NAME-
induced pressor responses, which might have been diminished, so that the 
possibilty of seeing a positive correlation between the pressor responses to 
L-NAME and the basal blood pressure would also be diminished. However, 
this interpretation of the results is contradicted by observations obtained in
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other studies in conscious rats, in which L-NAME caused only a slight, 
inconsistent bradycardia w ith  an increase in blood pressure (Gardiner et al,
1990). Their results suggests that, slowing o f the heart due to 
cardiovascular reflexes is unlikely to oppose the increase in the resting 
blood pressure produced by L-NAME. Furthermore, chronic oral treatment 
w ith  L-NAME can also cause hypertension in W istar rats, w ith  no major 
e ffect on the heart rate (MacLean, MacMillan, 1993). The observations in 
this study in the pithed and anaesthetised rats, therefore indicate tha t the 
normal sympathetic tone is not an important prerequisite for the release of 
endogenous NO in vivo. These results contradict those of some workers 
(Vargas et al, 1990; Lacolley et al, 1991) but are consistent w ith  those 
obtained by others (Pegoraro et al, 1992). L-NAME (45 m gkg '^)  did not 
enhance pressor responses to a,ft-mATP but increased the tox ic ity  o f this 
pressor agent in the pithed rat (Fig-25). The lethal e ffect of ar,ft-mATP may 
be due to its ability to constrict blood vessels tha t no longer have the 
capacity to produce NO because of the presence o f L-NAME. Vascular beds 
such as the pulmonary vascular bed may be involved in this tox ic  e ffec t of 
a,ft-mATP in the presence of L-NAME. In this study, L-NAME enhanced 
pressor responses to injected 5-HT but in most experiments, had no such 
effect on pressor responses to spinal nerve stimulation. This is surprising, 
especially since L-NAME did increase basal blood pressure in both 
anaesthetised and pithed rats. However, the inability of L-NAME in this 
study to potentiate pressor responses to spinal nerve stimulation (Fig-22) 
conflicts w ith the observations of MacLean et al (1994), who reported that 
L-NAME potentiated pressor responses to spinal nerve stimulation. An 
important difference between the results reported here and those of 
MacLean et al (1994) is that, in this study, the effect of L-NAME on pressor 
responses to spinal nerve stimulation were investigated in the presence of 
propranolol whereas in the study by MacLean et al (1994), the rats received
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no propranolol. In these circumstances it is likely tha t catecholamines would 
be released from the adrenals by spinal nerve stimulation and a substantial 
vascular fc-mediated vasodepressor component would oppose the 
vasoconstrictor effects of neuronally-released NA. In the present study, 
paradoxically, the vasopressor component of the response to spinal nerve 
stimulation might have been limited by propranolol, which would act 
presynaptically to  antagonize the action o f c irculating adrenaline on the &- 
adrenoceptors, thereby inhibiting the ability o f adrenaline to promote NA 
release. The nature of these prejunctional ft-adrenoceptors is not clear. 
There are some reports which indicate that these are &2 -adrenoceptors 
(Stjarne and Brundin, 1976) yet other reports suggest tha t these are ft-j- 
adrenoceptors (Majewski et al, 1980; Dahlof et al, 1975). This may be an 
indication tha t in d ifferent tissues the prejunctional ^-adrenoceptors may be 
of either the ft-j- or f^ -sub type . The discrepancy between the lack o f e ffect 
of L-NAME in this study on the nerve-mediated pressor response and the 
ability of L-NAME to enhance such pressor responses to spinal nerve 
stimulation in the absence of propranolol in the experiments of MacLean et 
al (1994), suggests that there may be a connection between the lack of 
effect of L-NAME in the presence of propranolol and the enhancement 
caused by L-NAME in the absence o f propranolol. One possibility is that a 
large part of the vascular ft-adrenoceptor-mediated vasorelaxation caused by 
circulating adrenaline released from the adrenals by spinal nerve stimulation, 
is associated w ith  the synthesis and release of NO within  the vasculature. If 
activation o f vascular ft-adrenoceptors leads ultimately to release o f NO, 
which is responsible for the vasodilatation (Gray & Marshall, 1992), then 
this vasodilator mechanism could be inhibited either by blocking the ft- 
adrenoceptors w ith  propranolol or by blocking the synthesis of NO w ith  L- 
NAME. Either drug would potentiate the pressor response to the nerve 
stimulation but potentiation by one would preclude potentiation by the
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other. In some experiments, L-NAME apparently did enhance the pressor 
response to spinal nerve stimulation at Tg_g at both 2 Hz and 20 Hz, but
-i
th is was only after exogenous NA (2 j j q  k g " 1) had inhibited this response 
(Figs-26,27). In these experiments, the apparent ability o f L-NAME to 
potentiate the nerve-mediated pressor response may merely have been due 
to  recovery o f the nerve-mediated pressor response from the inhibitory 
e ffec t o f NA. L-arginine the precursor for the biosynthesis o f the
endogenous vasodilator, NO (Moncada et al, 1989) lowered the basal blood
pressure in the presence of L-NAME (Figs-26,27). The dose o f L-arginine
1 1(45 mg k g ' )  which was the same as the dose o f L-NAME (45 mg kg" ) ,
only inhibited the first component of the pressor response to spinal nerve 
stimulation at 2 Hz and had no such e ffec t on the post-stimulation
com ponent of this response. L-arginine (45 mg kg"1) did not a ffect either
com ponent of the pressor response to stimulation at 20 Hz and did not
-i
a ffec t the NA (2 j j q  kg ' 1 )-induced pressor response.
Receptor-mediated modulation of peripheral NA release in various in vitro 
and in vivo preparations has been described extensively (reviews by 
Gillespie, 1980; Langer, 1981; Starke, 1981a,b, 1987). In this study, in the
-I
pithed rat, NA (0.1, 2 and 15 /vg kg' ) produced dose-dependent pressor 
responses in the absence and presence o f L-NAME (45 mg k g ' 1) w ith
•i
propranolol (2 mg kg ' ) being present th roughout the experiment (Fig-23).
The first dose o f NA (0.1 j j q  kg"1) inhibited the pressor responses to nerve
stimulation at 2 Hz but further administration o f higher doses of NA did not
inhibit the neuronal pressor responses further. The inhibitory e ffect of
exogenous NA could be mediated through activation o f a^-adrenoceptors on
the sympathetic nerve terminals. Such a mechanism would hinder the 
2 4 -Ca^ -dependent sympathetic neurotransmitter release during electrical 
stimulation of the sympathetic nerve roots at Tg_g o f the spinal vertebrae. It
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was surprising that higher doses o f NA did not produce larger inhibitions. 
This may have been because the inhibitory e ffect of the lowest dose o f NA
-i
(0 .1  /yg k g " 1), together w ith the endogenous feedback inhibition of 
neuronally-released NA, had a maximal e ffect. Antagonism o f these 
prejunctional ar2 -adrenoceptors can increase the stimulation-induced release 
of NA (Gillespie, 1980; Starke, 1981a) and there was some evidence in this 
study that the <72 -adrenoceptor antagonist yohimbine, potentiated pressor 
responses to spinal nerve stimuation (F igs-14,15).
The responses to 5-HT, which is normally inactivated to a large ex ten t by 
the pulmonary vasculature (Furchgott, 1984; Said, 1982), were d if fe ren t in 
the pithed and anaesthetized rats (Figs-29 panel B, 30). In the pithed rat, 5- 
HT only produced a pressor response but in the anaesthetised rat, 5-HT 
usually produced a triphasic response in the blood pressure. This response 
consisted of an initial brief depressor component, fo llowed by a secondary 
pressor component, which was then follwed by a final sustained depressor 
component. The triphasic response to 5-HT obtained in anaesthetised rat 
was similar to that in other studies (Kalkman et al, 1984; Page, McCubbin, 
1953). The triphasic nature of the response to 5-HT in anaesthetised rats 
became more evident as the doses were increased. The initial, brief 
depressor component was similar to that associated w ith  the Von Bezold- 
Jarisch-like reflex (Saxena and Villalon, 1990). In both preparations, 5-HT 
produced dose-related responses in the absence and presence o f L-NAME 
(F igs-28 ,29 ;31 ,30) (Moncada et al, 1991). In the pithed rat, 5-HT inhibited 
the pressor component to the spinal nerve stimulation at Tg_g at 2 Hz and 
20 Hz (Fig-29) and the significance of this inhibitory e ffect of 5-HT on the 
sympathetic nerve terminals can be seen in Fig-22. These results are 
consistent w ith  an inhibitory effect of 5-HT on the release of NA from  the 
sympathetic nerves, and suggest the presence of inhibitory 5-HT receptors
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on the peripheral sympathetic nerves. In the pithed rat, L-NAME enhanced
the pressor responses and prolonged recovery from  these responses to 5-
1 1HT, particularly at low  (6 j j q  k g " 1), medium (12 j j q  kg ') and submaximal
(25 j j q  kg"**) doses (Figs-28,24). In the anaesthetized rat, L-NAME reduced 
the initial brief depressor component, increased the secondary pressor 
component, prolonged recovery from this component, and reduced and 
shortened the final sustained depressor com ponent o f the response to 5-HT 
(Figs-31,30). The latter effect is similar to tha t reported in rat kidney, where 
L-NAME also inhibited vasorelaxation induced by 5-HT (Verbeuren et al, 
1991). These results are consistent w ith  the hypothesis that 5-HT can 
release NO, which would tend to oppose the vasoconstric tor effects o f 5- 
HT in both the pithed and anaesthetized rats, as well as adding to the 
vasodepressor components of 5-HT in anaesthetized rats. This mechanism 
would resemble tha t in the pulmonary vasculature, where the 
vasoconstrictor effects of 5-HT may be masked by the vasodilator effects of 
endogenous NO, which may be involved in maintaining the low blood 
pressure in the pulmonary circulation, perhaps by opening collaterals so that 
a larger fraction of the pulmonary endothelium is available to inactivate the 
5-HT. If this occurs then the blockade of the synthesis of NO by L-NAME 
would then increase the circulating levels o f 5-HT which might then exert a 
toxic effect on the heart. If NO is produced either directly in response to 5- 
HT acting on its receptors or indirectly, as a result of its vasopressor 
activ ity, then there must be a very substantial amount released, since it is 
likely that much of it would normally be taken up by erythrocytes and 
inactivated by haemoglobin (Hb0 2 > via sto ichiometric conversion to 
methaemoglobin (MetHb) and nitrate (Gillespie & Sheng, 1988; Wennmalm 
et al, 1992 and Martin et al, 1985).
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Since there were three components (an initial brief depressor component, a 
secondary pressor component and a final sustained depressor component) 
in the 5-HT-induced response in blood pressure in the anaesthetized rats, it 
is likely that d ifferent mechanisms would be involved in producing these 
opposing effects.
The initial brief depressor component to 5-HT could have been due to 
activation of 5 -HT3  receptors on the sensory vagal nerve endings in the 
heart, consequently causing a short-lasting bradycardia and reduction in 
cardiac output (Saxena and Villalon, 1990). T h is jn it ia l component of the 5- 
HT-induced response resembled that associated w ith  the Von Bezold- 
Jarisch-like reflex. However, there is some evidence tha t a short lasting 
vasodilatation may be obtained via 5 -HT3  receptors, which probably invoke 
an axon-like reflex (Blauw et al, 1988).
The secondary, pressor component of the 5-HT-induced response, would
O I
probably be produced by an increase in the free [Ca ] j ions in the 
vascular smooth muscle cells to activate the contractile mechanism (5-HT-|- 
like and 5 -HT2  receptor mediation). In isolated large arteries, the receptor 
mediating contraction belongs to the 5 -HT2 subtype (Van Nueten et al, 
1981; Cohen et al, 1981; Cohen et al, 1983a). However, in other blood 
vessels, the receptors mediating contraction resemble the 5-H T i- l ike  
subtype (Peroutka et al, 1983; Van Nueten et al, 1985; Houston, 
Vanhoutte, 1986). No attempt was made to identify the 5-HT receptor 
subtype involved in this study. Not all the blood vessels in the body have 
the same pattern of response to 5-HT and this probably reflects differences 
in the populations of 5-HT receptor subtypes. The secondary pressor 
component to 5-HT obtained in anaesthetised rats in this study could be 
related to the vasoconstriction of large blood vessels and was probably
162
mediated via 5 -HT2  and 5-HT-j-like receptors (Van Nueten et al, 1985; 
Feniuk and Humphrey, 1989). This 5-HT-induced vasoconstriction in the 
large blood vessels would increase the shear stress on the endothelial cells 
o f the blood vessels and this could lead to the production and release o f the 
endogenous vasodilator, NO and perhaps other relaxing factors, such as 
PGI2 , which is released in response to increased intraluminal pressure. In 
the microvasculature, 5-HT has more complex effects. It causes arteriolar 
vasodilatation and lowers the peripheral resistance. 5-HT also increases the 
permeability o f the capillaries and hence increases the level o f plasma 
leaving the blood vessels and accumulating in the interstitial spaces (ie. 
oedema). Vasoconstriction of the venules is another important response of 
the microvasculature to 5-HT (Houston, Vanhoutte, 1986).
The mechanisms underlying the predominant sustained depressor response 
to 5-HT seen in this study in anaesthetised rats are likely to be very 
complex. It has been reported that 5-HT can release vascular endothelial 
NO. This response is mediated by 5-HT^-Iike receptors (Cohen et al, 
1983a,b; Cocks, Angus, 1983; Martin et al, 1987; Houston, Vanhoutte,
9  4 -1988). The biosynthesis of vascular endothelial NO is a Ca"1 -dependent 
process and is catalyzed by the enzyme, NO synthase (Moncada et al,
1991). This NO-releasing effect of 5-HT may have been partially responsible 
for the final, sustained depressor component response to 5-HT, since it was 
reduced by L-NAME (Fig-30). NO released from the vascular endothelium 
would activate guanylate cyclase in the vascular smooth muscle and 
increase the synthesis of cGMP, causing vasodilatation. NO may also be 
synthesised in vascular smooth muscle where it occurs as a result of a
9  4 -Ca -independent process (Moncada et al, 1991) and has been suggested 
to be a major source of endogenous NO (Gonzalez et al, 1992). Therefore, 
the increase in the synthesis of both endothelial and non-endotheiial NO,
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resulting perhaps from the increase in the vascular tone, could contribute to 
the prolonged depressor effect of 5-HT. Vasodilator responses to 5-HT also 
occur in the canine and porcine coronary artery and are mediated by 5-HT-]- 
like receptors on endothelial cells and inhibitory 5-HT receptors on vascular 
smooth muscle (Cohen et al, 1984; Vanhoutte et al, 1986; Vanhoutte, 
1987; Luscher, Vanhoutte, 1990). The sustained depressor com ponent of 
the 5-HT-induced response could also be due to  activation o f some specific 
5 -H T i- l ike  receptors perhaps located in the nervous system. Some o f these 
5-HT-]-like receptors are located in the CNS, where 5-HT-| binding sites 
were originally described in the rat brain (Peroutka & Snyder, 1979) on the 
basis of radioligand binding studies. These binding sites have been 
subdivided into subtypes, termed 5-HT-|a, 5-HT-jb, 5-HT*ic and 5-HT-jq 
(Pedigo et al, 1981; Pazos et al, 1984; Hoyer et al, 1985; Heuring & 
Peroutka, 1987). The functional receptors which correspond to these 
binding sites are well established in brain tissue (De vivo & Maayanic, 1986; 
Engel et al, 1986; Conn et al, 1986; Schoeffter et al, 1988). These 5-HT-]- 
like receptors are not only located in the CNS, but also occur in the 
peripheral nervous system including autonomic neurons, enteric neurons 
and also in blood vessels. 5-HT-j -like receptors have an inhibitory e ffect on 
the central and peripheral sympathetic neurons through inhibition of 
neuronal adenylate cyclase. Activation of these receptors reduces the level 
of the neuronal cAMP and reduces transmitter release. Thus, activation of 
5-HT-j-like receptors decreases the sympathetic discharge and increases 
vagal nervous activ ity (Cohen et al, 1983a,b; Cocks and Angus, 1983; 
Martin et al, 1987; McGrath, 1977; Houston and Vanhoutte, 1988; 
Mylecharane and Phillips, 1989; Saxena and Villalon, 1990; Verbeuren, 
1990). This complex interaction of 5-HT w ith d ifferent components of the 
vascular and neuronal systems, together w ith its action on cardiac 5 HT3 
receptors (Fozard, 1989), results in it having a multiphasic influence on
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blood pressure in the intact organism (Vanhoutte, 1985; Vayssettes- 
Courchay et al, 1990).
In the anaesthetised rat, the maximal dose of 5-HT (55 //g/kg) injected after 
L-NAME produced an irregular pressor response (Fig-30). As the doses o f 5- 
HT increased and in the absence o f any endogenous NO, cardiac
irregularities occurred and interfered w ith  the outcome of the 5-HT-induced 
pressor response. These irregularities could perhaps result from reduced 
inactivation of 5-HT by the lungs as well as an excessive 5-HT-induced
release of catecholamines from the adrenal medullae, from which
catecholamines can be released by activation of 5-HT receptors (ie. 5-HT2 
receptors) (Feniuk et al, 1981; Kimura, Satoh, 1983; Saxena and Villaton, 
1990). Such a release of catecholamines from the adrenal medullae into the 
blood circulation could complicate and add to the pressor response to 5-HT 
in the vasculature of the vital organs such as heart, lungs and brain. The 
result would be an excessive vasoconstriction and perhaps interruption in 
the normal blood f lo w  and hence cardiac and pulmonary irregularities.
Since 5-HT and its receptors are involved in several cardiovascular diseases, 
the development o f new drugs that act on 5-HT receptors and its subtypes 
have potential therapeutic benefits in the treatment o f some cardiovascular 
pathologies such as hypertension, peripheral vascular diseases, cardiac
failure and migraine (Saxena and Villalon, 1990).
The results obtained in this study in pithed and anaesthetised rats are 
complex and agree only in part w ith  previous studies. They conflic t w ith 
observations which indicated that spinal nerve stimulation in the pithed rat 
produced a biphasic component, which consisted of a neuronal component 
that occurred during stimulation and an adrenal component that occurred
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only after stimulation had ceased (MacLean et al, 1994). Adrenalectomy not 
only abolished the post-stimulation, sustained pressor response but also 
greatly reduced the pressor response that occurred during stimulation. If 
spinal nerve stimulation releases adrenal catecholamines and particularly 
adrenaline during nerve stimulation, then this will have profound effects not 
only on the performance of the heart but also on the pressor responses to 
NA and its hypothetical co-transmitter, ATP, whose constric tor effects 
would be opposed by the circulating adrenaline. This study has drawn 
attention to the fact tha t stimulation of the spinal o u tf lo w  in the pithed rat 
causes release o f catecholamines from the adrenaL medulla and these 
contribute in a complex manner not only to the pressor response but 
probably also influence the heart and perhaps also affect, via presynaptic 
receptors, the release o f the sympathetic transmitter(s) (Rand et al, 1975; 
Majewski and Rand, 1981). Unless the effects o f neurally-released, 
circulating, adrenaline from the adrenal medulla are taken into account, 
analysis o f the nature of neurotransmission in the vasculature is likely to be 
fraught w ith  difficulties.
In this study the effects o f adrenaline on ft-adrenoceptors was blocked w ith 
propranolol so tha t the complications arising from the effects of neurally- 
released adrenaline would be avoided. However, the use of propranolol led 
to some difficulties. For example, in some rats w ith  very low  blood 
pressure, propranolol did not increase the pressor responses to spinal nerve 
stimulation but instead reduced these responses. This may have been 
because in these rats the heart was already inadequate to maintain a high 
blood pressure and the blockade of the effects of catecholamines on the 
heart further impaired the capacity of the heart to pump blood into the 
constricted blood vessels.
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The results also conflic t w ith  previous observations, which apparently 
indicated that the sympathetic neurotransmission in the blood vessels in the 
pithed rat involves co-transmission, in which both NA and ATP are released 
together to cause peripheral vasoconstriction. In this study, although ar,£- 
mATP produced pressor responses and these showed tachphylaxis w ith  
repeated administration, there was no evidence tha t the pressor responses 
to  spinal nerve stimulation was similarly affected. In fact, pressor responses 
to  spinal nerve stimulation did decline throughout experiments in which o,£- 
mATP-induced tachyphylaxis occurred but not to a greater extent than did a 
standard response to NA, which was used as a control. Moreover, when 
administration of cr,S-mATP was discontinued to a llow the sensitivity to a,£- 
mATP to recover, the sensitivity to exogenous NA and spinal nerve 
stimulation did not recover. These results together w ith  the observation that 
most o f the pressor response to spinal nerve stimulation is produced by 
adrenal cathecholamines rather than being neuronally mediated, cast some 
doubt on the idea that the sympathetic neurotransmission in the vasculature 
o f the rat involves co-transmission, in which NA and ATP are released 
together and are jointly responsible for the vasopressor response seen in 
this preparation during spinal nerve stimulation.
This study has also demonstrated that other factors influence the response 
o f the pithed rat to spinal nerve stimulation and probably make it an 
inappropriate preparation for characterising vascular receptor mechanisms 
or for studying neurotransmission. In particular, it is clear that All influences 
the response to spinal nerve stimulation and this study has provided indirect 
evidence for the presence of All in the pithed rat. This is not a new 
observation but it is a reminder of the complexity of the preparation, in 
which responses to NA and to nerve stimulation can be enhanced by All. 
However, even this apparently sta ightforward observation is capable of
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different interpretations since captopril, which was used to inhibit the 
enzyme that synthesises All, would also inhibit the destruction of 
bradykinin, which would be capable of releasing NO from the endothelium 
and thus acting as a physiological antagonist of NA. It is also possible that 
captopril inhibited pressor responses to NA and nerve stimulation because it 
inhibited both the synthesis of All and the destruction of bradykinin.
The role of NO in the pithed rat is also complex. The results obtained in this 
study conflict with those of MacLean et al (1994), who reported that L- 
NAME enhanced pressor responses to spinal nerve stimulation. The results 
obtained in this study show no potentiation of the pressor responses to 
nerve stimulation or to NA. This may have been because propranolol was 
present throughout this study. Since MacLean et al (1994) did not block the 
^-adrenoceptors with propranolol, it is likely that the catecholamines 
released from the adrenals in their experiments would be available to act on 
vascular ^-adrenoceptors and cause vasorelaxation but this would not be 
possible in the experiments described in this thesis. There arises the 
possibility that activation of vascular ft-adrenoceptors might lead ultimately 
to release of NO which might then be responsible for the vascular relaxation 
(Gray and Marshall, 1992). If this occurs then the lack of any potentiation 
of the pressor responses to spinal nerve stimulation might be explained by 
the fact that the effects of the circulating adrenaline were already blocked 
by propranolol and the subsequent administration of L-NAME could have no 
further effect, since the inhibitory mechanism had already been blocked at 
an earlier stage by propranolol.
Intravenous injection of 5-HT produced a triphasic response in the blood 
pressure in the anaesthetised rat which was more marked at higher doses of 
5-HT. This consisted of an initial brief depressor response which was
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followed successively by a short-lived vasopressor and then a sustained 
vasodepressor response. In contrast, in the pithed rat, 5-HT produced a 
pressor response but also inhibited pressor responses to spinal nerve 
stimulation. Unlike pressor responses to NA or spinal nerve stimulation, 
which were unaffected by L-NAME, pressor responses to 5-HT were 
potentiated and prolonged by L-NAME, suggesting that NO normally plays a 
part in regulating responses to and terminating the effects of intravenously- 
administered 5-HT. Whether the NO involved in opposing the 
vasoconstrictor effects of 5-HT is basally-released or is released in response 
to the pressor effect of 5-HT or is released directly by 5-HT remains to be 
determined. However, since L-NAME increased the resting blood pressure in 
the anaesthetised rat, it appears that there is a basal release of NO. Since 
the depressor components of the triphasic response to 5-HT were reduced 
but not abolished by L-NAME, it appears that these responses were not 
entirely mediated by NO. Another posibility is that the residual, 5-HT- 
induced depressor responses that persist in the presence of L-NAME in the 
anaesthetised rat may be due to the presynaptic inhibitory effects of 5-HT 
on the sympathetic nerves and to central stimulation of the parasympathetic 
nerves (Saxena and Villalon, 1990). Another possibility is that the 
endogenous NO, which opposes the pressor effects of exogenous 5-HT, 
might be released in a particular vascular bed where 5-HT is inactivated. In 
those circumstances, inhibition of the synthesis of NO would interfere with 
the destruction of 5-HT, whose pressor effects would therefore be 
prolonged, whilst any direct or indirect ability of 5-HT to release NO would 
be blocked.
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PERFUSED LUNGS PREPARATION
This study examined the effects of drugs in the perfused pulmonary 
circulation, which is very unlike the systemic vasculature in a number of 
ways (Murray & Nadel, 1986). For example, it is a low pressure circuit, in 
which the resistance to f low does not increase even when the cardiac 
output increases. An important feature of the pulmonary circulation and one 
that may explain to some extent its ability to remain a low pressure system 
even when cardiac output increases, is the fact that there is considerable 
redundancy in the system, with the possibility that additional vessels may 
come into operation as required (Murray and Nadel, 1988). A very important 
difference between the systemic and the pulmonary circulation is the fact 
that in the latter, hypoxia causes vasoconstriction (Staub, 1985), whereas 
in the systemic circulation, hypoxia causes vasodilatation (Murray and 
Nadel, 1988). Surprisingly, The mechanism underlying this important 
phenomenon, which diverts blood from hypoxic regions of the lungs to 
normoxic areas, is still poorly understood. Other important features of the 
pulmonary circulation include its importance as a site where vasoactive 
substances are activated (angiotensin II) or inactivated (5-HT) (Furchgott, 
1984; Said, 1982). Clearly, the pulmonary circulation is vital, not only in 
respiration but also in synthesising and removing important substances that 
have important and in some cases toxic effects elsewhere (Ganong, 1989c). 
In this respect, the pulmonary circulation has a protective effect on the 
heart and other organs.
This study examined the effects of 5-HT and other vasoconstrictors in the 
pulmonary circulation and sought to determine whether their effects were 
modified by endogenous NO. 5-HT is present in the lungs in neuroepithelial 
bodies, from which it may be released in response to neuronal and chemical
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stimuli. It may also be released by hypoxia and may therefore be involved in 
the hypoxic vasoconstriction that diverts blood to better ventilated areas of 
the lungs (Lauweryns & van Lommel, 1982; Johnson, 1991). This study 
demonstrated that responses of the pulmonary circulation to pressor agents 
are influenced by the release of NO, which may therefore have a role in 
regulating blood flow in the pulmonary circulation and in modifying the 
effects of drugs in this vascular bed. In particular, NO may have a role in 
maintaining the low resistance of the pulmonary circulation to perfusion. A 
comparison was made between the responsiveness to vasoactive drugs of 
the pulmonary circulation and the vasculature of the hindquarters. It 
appears that NO and perhaps prostaglandins play a larger part in modifying 
responses of the pulmonary circulation to drugs than they do in the 
hindquarters. One reason for the differences between the responsiveness of 
the two vascular beds may be the existence of collateral vessels in the 
lungs (Maseri et al, 1972).
In order to investigate the effects of vasoactive drugs in the pulmonary 
vasculature, it was necessary to obtain control pressor responses to 
vasopressor agents. The normal pressor responses to 5-HT (0.1-100 //M) 
and to PE (0.1-100 /vM), which act through Pl-turnover were small when 
perfused cumulatively and were not well-maintained, especially with 5-HT 
(Fig-34 Panel A). The pulmonary vasculature was less sensitive to pressor 
agonists, such as PE (Fig-33) and 5-HT when they were perfused 
cumulatively than when these drugs were perfused in separate, single 
concentrations, with recovery intervals between each dose. These 
vasoconstrictors may cause desensitization which may be in part due to 
some adaptation in the coupling mechanism or to the production of NO or 
PGI2 , produced by the increased shear stress. This seems likely since 
secretion of EDRF (NO) occurs spontaneously and is accelerated by
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increased shear stress on the vascular endothelial cells (Angus, Cocks, 
1989; Griffith et al, 1988; Vanhoutte et al, 1986). The modulatory effect of 
NO on the pulmonary vascular tone become even more important when the 
pulmonary circulation is perfused with Krebs-buffer, since there are no 
erythrocytes present to inactivate NO (Gillespie & Sheng, 1988).
5-HT has different mechanisms of action since it acts on various receptor 
subtypes which mediate distinctive and opposing effects. 5-HT has a direct 
vasopressor effect and an indirect sympathomimetic effect (Hollenberg, 
1988). NO may also be  ^involved in the vasodilator activity of 5-HT, which 
may release NO from the vascular endothelial cells (Newby and Henderson, 
1990 and Angus, 1990, 1989).
Increasing, cumulative concentrations of 5-HT (0.1-1000 / /M) produced only 
small pressor responses in the pulmonary vasculature in Wistar rats. 
However, if only basally-released NO was responsible for suppressing 
pressor responses to 5-HT, then 5-HT-induced responses to low 
concentrations of 5-HT should have been potentiated by L-NAME to a 
greater extent than responses to higher concentrations, because a constant 
basal level of NO would have been a less effective physiological antagonist 
of high concentrations of 5-HT. Instead, L-NAME potentiated responses to 
high concentrations of 5-HT to greater extent, suggesting that 5-HT either 
directly or indirectly increased NO release. In contrast, pressor responses to 
phenylephrine in the pulmonary vasculature were not enhanced to a greater 
extent at high concentrations by L-NAME and so there was less evidence 
that phenylephrine released NO than there was that 5-HT did.
L-NAME has been shown to have some selectivity of action on different 
agonists that act on subtypes of a-adrenoceptors in different species. For
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example, in rabbit pulmonary arteries L-NAME appears to increase the 0 2 - 
adrenoceptor mediated responses but in the rat pulmonary arteries, it 
increases responses to both a y  and 0 2 -adrenoceptor agonists (MacLean et 
al, 1993; Shaw et al, 1992c). There is some evidence that at least part of 
the adrenaline-induced vasorelaxation in vivo in the rat is mediated by 
endogenous NO since L-NAME inhibited the vasodilator response to 
adrenaline (Gardiner et al, 1991a,b). In this study a submaximal (10 //M ) 
and a maximal (100 y M) concentration of adrenaline added to the Krebs- 
buffer used to perfuse the lungs, produced small and poorly-maintained 
pressor responses (Fig-37). L-NAME enhanced the peak pressor response to 
adrenaline but did not affect the secondary depressor component that 
occurred during the pressor response. Whether this ability of L-NAME to 
increase the response to adrenaline indicates that adrenaline releases NO 
directly or indirectly via ^-adrenoceptor activation or merely because of its 
ability to cause vasoconstriction increases shear stress and therefore 
indirectly increases NO release, remains to be determined.
Some of the products of cyclo-oxygenase metabolism including 
prostaglandins, have vasoactive properties which affect pulmonary vascular 
resistance (Aiken, 1984; Wood et al, 1981). In this study, flurbiprofen 
which is a cyclo-oxygenase inhibitor, had no apparent effect on the basal 
perfusion pressure in the pulmonary circulation. Flurbiprofen only enhanced 
responses to KCI (30 mM) when it was perfused in a single perfusion to 
equilibrium in an increasing dose-response curve of KCI (3-80 mM) in the 
pulmonary vasculature of the rat (Fig-45). Flurbiprofen did not affect 
responses to PE (Fig-46) and had little effect on responses to 5-HT in the 
presence of L-NAME (Fig-47) or to NA (0.1-100 /vM) (Fig-48). These results 
indicate that, although flurbiprofen had no effect on the PE-induced pressor 
responses, its slight ability to enhance pressor responses to 5-HT and KCI at
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least at the middle concentration of their respective dose-response curves, 
indicates that vasodilator prostagandins (eg. PGI2 ) may he produced, 
perhaps as a result of shear stress acting on the vascular endothelial cells. It 
was surprising that flurbiprofen had so little effect since, it is known that 
PGI2  is produced and released in the pulmonary vascular bed and may be 
responsible for the low resistance of the pulmonary vasculature to perfusion 
(Pohl et al, 1986a,b; Bhagyalakshmi and Frango, 1989; Nakache, Gaub,
1988).
In pulmonary hypertension there is an augmentation. in the pulmonary 
vascular reactivity and this can be a factor in chronic obstructive lung 
disease (Reeves & Voelkel, 1989). Alterations in the intimai layer is one of 
the first signs of the development of pulmonary vascular disease (Magee et 
al, 1988). In this study, prior exposure of the pulmonary vasculature to KCI 
(40 mM) enhanced pressor responses to 5-HT (10-100 jjM) (Fig-38). This 
increased pulmonary vasculature reactivity could have been caused by the 
ability of KCI to produce powerful contractions of smooth muscle and to 
increase vascular permeability and thus cause oedema, in which vascular 
permeability to intraluminal fluid increases and thus more fluid passes 
through the vascular bed into the pulmonary parenchyma. KCI might 
increase the size of the gaps in the vascular endothelium and damage the 
fragile single layer of vascular endothelial cells, hence interfering with the 
normal production and release of prostacyclin (PGI2 ) that is produced in 
response to increased vascular tone. It is known that endothelial cells 
metabolise arachidonate to PGI2  and PGE2  (Eldor et al, 1983; Ragab- 
Thomas et al, 1987; Resink et al, 1987; Revtyak et al 1988; Whorton, et al, 
1982) as well as to other products. Therefore, if KCI does damage the 
endothelium, there would be less PGI2  released to antagonise, 
physiologically, the pressor responses to 5-HT.
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In order to investigate the effects of drugs in the pulmonary vascular bed, it 
is necessary to have a well-maintained response. Pulmonary blood vessels 
characteristically responded less to vasopressor agents such as PE and 5-HT 
when these pressor agents were perfused cumulatively. To enlarge the 
pressor responses to PE, perfused cumulatively to equilibrium, a mixture of 
L-NAME (400 /vM), propranolol (10 yM)  and yohimbine (1 //M) was used to 
inhibit the production and release of endogenous NO, whose basal release 
may be responsible for the low resistance of the pulmonary vasculature and 
to suppress the pressor responses to vasoconstrictor agents (Archer et al,
1989). This mixture also blocked the ft- and a2 -adrenoceptors so that a 
pure a-] -adrenoceptor-mediated pressor response to PE was obtained (Fig- 
41). The results suggested that the PE-induced pressor responses were 
enhanced in the presence of L-NAME, propranolol and yohimbine but even 
in this situation the pressor responses to PE were much smaller than those 
obtained in the hindquarters vasculature in the absence of these 
antagonists.
Humoral substances such as catecholamines, 5-HT, histamine can affect the 
tone of the pulmonary vasculature. Some of these vasoactive agents 
produce complex effects since they act on different receptors which 
mediate opposing effects. In this study, NA produced two different kinds of 
pressor responses in the perfused pulmonary vasculature of Wistar rats (Fig- 
36). In some experiments the pressor responses to NA were well-maintained 
with a rapid recovery after washing the drug out of the circulation with the 
physiological Krebs-buffer solution. However, in other experiments, NA 
produced a complex response, which consisted of an initial small pressor 
response which was unstable and quickly declined, although not to the 
original baseline. This decline occurred during the period of the NA
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perfusion. Interestingly, in these experiments, when the administration of 
NA was stopped and the NA had been washed out of the system, by 
perfusing with Krebs-buffer solution, the perfusion pressure rose again. The 
decline in the pressor response to NA was due to activation of &- 
adrenoceptors, since propranolol restored the perfusion pressure almost to 
the original level. The increase in perfusion pressure that occurred after NA 
administration could have been due to -adrenoceptor supersensitivity 
and/or ^ 2 -adrenoceptor subsensitivity, as these post-drug increases in 
perfusion pressure were observed mostly at higher concentrations of NA.
The vascular endothelium has been suggested by various groups to 
influence pressor responses to a-adrenoceptor agonists ( Carrier & White, 
1985; Lues & Schumann, 1984; Egleme et al, 1984) and the contribution of 
the endothelial cells may vary in different species and strains. In this study, 
a comparison of the pressor responses obtained to equilibrium 
concentrations of PE (0.01-100 /vM) in the Krebs-buffer perfused pulmonary 
vasculature of Wistar and Sprague Dawley rats (SDR), showed that the 
pressor responses to PE (0.1-1 /vM) in the middle range concentrations of 
the dose-response curve were larger in the Sprague Dawley rats than in the 
Wistar rats (Fig-39). This may indicate, a) larger amount of smooth muscle 
in the medial layer of the vasculature of Sprague Dawley rats so that when 
the a-|-adrenoceptors are activated more tone is generated, b) more a-1- 
adrenoceptors and perhaps higher sensitivity of -adrenoceptors on the 
smooth muscle cells, c) the coupling mechanism between the a-1- 
adrenoceptor and the enzyme phospholipase C may be more efficient and 
hence more Pl-turnover and production of IP3  and DAG occurs, d) higher
O  i
storage of Ca ions in the endoplasmic reticulum and facilitated release of 
this ion in response to IP3  activation and also facilitated influx of C a ^ + ions 
through the voltage sensitive C a ^+ ion channels in the plasma cell
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0 4 -membrane, e) higher sensitivity of the contractile mechanism to Ca ion 
in the vascular smooth muscle cell, f) vascular endothelium may also have a 
modulatory effect by producing and releasing various vasoactive agents 
mainly NO, in response to an increase in the vascular tone and shear stress 
through o-j-adrenoceptor activation by PE. One or more of these 
mechanisms may be responsible for the difference in the response to a 
particular drug in different strains.
The well-known ability of hypoxia to cause vasoconstriction in the 
pulmonary vasculature JStaub, 1985) may involve an endothelium- 
dependent mechanism (Holden & McCall, 1984) and it is thought that 
vasodilator factors produced and released from vascular endothelium have a 
major role (Tesfamariam et al, 1987). Hypoxia was shown to have an 
inhibitory effect on the vascular endothelium-derived relaxing factor in 
bovine pulmonary artery endothelial cells and in rabbit pulmonary arteries 
(Warren et al, 1989; Johns et al, 1989). Hypoxia diverts blood from areas 
where the O2  tension is low to the better ventilated areas, hence it aids in 
the regulation of ventilation-perfusion matching (Dawson, 1984). The 
pulmonary abnormalities that are related to hypoxia, include chronic 
bronchitis, chronic obstructive pulmonary disease, emphysema and cystic 
fibrosis, the hypoxia-induced vasoconstriction may add to the pulmonary 
hypertension (Rubin, 1984) and further aggravate the rise in the blood 
pressure.
Acute and chronic hypoxia have been shown to influence agonist-induced 
contractions. This has been attributed to different sites of action in blood 
vessels, including the endothelium and smooth muscle cells. In the vascular 
endothelium hypoxia modulates the release of vasoactive substances 
(Rakugi et al, 1990) and it may have a direct effect upon vascular smooth
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muscle cells (Murray et al, 1990; Dempsey et al, 1991; Butler et al, 1991). 
The underlying molecular mechanisms may be through the hydrolysis of 
phosphatidylinositol (4,5) bisphosphate [Ptd Ins (4,5) P2 ], the mobilisation 
of both extra- and intracellular C a ^+ ions or the activation of protein kinase 
C (Dempsey et al, 1991; MacLean & Nally, 1992; Jin et al, 1992).
In this study, in the perfused lungs, the pressor responses to NA were 
smaller when 14 % O2  (hypoxia) was used than they were when the normal 
95 % O2  was used. This indicates the necessity of enough O2  to generate 
sufficient energy (ATP) for vascular responses to vasoactive agents. 
Propranolol (10 /j M) still enhanced the pressor responses to NA when 14 % 
O2  was used (Figs-52,53) and suggested that the antagonism of ft- 
adrenoceptors and their suppressor effect on the NA-induced pressor 
response were still possible under a controlled level of hypoxia (14 % O2 L
Cyclic nucleotides including cAMP and cGMP are the main second 
messengers involved in vascular relaxation. Isoprenaline and various other 
ft-adrenoceptor agonists are generally considered to be endothelium- 
independent vasodilators, mediating their effects by activation of adenylate 
cyclase (Kukovetz et al, 1981) and increasing cAMP synthesis in the 
smooth muscle (Furchgott & Martin, 1985; Furchgott & Vanhoutte, 1989). 
In this study, increasing concentrations of isoprenaline (10“^-10 ' 4  M) 
perfused to obtain equilibrium responses and superimposed on the ongoing 
pressor responses to submaximal concentrations of 5-HT, PE and KCI, 
produced inhibitory effects that were dependent on the mechanism of 
action of the pressor agents involved (Figs-54,55,56). The inhibitory effect 
of isoprenaline on the pressor responses to 5-HT and PE, which act through 
Pl-turnover, was powerful enough to cause complete inhibition of these 
vasoconstrictions. However, in the case of KCI, the inhibitory effect of
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isoprenaline was only partial and reduced the peak pressor response to KCI 
by approximately 10 %. These results indicate that isoprenaline can oppose 
the rise in the [Ca^ + ]j resulting from 5-HT- and PE-induced increases in Pl- 
turnover in densely distributed resistance arteries and so there may be some 
blood vessels that are involved to a greater extent than others in responses 
to 5-HT and PE. Isoprenaline may also act on limited parts of the 
vasculature to reduce the vascular resistance in the AV-shunts (or AV 
anastomoses) through ^ 2 -adrenoceptor activation and increased synthesis 
of cAMP. On the other hand, KCI has a widespread depolarising effect and 
so produces large and well-maintained pressor responses, which are only 
partially inhibited by isoprenaline.
L-NAME (400 /yM) did not affect the inhibitory responses to isoprenaline on 
the ongoing pressor response of 5-HT (50 //M) in the pulmonary vasculature 
(Fig-54). These results suggest that, the main inhibitory activity of 
isoprenaline in the pulmonary circulation does not involve endogenous NO 
but is exclusively due to activation of ft-adrenoceptors and increased 
synthesis of cAMP.
SNP was perfused cumulatively to obtain equilibrium inhibitory responses 
that were superimposed on the ongoing pressor responses to submaximal 
concentrations of PE, 5-HT and KCI. SNP produced inhibitory effects which 
were greater when the Pl-mechanism was involved (PE,5-HT) than when 
KCI depolarization caused the contraction (Figs-58,57,59). The inhibitory 
effects of SNP on both PE and KCI were small and partial. However, SNP 
produced a more marked inhibitory effect in the presence of L-NAME. This 
was a surprising observation and suggests that normally, in the absence of 
L-NAME, NO is produced, so that when the SNP is added to the perfusing 
solution, the inhibition produced by the NO that is derived from SNP has an
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effect that is additive with that of the endogenous NO. In effect, the 
endogenous NO is probably already exerting an inhibitory effect on the 
pressor response and so to the extent that this is happening, there is less 
opportunity for the exogenous NO, derived from SNP to have an inhibitory 
effect. The administration of L-NAME would inhibit the synthesis of 
endogenous NO but would not affect the release of NO from SNP and so 
with the loss of the inhibition derived from endogenous NO, there would be 
more opportunity for the exogenous NO, released from the SNP to produce 
an inhibitory effect. The inhibitory action of SNP would apparently be 
enhanced but this would only be because now the full range of the 
inhibitory dose-response curve for NO was available rather than only part of 
it, as was the case prior to the administration of L-NAME.
PERFUSED HINDQUARTERS PREPARATION
Blood vessels have the ability to maintain a residual vascular tone which is 
known as basal vascular tone. This occurs even in the absence of 
neurogenic, metabolic and hormonal influences. Two major physical forces 
including the fluid shear stress, resulting from the flow of blood, and the 
distending transmural pressure influence the vascular basal tone. The fluid- 
induced shear stress only acts on the vascular endothelial layer whereas an 
increase in the transmural pressure is balanced by viscoelastic forces of the 
vascular medial and adventitial layers. An increase in the shear stress may 
be the underlying reason for the flow-induced endothelium-dependent 
vasodilatation (Davies, 1989; Griffith et al, 1988) which is needed for 
adequate blood supply to the tissues.
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Flow-induced endothelium-dependent vasodilatation was first recognised in 
conduit arteries (Smiesko et al, 1985; Pohl et al, 1986b; Melkumyants et al,
1987), and since then has also been observed in resistance arteries (Griffith 
et al, 1987; Koller & Kaley, 1990a). This endothelium-dependent dilatation 
is mainly mediated by EDRF (Hutcheson & Griffith, 1991), which is NO 
(Palmer et al, 1987) and additionally in some vascular regions by PGI2  (Pohl 
et al, 1986a; Koller & Kaley, 1990b).
The hindquarters of the rat is a sensitive preparation for investigating the 
effects of vasoactive agents (Folkow et al, 1970; Ostman, 1975 and 
Cooper and Wylie, 1979). This preparation is easy to set up and takes only 
a short time to dissect so there will be less damage due to hypoxia and 
ischaemia, in the vascular tissue as well as in the other surrounding tissues 
that are involved. This preparation has all the blood vessels including 
arterioles, capillaries and venules and is part of the systemic vascular 
system. The physiological effect of 5-HT and endogenous NO which 
mediates vascular relaxation (Moncada et al, 1987) and modulates agonist- 
induced contractile responses of the vasculature (Miller et al, 1988) were 
also examined in this preparation.
The effects of perfusing increasing cumulative concentrations of 5-HT (0.1- 
100 uM), PE (0.1-100 uM) and KCI (3-300 mM) were examined and found 
to produce well-maintained dose-related pressor responses in all three 
strains of rats hindquarters (Wistar, SHR, WKY). The maximal pressor 
response to equilibrium-perfused, cumulative concentrations of KCI, was 
approximately the same as they were for 5-HT and PE in Wistar rats.
In hypertension, the resistance of the peripheral vasculature is increased. 
The underlying reason may be due to an augmentation of the arterial
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contractility. The vascular cellular C a ^+ ion uptake and/or content may be 
increased in essential hypertension. In particular, an abnormality in the
O I
Ca'1"r handling of arterial smooth muscle has been identified in 
spontaneously hypertensive rats (SHR) (Bohr & Webb, 1988; Postnov & 
Orlov, 1985: Lau & Eby, 1985). Since the vascular contractile-mechanism is 
activated by a rise in the free cellular C a ^+ ion content, a change in the 
cellular C a ^+ ion uptake and/or content may be a likely cause for some of 
the abnormal functions associated with hypertension, such as an increased 
incidence of myogenic tone, hyper-reactivity to vasoconstrictors and 
decreased relaxation to vasodilators.
Arteries from SHR exhibit a spontaneous active tone ( Asano et al, 1986; 
Winquist & Bohr, 1983; Fitzpatrick & Szentivanyi, 1980; Noon et al, 1978). 
This spontaneous active tone is independent of regional innervation and 
circulating hormones and is known as myogenic. The myogenic tone is 
abolished by the removal of external C a ^+ ions (Winquist & Bohr, 1983; 
Fitzpatrick & Szentivanyi, 1980; Noon et al, 1978) and by C a ^+ ion 
channel blockers (Asano et al, 1986), indicating that the influx of Ca^ + 
ions to the vascular smooth muscle cell is required for myogenic tone.
In this study, there was no significant difference between the pressor 
responses to 5-HT, PE and KCI that were obtained in SHR and WKY control 
hindquarters vasculature (Fig-69). However, the peak pressor response 
produced by the maximal concentration of KCI was larger than either the 
peak pressor response to 5-HT or to PE in WKY control rats, whereas the 
peak pressor response to KCI was only larger than the peak response to PE 
in SHR hindquarters vasculature (Fig-71). Therefore, KCI was still capable of 
producing its potent vasoconstrictor activity in both SHR and WKY control
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rats, although there are some functional and structural differences in the 
blood vessels of these two different strains of rats.
It is well established that 5-HT can cause endothelium-dependent relaxation 
in a variety of preparations, by acting on a receptor which resembles a 5- 
HT-j-like receptor (Angus & Cocks, 1989). Much evidence suggests that 
endothelium-dependent relaxation to 5-HT is not through a specific subtype 
of 5-HT receptors but occurs via a heterogenous receptor group. In porcine 
coronary artery (Schoeffter & Hoyer, 1989; 1990), the endothelial receptor 
shows characteristics, close to the 5-HT*i d  receptors in both rabbit 
saphenous vein (Martin et al, 1991) and guinea pig frontal cortex 
(Middlemiss et al, 1988). In contrast, endothelial 5-HT receptors in both 
rabbit jugular vein (Leff et al, 1987) and porcine vena cava (Sumner, 1991) 
show similar characteristics but do not appear to relate to the subtypes of 
5-HT receptor currently recognised.
In this study, increasing cumulative concentrations of 5-HT perfused to 
equilibrium and superimposed on a submaximal, PE-induced pressor 
response, showed additive pressor effects (Fig-63). The objective of this 
experiment was to find out if it was possible to obtain a vasodilatation to 5- 
HT when the hindquarters vascular tone was already raised with PE. 
However, there was no evidence that 5-HT could relax the PE-induced 
pressor response at any dose in the Wistar hindquarters vascular bed. This 
observation, indicates that vascular 5-HT receptors are predominantly 
excitatory, causing vasoconstriction in the hindquarters vasculature. The 
final vasodilator component of the 5-HT-induced response in anaesthetized 
rats could be partly mediated through inhibitory 5-HT receptors in the CNS 
and particularly in the peripheral nervous system.
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It is known that in vascular endothelial cells, an increase in the [Ca ] j 
produced by agonists such as ATP, bradykinin and 5-HT, causes the 
production and release of NO and PGI2  (Newby & Henderson, 1990). This 
mechanisms involves activation of specific receptors on the vascular 
endothelial cells, leading to stimulation of the phosphoinositol pathway. It is 
maintained by an influx of extracellular C a ^+ ions, presumably through cell 
surface non-selective cation channels (Hallam et al, 1989; Olesen et al,
1988).
In this study, 5-HT produced larger pressor responses in the hindquarters 
than in the pulmonary circulation. L-NAME produced a small, prolonged 
increase in the basal perfusion pressure in the Krebs-buffer perfused 
hindquarters, suggesting that a small basal release of endogenous NO 
occurs in this vascular bed. Neither L-NAME nor indomethacin had any 
effect on the responses to cumulative concentrations of 5-HT in Krebs- 
buffer perfused hindquarters vasculature. It is notable that the 5-HT-induced 
response after administration of L-NAME and indomethacin was apparently 
enhanced. However, when comparison was made with the corresponding 
time control, there was no significant difference in the responses, 
suggesting that endogenous NO and vasodilator prostaglandins were not 
produced in the hindquarters vasculature or had only a slight effect. This 
suggests that these endogenous vasodilators are less important in the 
hindquarters than they are in the lungs, where they may contribute to the 
low pressure system. This might explain the difference between the high 
resistance blood vessels in the hindquarters vascular bed and low resistance 
blood vessels in the pulmonary vascular bed. Unlike NO formation, PGI2  
biosynthesis depends on the release of C a ^+ ions from intracellular stores 
(Luckhoff et al, 1988; White & Martin, 1989). However, shear stress may 
activate a set of non-selective C a ^+ stores (Schwarz et al, 1992). As a
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consequence, shear stress may elevate endothelial [Ca^ + ]j and hence 
stimulate NO and PGI2  biosynthesis.
Increasing concentrations of SNP were perfused to equilibrium and the 
effects of SNP were superimposed on responses to submaximal 
concentrations of the pressor agents, PE, 5-HT and KCI. SNP was effective 
in inhibiting these pressor responses and was particularly effective in 
opposing the pressor responses to PE and 5-HT, which act on receptors 
that operate the Pl-mechanism. In contrast, SNP was less effective in 
inhibiting responses to KCI, which acts by depolarising vascular smooth 
muscle. The difference between the ease with which SNP inhibits Pl- 
mediated constriction, produced by PE or 5-HT, and its poorer ability to 
inhibit KCI-induced constriction, may reflect the fact that the receptors for 
PE and 5-HT are not uniformly distributed throughout the vasculature but 
are located mainly in some blood vessels, such as resistance arteries, 
whereas KCI exerts its depolarizing action on all blood vessels.
The presence of functional vascular endothelial cells has been demonstrated 
to suppress the contractile actions mediated through o-adrenoceptor 
agonists in rat isolated aortic rings (Allan et al, 1983; Egleme et al, 1984; 
Lues & Schumann, 1984; Carrier & White, 1985); an action attributed to 
the production and release of endogenous NO and its subsequent opposing 
effect on the pressor responses evoked by o-adrenoceptor agonists. The 
role of vascular endothelium in influencing the binding of subtype-specific 
adrenoceptor radioligands to vascular 0 -]- and 0 2 -adrenoceptor sites was 
described by Carman-Krzan (1985). It was reported that the density of the 
a<\ -adrenoceptors would be increased by removal of the vascular endothelial 
cells, w ith little effect on the affinity of the agonist for the receptors.
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Carman-Krzan (1985) suggested that the loss of vascular endothelium might 
have uncovered previously undetectable receptor sites.
This study compared the vasodilator potency of SNP (exogenous NO) on 
PE-induced increases in the systemic vascular tone in three different strains 
of rats (ie. Wistar, SHR and WKY). EC7 0  concentrations of PE were 
perfused in all three of them and SNP was perfused in increasing doses and 
its effect was superimposed on a PE-induced pressor response. An EC7 0  
concentration of PE (10 jjM) induced a bigger pressor response in Wistar 
hindquarters (ie. approximately about 2.5 times bigger) than in SHR and 
WKY hindquarters. The sizes of PE-induced pressor responses were almost 
the same in the latter two strains.
In general, the hindquarters vasculature, which is part of the systemic 
vasculature, has been found to be very useful for studying the effect of 
vasoactive agents (Folkow et al, 1970; Ostman, 1975 and Cooper and 
Wylie, 1979) including vasoconstrictors such as 5-HT, PE and KCI and 
vasodilators such as carbachol and SNP. The responses obtained to these 
vasoactive agents were much larger than those obtained in the pulmonary 
vasculature. Some of the reasons why this preparation responds well to the 
vasopressor substances include: there may be larger amounts of structural 
smooth muscle in the vasculature, lower production and release of 
endogenous vasodilators such as NO and PGI2 , fewer collateral blood 
vessels in the hindquarters and less inactivation of vasopressor agents, 
including 5-HT, in the hindquarters vasculature.
5-HT may release vasodilator substances such as NO and PGI2  through an 
increase in the [Ca^ + ]j in the vascular endothelial cells (Newby & 
Henderson, 1990). In this study, L-NAME apparently potentiated the pressor
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responses to 5-HT, but when comparisons was made with appropriate time 
controls, which had not received L-NAME, there was no enhancement of 
the pressor responses to 5-HT. Indomethacin, which inhibits 
cyclooxygenase had no effect on the pressor responses to 5-HT. SNP which 
is a source of exogenous NO, produced large inhibitions when it was added 
to the Krebs-buffer, containing submaximal concentrations of either 5-HT, 
PE or KCI. This may indicate that in the hindquarters vasculature, the 
production and release of endogenous NO is insufficient to inhibit pressor 
responses to vasoconstrictor agents. There was also no difference between 
the inhibitory effects produced by increasing concentrations of SNP when it 
was perfused on the ongoing pressor response to a submaximal
concentration of PE (SHR and WKY rats).
Carbachol inhibited NA-induced vasoconstriction, via a mechanism which is 
dependent on the release of endogenous NO, but independent of the release 
of PGs in the mesenteric arterial bed of the rat (Randall & Hiley, 1988). The 
results obtained with carbachol in this study were complex. When carbachol 
was added to the Krebs-buffer, which contained a submaximal 
concentration of PE and was used to perfuse the vasculature of the 
hindquarters of SHR and WKY rats, it produced an initial pressor response, 
followed by a depressor response. These results suggest that different
cholinoceptors may be activated during administration of increasing
concentrations of carbachol. However, it appears that the effects of
carbachol are not the same in hindquarters from SHR and from WKY rats.
The results obtained in this study indicate that endogenous vasodilators, 
such as NO and prostacyclin are produced and released in the hindquarters 
vasculature but to a lesser extent than in the lungs, in which the abundance
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of NO in particular may be important in the maintaining the low resistance 
to perfusion that is characteristic of this vascular bed.
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